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Abstract 
 
Background: Fruits and vegetables may counteract the development of colorectal 
cancer by stimulating the production of detoxification enzymes. Interindividual 
genetic variation in detoxification enzymes, especially in regulatory regions 
responsive to fruit and vegetable components, may influence this effect. Two types 
of detoxification enzymes, that are known to be inducible and polymorphic, are the 
glutathione S-transferases (GSTs) and NAD(P)H:quinone oxidoreductase (NQO1).  
Aim and methods: The aim of the present research was to evaluate fruit and 
vegetable intake and polymorphisms in the GSTA1, GSTP1 and NQO1 genes in 
relation to 1) the expression and enzymatic activity (enzyme phenotype) of GSTA1, 
GSTP1 and NQO1 and 2) the occurrence of colorectal adenomas. Polymorphisms 
were determined by PCR-RFLP or pyrosequencing. GST and NQO1 enzyme 
phenotypes were measured in rectal biopsies and white blood cells among 90 
endoscopy-based subjects and their fruit and vegetable intake was assessed by 
food record. Colorectal adenoma risk was estimated from a population of 750 
adenoma cases and 700 endoscopy-based controls and their fruit and vegetable 
consumption was measured by food frequency questionnaire.   
Results: Overall, GST or NQO1 activity was not increased by fruit and 
vegetable intake. Rectal GST isoenzyme levels did appear to differ between those 
who had and had not consumed certain fruit and vegetable subtypes. GST and 
NQO1 activity was most strongly influenced by the GSTP1 313G>A and NQO1 
609C>T polymorphisms, respectively. There was no or only low correlation 
between rectal and white blood cell activities. The combination of the low activity 
GSTP1 or low expression GSTA1 genotypes and higher than median cruciferous 
vegetable intake resulted in a higher colorectal adenoma risk (OR 1.76, 95%CI 1.16-
2.69). Also, the combination of the low activity NQO1 genotype and smoking 
resulted in a higher colorectal adenoma risk (OR 1.96, 95%CI 1.40-2.76).  In 
addition, polymorphism combinations of NQO1 and transcription factor NFE2L2 
increased adenoma risk. 
Conclusions: Fruits and vegetables do not seem to confer protection against 
colorectal adenomas through the GST and NQO1 detoxification systems. Common 
genetic variants in regulatory regions of GSTA1, GSTP1 or NQO1, responsive to 
fruits and vegetables, may not exist. In combination with dietary, other lifestyle or 
other genetic factors, common genetic variants in the GSTA1, GSTP1 or NQO1 
detoxification genes, resulting in lower enzyme expression or activity, may be 
associated with higher adenoma risk. Currently, however, this does not justify the 
tailoring of fruit and vegetable advice based on genotypes. 
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PROBLEM DEFINITION 
Colorectal cancer is one of the most common cancers in the Netherlands, 
accounting for 13-14% of new cancer cases (i.e ~10.000 individuals) in 2003, 
affecting men and women almost equally1. Five-year survival is ~50%, varying 
greatly depending on tumor stage1. Incidence rates vary ~25-fold around the 
world, with the highest rates in the developed world2. Cancer is a disease 
originating in the DNA. Most colorectal cancer-causing mutations are somatic3. 
Unfavourable lifestyle factors create the environment in which these mutations 
have a higher chance of occurring and colorectal cancer is thus potentially 
avoidable4, 5. One protective factor, of inconsistent magnitude, is a high 
consumption of fruits and vegetables6, 7. One proposed mechanism is that fruit and 
vegetable constituents stimulate the production of beneficial detoxification 
enzymes8. These enzymes act on carcinogens and facilitate their detoxification and 
excretion out of the body. As a consequence, DNA damage leading to tumor 
formation is prevented. However, these enzymes are subject to genetic variation 
affecting their levels or activity and possibly also causing individuals to respond 
differently to fruits and vegetables. This hereditary component of low-penetrant 
disease prevention may obscure epidemiological associations between fruit and 
vegetable consumption and cancer.  
This thesis describes the results of two human observational studies 
investigating colorectal adenomas and rectal enzyme levels and activities (enzyme 
phenotype) in relation to fruit and vegetable consumption and genetic variation 
(genotype) in two types of biotransformation enzymes: GSTs and NQO1. The 
present chapter describes, narrowing in on potential mechanisms and using mostly 
results from studies in humans, the relevant existing knowledge, its gaps and the 
rationale for the present studies. It ends with the research questions and the thesis 
outline. 
  
 
 
 
 
Chapter 1 
 
 
 
 
Introduction 
 
   
 
 
 
 
 
10 Chapter 1 
 
FRUITS, VEGETABLES AND COLORECTAL TUMORS  
Epidemiology. High consumption of fruits and vegetables has been reported to 
protect against colorectal cancer6, 9. Special attention as possible cancer-protective 
components of the human diet has been given to citrus fruits, green leafy 
vegetables, allium vegetables and especially cruciferous vegetables10, 11. A 
convincing protective effect is supported by most case-control studies, but less so 
by more recent prospective cohort studies6, 7, 12, 13, conferring uncertainty to the 
degree of risk reduction by consumption of fruits and vegetables. Design-related 
reasons for the inconsistencies include recall bias or actual change in dietary habits 
due to disease state in case-control studies14. Time-related issues may be found in 
content of protective components due to use of fertilizer, pesticides and continued 
genetic selection on plant yield15-17. More general reasons for the non-significance 
of a protective effect are random measurement errors in food frequency 
questionnaires (FFQs)14, 18 with consequent inability to detect differences, 
variability of exposure due to differences in plant cultivars, industrial handling or 
cooking methods19-21 22 and variability of human metabolism, which may all 
attenuate a true relative risk and lead to an obscured association.  
A number of studies have investigated colorectal adenomas as the endpoint in 
relation to fruit and vegetable consumption. Adenomas are the proposed 
intermediates in the multistage process of colorectal carcinogenesis7, 23, interesting 
from a viewpoint of primary and secondary prevention24, relatively close in time to 
relevant lifestyle exposure and relatively abundant25. This abundance increases the 
practical and financial feasibility of adenoma studies, but limits their specificity: an 
estimated 85% of adenomas do not progress to carcinomas26. Adenoma case-
control studies are thought to suffer less from recall-bias than cancer case-control 
studies, because adenomas are relatively asymptomatic. The association between 
fruit and vegetable consumption and colorectal adenomas has mostly been 
investigated in case-control design27-37. Most studies report inverse associations, 
which are significant for consumption of total vegetables29-31, 33 and/or total fruits28, 
31, 32 and fruit juice34. Two cohort studies, the Health Professionals’ Follow-up 
Study36 and the Nurses’ Health Study37, report a decreased adenoma risk with 
frequent fruit but not vegetable consumption.  
Potential mechanisms. The fact that recent epidemiological studies find only 
weak protective or null associations does not exclude the possibility that specific 
fruit and vegetable constituents have anticancer properties. A number of fruit and 
vegetable constituents have been postulated as causative protective factors. Fruits 
and vegetables are rich in fiber and contain vitamins and a large variety of 
bioactive secondary metabolites, so-called phytochemicals38-40. These plant 
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components help plants to respond to wounding, pathogens and pests, and a 
changing environment and trigger a range of effects in their consumers. 
Phytochemicals can be divided into several families: polyphenolics (among which 
are the flavonoids), terpenes (among which are the carotenoids), sulfides (among 
which are the isothiocyanates and allylsulfides) and saponins41. Some of the 
bioactive compounds are more universally present, e.g. the carotenoids in yellow 
to red coloured plants and chlorophyll in green plants. Some are more typical to 
certain fruit and vegetable botanical subtypes, e.g. allylsulfides to allium 
vegetables and glucosinolates to cruciferous vegetables which, in themselves 
biologically relatively inert, can be hydrolysed by the cruciferous plant enzyme 
myrosinase to cancer-protective active components such as isothiocyanates and 
indoles42. As a surrogate measure for the intake of these specific phytochemicals, 
fruits and vegetables can be grouped and evaluated botanically43.  
It is likely that the concerted action of the bioactive compounds, and not just a 
few so-called “magic bullets”, are important in human anti-cancer mechanisms44. It 
is not known how many of the proposed mechanisms38, 39 are actually relevant for 
human cancer. Anti-carcinogenic phytochemicals are proposed to inhibit various 
stages of cancer, which can be broadly divided in actions blocking tumor initiation 
and those suppressing malignant cell transformation39, 45. They are thought to affect 
carcinogen activation and detoxification, DNA repair, cell-cycle progression, 
differentiation and apoptosis, expression and functional activation of oncogenes or 
tumor-suppressor genes, angiogenesis and metastasis, and hormonal and growth-
factor activity46-48. The first mechanism, carcinogen activation and detoxification, 
involves the biotransformation enzyme system, i.e. the handling of foreign 
compounds (xenobiotics) in the body. It is the first line of defence against cancer-
initiating compounds, in which individuals appear to vary substantially. 
Narrowing in on this biochemical mechanism and the genes involved, in human 
context and with specific endpoints, may provide us with observations concerning 
the possible anticancer properties of fruits and vegetables that cannot be obtained 
when solely studying the association between fruits and vegetables and cancer.  
 
In conclusion: A diet high in fruits and vegetables may be beneficial for human colorectal 
cancer prevention, though recent epidemiological studies do not convincingly support this. 
This may be related to the difficulty of a valid and reproducible assessment of fruit and 
vegetable intake and their possible bioactive constituents. Also, individual (genetic) aspects 
of xenobiotic metabolism may play a role. 
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FRUITS, VEGETABLES AND DETOXIFICATION 
Biotransformation enzymes. These enzymes render xenobiotics more hydrophilic 
in order to facilitate their excretion from the body or make them less reactive, as 
part of an adaptive response to electrophilic carcinogens and oxidative stress49. 
Two types of reactions are usually distinguished: functional group modification by 
oxidation, reduction or hydrolysis reactions (referred to as phase I, most 
importantly represented by the cytochrome P450’s), which often result in a more 
reactive product; and conjugation reactions with endogenous ligands such as 
glutathione, glucuronic acid and sulfate (phase II), which essentially detoxifies the 
xenobiotic and facilitates excretion. Phytochemicals such as isothiocyanates and 
allyl sulfides are capable of upregulating detoxification gene transcription thus 
causing higher levels of these detoxification enzymes, a process known as 
induction40, 50. In the field of cancer biochemoprevention, compounds are sought 
that selectively inhibit phase I enzymes and/or that selectively induce phase II 
enzymes, so-called monofunctional induction, i.e. to specifically increase 
detoxification.  
Gene regulation. Induction, and gene regulation in general, is complex. A 
gene consists of two functional parts: a DNA sequence that holds the information 
about the protein that is produced (coding region) and a physically linked 
upstream region where the general transcription factors assemble to start 
transcription, referred to as the promoter51. The transcription initiation site can 
typically be found at ~25 nucleotide pairs downstream from the so-called TATA 
box51. In some genes, such as heme oxygenase, γ-glutanyl cysteine synthase, 
NAD(P)H:quinone oxidoreductase (NQO1) and glutathione S-transferase (GST) 
P1, phytochemicals interact with a specific DNA enhancer sequence in the 
promoter region, the so-called anti-oxidant or electrophile-responsive element 
(ARE/EpRE)52, 53. Gene expression is controlled through transcription factors, 
proteins that bind DNA at regulatory regions. In the regulation of EpRE mediated 
gene expression, transcription factor NFE2L2 (official human nomenclature for the 
more commonly known Nrf2) has a central role54-56. NFE2L2 is anchored in the 
cytoplasm by a protein named Kelch-like ECH-associated protein 1 (KEAP1)57. 
Inducers disrupt the NFE2L2-KEAP1 complex, resulting in higher levels of free 
NFE2L2 and its translocation to the nucleus where it binds the EpRE as a 
heterodimeric complex with other transcriptional regulators39, 57, 58. The EpRE is 
responsive to a wide range of structurally diverse phytochemicals and other 
compounds57, is both anciently conserved and species specific59, 60 and many of the 
proteins whose expression is mediated by the EpRE have an endogenous role in 
cellular redox status61. Regulatory sequences are found not only in the near 
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vicinity of the promoter area, but can also be thousands of nucleotide pairs away 
from the promoter, upstream or downstream, and form loops towards the 
promoter DNA to allow interaction of the bound transcription factors with the 
basal transcription complex on the promoter to modulate the transcription level51. 
Many DNA sequences that serve as recognition sites for the binding of specific 
gene regulatory proteins have been identified in biotransformation genes. 
Examples are the Sp1 and AP-1 regulatory protein-binding sites62. Gene regulatory 
proteins can act as activators or suppressors. The combination of the promoter and 
all the regulatory sequences has been referred to as the “gene control region”51. 
Thus, for induction by fruits and vegetables, the EpRE is important, but other 
regions can be relevant as well. Two interesting biotransformation systems in this 
respect are the GSTs and NQO1. 
 
In conclusion: Some fruit and vegetable components, so-called phytochemicals, are thought 
to induce biotransformation enzymes via regulatory DNA sequences such as the 
electrophile responsive element (EpRE), enabling the body to respond to genotoxic 
carcinogens and oxidative stress. 
 
 GSTS, NQO1 AND INDUCTION BY FRUITS AND VEGETABLES 
Two important types of phase II biotransformation enzymes that are inducible by 
fruit and vegetable components and contain EpRE’s are the GSTs and NQO1. Their 
upregulation could benefit the colorectum because they metabolize relevant 
environmental carcinogens. They show differences in tissue distribution and 
considerable interindividual variation. GSTs are expressed at relatively low levels 
in the colorectal area as compared to other parts of the digestive system63. NQO1 is 
expressed ubiquitously in all the tissues, with relatively high levels in colon53. 
The GSTs have been extensively reviewed64, 65. GSTs catalyze the conjugation 
of xenobiotics with glutathione. They are sensitive to many different compounds65. 
The GST superfamily consists of soluble cytoplasmic (often termed “cytosolic” 
because they end up in the cytosolic fraction upon isolation), mitochondrial and 
membrane-bound (often termed “microsomal”) GSTs. The “cytosolic”  superfamily 
has been divided in 7 classes, arbitrarily based on sequence similarity, which in 
general share broad overlap in substrate specificity66 and of which GSTA, GSTM, 
GSTT and GSTP are the most well-known. GST expression decreases from the 
upper to the lower digestive tract, where it makes up less than 0.2% of cytosolic 
proteins63.  
Total GST activity has been found to be increased in plasma and saliva after 
cruciferous vegetable consumption67-69; It was increased in colon tissue and 
14 Chapter 1 
 
peripheral mononuclear cells after a single dose of the synthetic dithiolethione 
Oltipraz70, although not after chronic dosing or after broccoli supplements71; and 
an observational study noted a positive association with cruciferous vegetables 
and citrus fruits in colon tissue72. Intervention with green tea catechins (a group of 
flavonoids) resulted in a higher lymphocyte total GST activity among individuals 
with lower baseline GST activity, yet in lower lymphocyte total GST activity 
among those with higher baseline GST activity73. 
GSTA is the most abundant GST in the liver74. Within the digestive tract, it is 
highly expressed in duodenum and small intestine, but lowly in stomach and 
colon75. Among others, GSTA is capable of metabolizing polycyclic aromatic 
hydrocarbon (PAH) diolepoxides, found in cigarette smoke and grilled and 
smoked meats76, 77 and it is the most sensitive GST in metabolizing the carcinogenic 
heterocyclic amine (HCA) N-acetoxy-PhIP, the most mass abundant HCA in meats 
cooked at high temperature76, 78. GSTA has been shown to inhibit the binding of N-
acetoxy-PhIP to DNA efficiently76, 79.  
GSTA levels have been noted to be inducible by cruciferous vegetables in 
human intervention studies in rectum80. Upregulation was also seen in plasma, 
which is thought to reflect normal hepatic expression through normal hepatocyte 
turnover81, among males82, 83 and a genetic subgroup in females84. These notions are 
supported by studies in different human (cancer) cell lines reporting increased 
transcription with the isothiocyanate sulphoraphane: HT29 and Caco-2 (colonic 
adenocarcinoma), HepG2 (hepatoma), and several prostate cancer lines85-87. In 
human hepatocytes, 1,2-dithiole-3-thione and its 5-(2-pyrazinyl)-4-methyl 
derivative, oltipraz increased GSTA transcription (but not GSTP1 transcription)88. 
In an observational study of the upper gastrointestinal tract, high intake of 
vegetables was associated with higher duodenal GSTA89. However, an EpRE has 
not been identified in the regulatory region of the genes encoding human GSTA90 
and the nucleotide elements responsible for induction are not known. In contrast, 
an intervention study with green tea catechins noted a lower plasma GSTA level 
among those with higher baseline levels73.  
GSTP1 is the most abundant GST in the colorectum80.  It metabolizes, among 
others, PAH diolepoxides, HCAs and nitroso-compounds91. It has been shown to 
moderately inhibit the binding of N-acetoxy-PhIP to DNA76, 79 and to inhibit its 
enzymatic activation in a human prostate adenocarcinoma cell line92. GSTP1 is 
overexpressed in the majority of human tumors, among which colon tumors64, 93.  
Intervention studies have noted upregulation of GSTP1 with Brassica 
vegetables in rectum80 and in plasma68, 69 and with green tea catechins in 
lymphocytes among individuals with lowest baseline level tertile73, yet found 
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downregulation in lymphocytes after mixed vegetables94. In an observational 
study, downregulation in rectum with habitual Allium consumption was seen72. In 
another observational study, high intake of vegetables was associated with higher 
GSTP189.  
GSTM1 and GSTT1 have gained the most research attention so far, not so 
much from the perspective of induction by fruit and vegetable components, but 
from the perspective of the clear individual variation in their expression, which 
will be explained under the next heading. GSTT1 is highly expressed in the 
colorectum95 whereas GSTM1 is not80. In this thesis, the main focus of attention is 
on GSTA1 and GSTP1. 
NQO1. Quinones are aromatic compounds widely present endogenously and 
in our environment: as components of plants and exhaust fuels or used in dyes, 
photography and chemotherapy96, 97. If reduced by one electron, the reactive 
intermediate might give rise to the formation of reactive oxygen species, and DNA 
and protein adducts98. Thus it is thought that in evolution there has been strong 
selection for the development of enzymes that catalyze the two-electron reduction 
of quinones. NQO1 hydrolyses quinones to hydroquinones99. There is debate 
whether NQO1 should be termed a phase I or phase II biotransformation 
enzyme100. Arguments in favour of phase II are that NQO1 does not introduce new 
functional groups, it is often induced co-ordinately with other phase II enzymes 
and it exerts protective functions101. However, besides its detoxifying function it 
can also bioactivate102. Confusingly, in the (older) literature, NQO1 has also been 
referred to as “DT-diaphorase”97. The use of ‘diaphorase’ to denote a ‘coenzyme’ 
was widespread in earlier enzymatic studies and ‘DT’ refers to DPNH (NADH) 
and TPNH (NADPH) because the enzyme works well with both.   
In human intervention studies, NQO1 activity increased in saliva after broccoli 
consumption67. NQO1 mRNA increased in peripheral mononuclear cells and 
colonic biopsies after single administration of the synthetic dithiolethione 
Oltipraz70, but not after chronic dosing103. In cell studies, indoles and 
isothiocyanates increased NQO1 protein in colon cancer cells LS-174104; Synthetic 
dithiolethione 1,2-dithiole-3-thione (D3T) increased NQO1 activity in mitogenized 
human lymphocytes101 and several human tumor cell lines105; Garlic organosulfur 
compounds enhanced NQO1 gene expression in HepG2 cells106; β-Carotenes 
(retinol and retinoic acid but not lycopene), α-tocopherol and ascorbic acid 
induced NQO1 (but not GST) activity in human colon cancer cells, colo205107; And 
several compounds, among which isothiocyanates, catechol, epigallocatechin 
gallate (EGCG), quercetin and curcumin, induced NQO1 in a human prostate 
cancer cell line, LNCaP; and human hepatoblastoma cell line, HepG286, 108. 
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In conclusion: The biotransformation enzymes GSTP1, GSTA1 and NQO1 are interesting 
in light of colorectal cancer risk modification by fruit and vegetable consumption because 
they are known to be under transcriptional control of an EpRE (NQO1, GSTP1) or are 
otherwise inducible (GSTA1) by plant components, such as isothiocyanates, flavonoids, 
carotenoids, sulfides and phenols. The inducibility of human GST levels by consumption of 
fruits and vegetables, such as cruciferous vegetables, has been shown in vivo. However, 
results are inconsistent or only one GST isoenzyme or fruit and vegetable subtype was 
studied, most often in blood. For NQO1 there are little in vivo data in humans. 
 
GENETIC POLYMORPHISMS IN GSTS AND NQO1 
The first draft of the human DNA sequence was published in 200109-111, the greatly 
anticipated result of the Human Genome Project112. The HGP is the largest and 
most ambitious research project in the history of biology, started officially in 1988, 
with the aim to obtain a detailed map and complete DNA sequence of the human 
genome. The working draft of the euchromatic sequence was reported in 2001110, 113 
and in 2004 a major improvent of this working draft was published111. The gene 
count, once estimated to be 100.000, was corrected to 20-25.000. Though human 
DNA is the same between individuals for > 99.9% of the 3 billion base pairs, 
interindividual sequence variation exists throughout the genome, such as 
deletions, copy number variants, variable tandem repeats and, most common, 
single nucleotide differences called single nucleotide polymorphisms (SNPs). 
Another large project, the HAPMAP project114, has been devoted to compare the 
genetic sequences of different individuals to identify chromosomal regions where 
genetic variants are shared. SNPs have been estimated to occur on 10 million 
locations114, but this can be reduced to approximately 250.000 haplotype bins in 
Caucasians115, 116. Most SNPs are non-functional on a molecular level, i.e. a 
nucleotide difference does not lead to an amino acid change or occurs in a 
sequence without regulatory consequences. In some cases, they are functional on a 
molecular level, i.e. the level or activity of a gene product is changed, with possible 
consequences for susceptibility to disease. Unlike rare hereditary mutations in key 
genes such as APC or mismatch repair genes, with a penetrance of 80 – 100%3, 
genetic differences in detoxification genes do not so much affect the risk of cancer 
per se, but are associated with a modified risk in relation to exposure to a potential 
carcinogen or cancer chemoprotectant117.  
GSTA1 polymorphisms. The GSTA genes are clustered on chromosome 6p12 
and consist of 5 genes: GSTA1 – A5 and 7 pseudogenes90. The GSTA protein 
consists of homo- and heterodimers of the proteins encoded by the GSTA1 and 
GSTA2 genes. The GSTA1 subunit is the most prevalent subunit in liver and most 
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other tissues74, 81, but in the colon they are approximately equally low75. A lot less is 
known about GSTA3 and GSTA4 and the GSTA5 gene may not be expressed at 
all90. GSTA1 consists of 7 exons, spanning ~12kb and encoding a total of 222 amino 
acids. A number of SNPs have been reported in the GSTA1 gene118-120, the most 
important to date being the haplotype consisting of 3 linked base substitutions in 
the proximal promoter: -567T>G, -69C>T, and -52G>A resulting in a ~4-fold lower 
expression in human liver samples (but not in pancreas)119. It has been referred to 
as GSTA1*A and GSTA1*B, has mostly been genotyped at position -69 and has an 
allele frequency of ~40% in Caucasians90. Its functionality has been shown in 
luciferase reporter constructs and has been attributed to the -52G>A SNP causing 
alteration of the binding of transcription factor Sp1119, 121. Compared to 
homozygous wild-type and heterozygous individuals, individuals carrying two 
variant GSTA1 alleles were shown to have higher lymphocyte PhIP-adduct levels 
in a subgroup of young individuals122 and those consuming well-done meat 
frequently (>2 servings/wk) were observed to have higher colorectal cancer risk123.  
GSTP1 polymorphisms. The GSTP1 gene is located on chromosome 11q13. It 
is a single gene, consisting of 7 exons, spanning ~2.8 kb and encoding a total of 209 
amino acids. Functional coding polymorphisms in the GSTP1 gene have been 
reported: an A>G SNP at position 313 (termed GSTP1*B) and an additional C>T 
SNP at position 341 (containing both SNPs and termed GSTP1*C)124. Both 
nucleotide changes translate into amino acid changes (isoleucine to valine and 
alanine to valine, respectively) and both amino acid changes are in the electrophilic 
substrate-binding site of the GSTP1 protein, reducing its catalytic activity124, 125. The 
GSTP1*B allele affected GSTP1 activity in lung tissue126 and total GST activity 
(CDNB) in erythrocytes127. The GSTP1 *B and *C allele frequencies are ~26% and 
7% in Caucasians128. The variant GSTP1 313 G-allele was associated with higher 
DNA damage in breast tissue (especially in combination with the A-463 variant in 
the myeloperoxidase gene; but not GSTT1, GSTM1 or NQO1 variants)129, and in 
mononuclear white blood cells in smokers with the GSTM1- genotype130. 
In the regulatory region of GSTP1, a functional haplotype has recently been 
identified which displays higher basal GSTP1 mRNA and protein expression. In 
this Caucasian study population of 40 individuals, there were three heterozygotes 
and one homozygote131.  
GSTM1 and GSTT1 polymorphisms. GSTM1 and GSTT1 are located on 
chromosomes 1p13.3 and 22q11.2, respectively. In about 50% and 20% of 
Caucasians, respectively, the genes are partially deleted on both alleles, resulting in 
absence of activity128, 132. The switch from a vegetarian diet to a high-meat diet 
significantly increased the amount of DNA single-strand breaks in exfoliated 
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colonic mucosa cells among individuals with a GSTM1- genotype but not among 
those with GSTM1+ genotype133. A Human Genome Epidemiology (HUGE) review 
did not observe consistent associations between GSTM1 or GSTT1 genotype and 
colorectal cancer132.  
Only in recent years laboratory assays discerning individuals with one and 
two alleles present have become feasible and more common practice134-136. Allele 
frequencies of 0.77 for GSTM1-135 and 0.43 for GSTT1-134 in Caucasians have been 
reported. The resulting study data indicate that the former grouping together of 
heterozygotes and homozygous wild-types does not do justice to the phenotypic 
differences that appear to exist. In erythrocytes, GSTT1 activity was found to 
correlate with number of alleles, with an intermediate activity (towards 
dichloromethane) for the GSTT1 heterozygous genotype134. Having one or two 
inactive GSTT1 alleles was associated with 40% increased left-sided advanced 
colorectal adenoma risk, among smokers136. For left-sided advanced colorectal 
adenomas, risks were essentially the same for GSTM1 heterozygotes and 
homozygous null variants, both were decreased by 40%136; In breast cancer risk, a 
similar observation was made135.  
NQO1 polymorphisms. The NQO1 gene is located on chromosome 16q22.1. It 
contains 6 exons, spanning ~20 kb, totalling 274 amino acids. There are two known 
functional polymorphisms; one C>T substitution at cDNA position 609, with an 
allele frequency of ~20% in Caucasians137, resulting in rapid degradation of the 
variant protein138 and loss of enzymatic activity as shown in saliva139, lung tissue140 
and bladder tumors141; and one C>T substitution at position 465, with an allele 
frequency of ~5% in Caucasians, resulting in an alternatively spliced transcript 
lacking exon 4 which contains the quinone binding site142, 143. The NQO1 609C>T 
SNP appears to be associated with an increased cancer risk in benzene-exposed 
populations144, but the association is less clear for other populations145, 146.  
 
In conclusion: Genetic variation exists in GST and NQO1 detoxification enzymes. There is 
little evidence for an important role in cancer risk for genetic variation in itself. It is 
thought to be relevant in combination with exposure to specific pro- or anti-carcinogens. 
The specific impact of GST and NQO1 polymorphisms on colorectal phenotypes, e.g. 
enzymatic capacity or tumour formation, is not sufficiently known. Little is known about 
functional polymorphisms in GST or NQO1 regulatory regions, which could be 
particularly important because they may lead to differences in (constitutive and inducible) 
gene expression and therefore affect susceptibility to environmental exposure and cancer-
chemoprotective efficacy.  
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FRUIT AND VEGETABLE CONSUMPTION AND POLYMORPHISMS IN GSTS AND NQO1: 
INTERACTIONS WITH RESPECT TO HUMAN COLORECTAL CANCER-RELATED ENDPOINTS  
Polymorphisms are known to occur in regulatory regions, as has been described 
for GSTA1, GSTP1 and other genes119, 131, 147, 148. It is conceivable that regulatory 
sequence variation exists specifically in nucleotide sequences responsive to 
phytochemicals, for example in the EpRE149, causing differences in the effectiveness 
of these cancer-preventive constituents among individuals. This may be true in a 
suppressive manner for the recently described GSTP1 haplotype with increased 
constitutive expression131. There, strikingly, the presumed inducers sulforaphane, 
EGCG and benzyl isothiocyanate (BITC) in vitro decreased the haplotype promoter 
activity to a level identical to the other haplotypes, for which these compounds 
were inactive. 
Genetic variation in the coding region affecting the function of the enzyme 
may also be relevant in relation to fruit and vegetable consumption. When the 
detoxification function of an enzyme is affected, a higher fruit and vegetable 
consumption may be able to combat carcinogen load via induction of the available 
detoxification capacity. Alternatively, besides carcinogens, some phytochemicals 
are also substrates for the enzymes, and when the affinity for certain 
phytochemicals is affected, phytochemicals may be metabolized at a different rate.  
Studies investigating the colorectal or systemic effects of fruit and vegetable 
consumption while taking into account polymorphisms in GSTs and NQOs have 
focussed on enzyme levels or activities, DNA damage or tumor occurrence (See 
table I) and have often investigated cruciferous vegetable intake. GSTs metabolize 
the cruciferous vegetable-derived bioactive isothiocyanates, hypothetically 
diverting them from their enzyme induction pathway to excretion. Slower 
metabolising genotypes would then retain these isothiocyanates longer and thus 
confer more protection. Urinary ITC excretion has been measured to specifically 
test this hypothesis. Interactions between regulatory polymorphisms and fruits 
and vegetables in colorectal cancer have not been studied in human populations so 
far. 
The available study results suggest that there are differences between 
GST/NQO1 genotypes with regard to associations between fruit and vegetable 
consumption and enzyme levels or activities, DNA damage or tumor occurrence in 
the colorectal area (Table I). There is some evidence for a lower colorectal cancer 
risk with higher cruciferous vegetable intake and GSTT1150, 151 or GSTM1 
homozygous null genotype152, but studies measuring urinary ITC excretion do not 
yield consistent results supporting the mechanism of slower excretion with slower 
metabolising genotype153, 154.  
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Polymorphisms in GSTP1, GSTA1 and NQO1 have not often been related to fruit 
and vegetable consumption in colorectal cancer risk and do not deliver consistent 
results. 
Joint effects of cruciferous vegetable intake and GSTM1/T1 polymorphisms 
have been studied in several other cancer types (not in table), with conflicting 
results, as summarized in Steck et al.155 In a Danish nested case-control study of 
lung cancer there was a risk reduction of ~25% for the homozygous variant GSTP1 
313GG genotype per 50% increase in vegetable consumption156. In a breast cancer 
case-control study in Shanghai, China, there was no modifying effect from 
cruciferous vegetable consumption between GSTP1 313A>G genotypes157. A large 
population-based breast cancer study in the USA found an increased risk among 
those with the homozygous variant GSTA1 genotypes (*B/*B) as compared to those 
with the homozygous wild-type genotypes (*A/*A) in the lowest two tertiles of 
cruciferous vegetable consumption158.  
 
In conclusion: Some interactions between consumption of fruits and vegetables and GSTs 
and NQO1 in colorectal cancer-related endpoints have been shown. A special interest for 
biochemoprevention purposes lies in phytochemical-responsive SNPs in gene regulatory 
regions. Only recently a phytochemical-responsive promoter haplotype has been identified 
for GSTP1. Simultaneous assessments of polymorphisms, including phenotypic 
measurement in the colorectum, and thorough evaluation of genetic variation in regulatory 
regions has been scarce. 
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The following pages will summarize the rationale for the studies, state the research 
questions and will outline the thesis structure. 
 
RATIONALE FOR THE STUDIES IN THIS THESIS        
  
Promotion of total fruit and vegetable consumption or of subtypes such as 
cruciferous vegetables may be beneficial for colorectal cancer prevention. One 
hypothesized mechanism for a beneficial effect is that fruit and vegetable 
components, such as isothiocyanates, flavonoids, carotenoids, sulfides and 
phenols, can induce biotransformation enzymes via regulatory DNA sequences 
such as the electrophile-responsive element (EpRE), and thus increase the amount 
of biotransformation enzyme that is available for detoxification purposes. These 
detoxification enzymes then reduce the levels of carcinogens in the tissues and 
cells and therefore can contribute to the reduction of DNA damage and cancer risk.  
GSTs and NQO1 are common biotransformation enzymes which metabolize 
carcinogens relevant for the colorectal area and which have been reported to be 
inducible in humans by consumption of fruits and vegetables. GST levels and / or 
activities have been noted to be upregulated by consumption of cruciferous and 
allium vegetables and citrus fruits. However, results are inconsistent and usually 
only one fruit and vegetable subtype or GST isoenzyme is studied, most often in 
blood as a surrogate tissue. For NQO1 there are little data in humans. Thus, 
detailed GST and NQO1 phenotype information is needed in colorectal tissue, as 
is the consideration of several different fruit and vegetable subtypes. 
Also, functional (coding) polymorphisms are known in GST and NQO1 
detoxification enzymes, resulting in reduced enzyme function. This may reduce 
the capacity for detoxification of pro-carcinogens, e.g. from cigarette smoke, or 
prolong the presence in the body of anti-carcinogens, e.g. isothiocyanates. The 
specific impact of GST and NQO1 polymorphisms on colorectal enzymes or 
adenoma formation is not sufficiently known. Of special relevance for the 
colorectal cancer risk-modulating effects of fruits and vegetables are 
polymorphisms in regulatory DNA sequences of biotransformation enzymes that 
result in altered responsiveness to inducing plant food components and thereby 
change the availability of the biotransformation enzymes, resulting in altered 
protection against (pro)carcinogens. From previous research, little is known about 
polymorphisms in GST or NQO1 regulatory regions. Thus, an evaluation of genetic 
variation in regulatory regions of human GSTs and NQO1 is needed, with, if 
found, confirmation of functionality in cell assays and human colorectal tissue.  
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There are only few and inconsistent indications for interactions between 
consumption of fruits and vegetables and (intermediate) cancer endpoints.  
Integrating the above, it is desirable to perform: 
-a thorough evaluation of genetic variation in regulatory regions of GSTP1, GSTA1 
and NQO1  
-simultaneous assessment of known polymorphisms  
-further evaluation of the (combined) roles of both fruit and vegetable 
consumption and regulatory and coding polymorphisms in biotransformation 
genes in colorectal biotransformation phenotype and occurrence of colorectal 
tumors. 
This is relevant because if functional (coding and regulatory) polymorphisms 
in combination with exposure to fruits and vegetables change the human GST and 
NQO1 detoxification enzyme level or activity, and adenoma risk, they may be 
important in human nutrition-related cancer prevention. 
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RESEARCH QUESTIONS         
 
The overall question to be answered in this thesis is whether genetic variations in 
GST or NQO1 detoxification enzymes are functional in colorectal cancer 
prevention by fruits and vegetables, as operationalized by their enzyme phenotype 
and adenoma occurrence. 
 
The following research questions were specified: 
 
I. Enzyme phenotype (i.e. mRNA level, enzyme level, enzymatic activity level)  
1) are genetic polymorphisms in regulatory and coding DNA sequences of GSTP1, 
GSTA1 and NQO1 associated with altered GST and NQO1 enzyme phenotype? 
2) is recent fruit and vegetables consumption associated with altered GST and 
NQO1 enzyme phenotype? 
3) does high fruit and vegetables consumption modulate enzyme phenotype in 
combination with specific genotypes (is there gene-environment interaction)? 
4) is white blood cell GST and NQO1 enzyme phenotype a good surrogate 
measure for colorectal GST and NQO1 enzyme phenotype?  
(chapters 2 and 4) 
 
II. Adenoma risk         
1) are genetic polymorphisms in regulatory and coding DNA sequences of GSTP1, 
GSTA1 and NQO1 associated with altered adenoma occurrence? 
2) is fruit and vegetable consumption associated with altered adenoma 
occurrence? 
3) is fruit and vegetable consumption associated with a different adenoma 
occurrence between genotypes (is there gene-environment interaction)? 
(chapters 3 and 5) 
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Answers to these questions were sought by means of the following studies:  
 
Genotype-phenotype study          
In this observational study among 94 sigmoidoscopy patients without colorectal 
inflammation or cancer, GSTA1, GSTP1, GSTM1, GSTT1, NQO1 and NFE2L2 
polymorphisms were determined, recent fruit and vegetable consumption was 
assessed, and GST and NQO1 enzyme levels and activities were measured in rectal 
biopsies. 
 
 
 
 
Case-control study on colorectal adenoma risk      
In this case-control study among 1477 endoscopy patients (746 adenoma cases and 
698 controls), GSTA1, GSTP1, GSTM1, GSTT1, NQO1 and NFE2L2 polymorphisms 
were determined and habitual fruit and vegetable consumption was assessed.  
 
 
 
 
 
 
The search for new polymorphisms and the experimental evaluation of their 
functionality is the subject of a related project (I.M.C.M. Rietjens, J.M.M.J.G. Aarts, 
A.M.J.F. Boerboom, Department of Toxicology, Wageningen University). 
 
 
OUTLINE OF THE THESIS 
 
GST enzymes are subject of chapter 2 and 3, the NQO1 enzyme is subject of 
chapter 4 and 5. In chapter 2, GST enzyme phenotypes are described in relation to 
GST genetic variation and fruit and vegetable consumption. In chapter 3, colorectal 
adenoma risk is evaluated in relation to GST genetic variation and cruciferous 
vegetable consumption. In chapter 4, NQO1 enzyme phenotype is described in 
relation to NQO1 genetic variation and fruit and vegetable consumption. In 
chapter 5, colorectal adenoma risk is evaluated in relation to NQO1 genetic 
variation, fruit and vegetable consumption and other lifestyle factors. In chapter 6, 
the results are placed in a broader context of concepts and methodology. 
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ABSTRACT 
High glutathione S-transferase (GST) activity may contribute to colorectal cancer 
prevention. Functional polymorphisms are known in the GSTM1, GSTT1, GSTA1 
and GSTP1 genes. The influence of these GST polymorphisms and recent fruit and 
vegetable consumption on GST levels and activity has not been investigated 
simultaneously in a human population. Also, it is not clear if blood GST activity 
reflects rectal GST activity. Therefore, we determined GST polymorphisms in 94 
patients scheduled for sigmoidoscopy. Rectal GST isoenzyme levels (GSTM1, 
GSTM2, GSTT1, GSTA and GSTP1) were measured by quantitative Western 
blotting, and rectal and white blood cell total GST activities were measured 
spectrophotometrically using 1-chloro-2,4-dinitrobenzene (CDNB) as a substrate. 
Vegetable and fruit consumption was assessed by dietary record. As expected, the 
GSTM1 and GSTT1 deletion polymorphisms, and the GSTA1 g.-69C>T 
polymorphism significantly affected the respective isoenzyme levels. Also, rectal 
GST isoenzyme levels differed between those with and without recent 
consumption of Alliaceae, Cucurbitaceae, Apiaceae and citrus fruit. Rectal GST 
activity, however, was not clearly influenced by fruit and vegetable consumption. 
It was most significantly determined by the GSTP1 c.313A>G polymorphism; 
compared to the 313AA genotypes, the 313AG and 313GG genotypes showed 36 
and 67 nmol/min.mg protein (p<0.001) lower GST activity, respectively. The 
correlation between rectal and white blood cell GST activities was low (r=0.40, 
p<0.001), and the relevance of the various genetic and dietary factors appeared to 
differ between the two tissues. In conclusion, this study indicates that the GST 
enzyme system is influenced by both GST polymorphisms and consumption of 
fruits and vegetables. The latter appeared more important for individual rectal 
GST isoenzyme levels than for total GST activity, which could affect detoxification 
of isoenzyme-specific substrates. The study results do not support the use of white 
blood cell GST activity as a surrogate measure for rectal GST activity. 
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INTRODUCTION 
The gastro-intestinal tract is constantly exposed to exogenous compounds with 
genotoxic potential. This genotoxicity can be inherent to the compound itself or the 
result of endogenous bioactivation. The human body is equipped with a defense 
system, among which are phase II biotransformation enzymes, which alter the 
toxic compounds and facilitate their excretion. Phase II biotransformation enzymes 
have been classified into several families, based on the type of reaction they 
catalyze, one of the most important being the glutathione S-transferases (GSTs, EC 
2.5.1.18)1. These enzymes catalyze the conjugation of reduced glutathione to a wide 
range of electrophilic substrates, including ultimate carcinogens2, 3. In the distal 
part of the gastro-intestinal tract, the colon and rectum, occurrence of neoplasia is 
high4. This may in part be due to its high cell turnover5, but also be due to low 
basal GST expression6, 7. Support for an inverse association between GST capacity 
and tumor incidence is, however, mostly indirect. Other tissues, e.g. breast and 
lung, also show high tumor risk with relatively low GST expression and the 
reverse, low tumor risk with high GST expression, applies to the small intestine 
and liver8. In observational studies, lower cancer incidence has been linked to diets 
high in fruits and vegetables9. An explanation for this observation may be that fruit 
and vegetable components, e.g. from Brassica vegetables and citrus fruits, induce 
detoxification enzymes such as GSTs10. In a small number of human dietary 
intervention studies GSTs have been reported to be inducible, in various tissues; in 
the colorectal area11, 12, in plasma or peripheral lymphocytes13-16, and in saliva16, 17. 
Because GST levels are relatively low in the colorectal area as compared to other 
organs, upregulation of GST-enzymes may have considerable protective impact in 
the colon and rectum6, 7. The induction process involves activation of certain signal 
transduction pathways by fruit and vegetable components acting through 
transcription factor binding sites which are present in the promoters of GSTs18.  
Interestingly, interindividual polymorphic variation exists in the GST genes3. 
Depending on exposure to (pro)carcinogens, individuals with different genetic 
GST variants have been reported to have moderately different cancer risks3, adding 
more support for a role of GSTs in human cancer susceptibility. In the coding 
sequence of GST genes, genetic polymorphisms can affect e.g. the catalytic activity 
of the enzymes19. In the regulatory sequence, genetic variation can result in altered 
binding of transcription factors and altered mRNA levels20, translating into 
changes in GST isoenzyme levels21. In light of the effects that fruit and vegetable 
components may have on the regulatory region, polymorphisms in this area could 
be important for nutritional strategies aiming to upregulate GST enzyme capacity. 
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The aim of the present human observational study was to comprehensively 
assess GST protein phenotypes (i.e. GST isoenzyme levels and total GST activity) in 
the rectum in relation to genetic variation (i.e. GSTM1, GSTT1, GSTA1 and GSTP1 
polymorphisms) and recent consumption of fruits and vegetables. Moreover, white 
blood cell GST activities were measured to investigate if these factors show similar 
effects on blood GST phenotype, and thus if blood can be used as a surrogate 
tissue.  
 
METHODS 
Population. Participants were recruited in two outpatient endoscopy clinics in the 
Netherlands from patients scheduled for a sigmoidoscopy, between January 2003 
and June 2004. Eligibility criteria were: age between 18 and 75 years, Caucasian, no 
chronic inflammatory bowel disease (past or present), no inflammation in the 
distal colon at the time of endoscopy, no sporadic colorectal cancer (past or 
present), and no bowel resection. Of all eligible patients, 235 (64%) were invited to 
participate in the study. Invitation was dependent on whether the time between 
identification of the patient and the start date of the food record was sufficient for 
the consent procedure. Of all invited patients, 105 agreed to participate (45%). 
Main reasons for not participating were the stress caused by the prospect of the 
endoscopy in general and fear for the biopsy specifically. Of all participants, 11 
were excluded at endoscopy or after inspection of tissue pathology (PA) results 
because inclusion criteria were not met. This resulted in a final study population of 
94 individuals. The study was approved by the Medical Review Boards of both 
hospitals. All participants gave their written informed consent.  
Medical, dietary and lifestyle information. The indication for endoscopy was 
recorded from the endoscopy request form. Information on the macroscopic and (if 
available) microscopic result of the endoscopy was recorded from the endoscopy 
report and (if available) PA report. 
Participants kept a 3-day dietary record, the third day ending at the time of 
endoscopy. Type and amount of food consumed were recorded in a structured 
open entry format. All records were checked for quality and completeness by the 
same, trained dietician of the division of Human Nutrition of Wageningen 
University; about 50% of dietary records required follow-up by telephone, which 
was successful for the majority within 3 days after endoscopy. Processing into food 
quantities and coding was done according to the most recent standard manual on 
food portions and household measures and the Dutch Food composition Table22, 23. 
Conversion into amounts of nutrients was done using the VBS Food Calculation 
System24. Fruits were subdivided in citrus (fruit and juice) and non-citrus fruits, 
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vegetables in botanically defined subtypes: Alliaceae (e.g. garlic, leek), Apiaceae 
(e.g. celery, carrot), Brassicaceae (e.g. cauliflower, broccoli), Compositae (e.g. 
endive, lettuce), Cucurbitaceae (e.g. zucchini, cucumber), Solanaceae (e.g. bell 
pepper, tomato; potato not included), and a restgroup.  
General lifestyle information was collected through a semi-structured 
questionnaire containing questions about age, sex, weight, height, smoking habits, 
medication, disease and family history of cancer. 
Specimen collection and preparation. Biopsies. Flexible sigmoidoscopy was 
performed with the patient in left lateral decubitus position. Biopsies 
(approximately 20 mg each) were taken from normal rectal mucosa at a distance of 
5 to 15 cm from the anal verge and were snap-frozen in liquid nitrogen. Blood. 
Blood (3 x 9 ml) was drawn shortly after endoscopy by venipuncture in Vacuette 
EDTA K3 Tubes (Greiner Bio-One, Alphen a/d Rijn, the Netherlands). Leukocytes 
and lymphocytes. Within 5 min after blood draw, duplicate portions of 1.4 ml whole 
blood were mixed with 12.6 ml Puregene RBC lysis solution (Gentra systems, 
BIOzym group, Landgraaf, The Netherlands) and kept on ice for 10-30 minutes. 
Samples were then centrifuged at 4°C and 2500 g for 10 min. Leukocyte pellets 
were not collected of the first 19 participants. Duplicate portions of 4 ml of whole 
blood were used for isolation of lymphocytes on Histopaque-1077 (Sigma-Aldrich, 
Zwijndrecht, The Netherlands) according to the instruction of the manufacturer. 
Leukocyte and lymphocyte pellets were resuspended in 1 ml phosphate buffered 
saline (PBS, pH 7.4, Invitrogen, Breda, The Netherlands), centrifuged for 5 minutes 
at 10,000 g and stored at -80°C. Leukocyte DNA. One tube of whole blood was 
centrifuged at 1100 g for 10 min. After removal of plasma, the buffy coat layer was 
remixed with the blood remnant for later DNA extraction and stored at -80°C.  
Laboratory analyses. Genotyping. DNA was extracted from buffy coat cells 
(QIAamp 96 DNA blood kit, Qiagen Benelux B.V., Venlo, The Netherlands), and 
samples were stored with negative controls at 4°C. The GSTM1 and GSTT1 
deletion polymorphisms were determined simultaneously by allele-specific 
multiplex PCR25, in which a ß-globin gene fragment was co-amplified as internal 
positive control. The GSTA1 g.-69C>T polymorphism was determined by PCR-
RFLP according to Coles et al.26. Some modifications to the Coles’ protocol were 
made; annealing temperature was set at 61°C and Eam1104I (Fermentas GmbH, St. 
Leon-Rot, Germany) was used as restriction enzyme. The GSTP1 c.313A>G 
polymorphism was assessed by PCR-RFLP according to Harries et al.27. GSTA1 g.-
69C>T and GSTP1 c.313A>G genotypes were in Hardy Weinberg Equilibrium 
(HWE; χ2=2.37, p-value=0.12 and χ2=0.07, p-value=0.79, respectively). The 5’ 
regulating region of the GSTP1 gene was screened for new polymorphisms by 
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DNA sequencing of the -434 to +296 region of the GSTP1 gene (relative to the 
translation initiation site of GenBank Accession AY324387; experimental details 
available on request). No new polymorphisms were identified. We confirmed the 
GSTP1 g.217G>A (rs1079719 on the NCBI SNP website), g.227G>A (rs1871041) and 
g.272C>G (rs4147581) polymorphisms and genotyped them by pyrosequencing 
(the g.223 G-insertion polymorphism was also confirmed, but genotyping was 
unsuccesful). For genotyping, PCR was performed with AccuPrime GC-rich DNA 
polymerase (Invitrogen). The resulting 279 bp amplicon was used for two reverse 
directed pyrosequencing analyses; the first to analyze the 233 to 209 region of 
GSTP1 in order to genotype the g.217G>A and g.227G>A polymorphisms and the 
second to analyze the 275 to 266 region of GSTP1 in order to genotype the 
g.272C>G polymorphism. The GSTP1 g.217G>A and g.227G>A genotypes were in 
HWE (χ2=0.15, p=0.70 and χ2=1.74, p=0.19, respectively), whereas the GSTP1 
g.272C>G polymorphism was not (χ2=5.58, p=0.018). All polymorphisms were 
genotyped in duplicate; reproducibility was 100%. 
Protein assays. Two rectal biopsies were homogenized on ice using a frozen (-
20°C) pestle, and suspended in 100 μl of 20 mM Tris-HCl (pH 7.5). Leukocyte and 
lymphocyte pellets were resuspended in 100 μl 20 mM Tris-HCl and cells were 
lysed by sonification (Sonorex RK100 ultrasonic bath, Bandelin electronic, Berlin, 
Germany) on ice during 10 min. The resulting rectal tissue and white blood cell 
lysates were centrifugated at 16,000 g and supernatants were alliquoted and 
refrozen at -80°C, until further measurement. 
Total protein was measured by the BCA protein assay reagent kit (Pierce 
Rockford, IL, USA) using BSA as a standard, following the manufacturer’s 
instructions.  
Levels of rectal GST M1, M2, T1, A and P1 were determined by western 
blotting using monoclonal antibodies11 and subsequent densitometric analyses of 
immunoblots. Known amounts of purified GSTs were run in parallel with the 
samples and served as standards. For quantification of GSTM2 protein, M2 bands 
were calculated relative to the M1 standard. The detection limit of the immunoblot 
assays was 20 ng GST protein/mg total protein. GST isoenzyme levels were was 
normalized to total protein content and expressed as ng GST protein/mg total 
protein. 
Total GST enzyme activity was measured spectrophotometrically using 1-
chloro-2,4-dinitrobenzene (CDNB, Sigma-Aldrich) as a substrate according to the 
method of Habig et al.28, but adapted for microplate reader (SpectraMax 340, 
Molecular Devices Corporation)29. Measurements were performed at 340 nm and 
37°C, for 3 minutes, in triplicate. Data were analyzed using SOFTmaxPRO software 
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(version 2.2.1, Molecular Devices Corporation). The average coefficient of variation 
in GST activity was 7.3% for rectal samples, 12.4% for leukocytes and 11.2% for 
lymphocytes. GST enzyme activity was expressed as nmol 2,4-dinitrophenyl-S-
glutathione (DNP-SG) produced/min.mg total protein. Sample storage. White blood 
cell pellets were stored intact at -80°C for 6.3±4.5 months after blood sampling until 
preparation and refreezing. GST activity was then measured within 1 month. 
Rectal biopsies were stored intact at -80°C for 7.5±4.5 months after tissue sampling 
until homogenation and refreezing; GST activity was then measured within 1 
month and GST isoenzyme levels ~3 months later. 
Statistical analyses. From two subjects no rectal tissue was obtained and for 
another two subjects there was no dietary information available. One extreme 
outlier in lymphocyte GST activity (523 nmol/min.mg protein) was excluded from 
lymphocyte-analyses. For two subjects with the GSTM1 null genotype, a GSTM1 
protein value was measured. Since some cross-reactivity with other GSTM proteins 
may have occurred here, these two GSTM1 values were set to zero.  
Vegetable and fruit consumption was dichotomized as did or did not consume 
on one of the two days before endoscopy. Linear regression models were used to 
evaluate factors confounding the associations between genotype and phenotype, or 
between fruit and vegetable consumption and phenotype (i.e. >10% change in β-
estimate), or statistically significantly contributing to phenotype (i.e. p<0.05). GST 
genotype-phenotype associations were evaluated for age, sex, sample storage time 
and family history of colorectal cancer, and models were adjusted for age, sex and 
sample storage time. Sample storage time was calculated as the time between 
specimen collection and measurement performance, and contributed statistically 
significantly to phenotype in most models. Although age and sex did not 
contribute significantly, they were included because they are important general 
population parameters. Fruits and vegetables-GST phenotype associations were 
evaluated for age, sex, sample storage time, outpatient clinic, family history of 
colorectal cancer, season, smoking, coffee consumption, alcohol consumption, 
presence of diverticula, hemorrhoids, and adenomas, and models were adjusted 
for age, sex, sample storage time and smoking. Smoking was defined as smoking 
on one of the two days before endoscopy.  
The difference in GST phenotype outcome and its 95% confidence interval was 
reported for the variant genotypes as compared to the most common homozygous 
genotype variant, and for the ‘did-consume’ groups as compared to the non-
consumers. For the reference groups (the most common homozygous genotype 
variant and the non-consumers), least-squares adjusted means were calculated, 
using mixed models. 
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Pearson correlation coefficients were calculated to evaluate the strength of the 
association between rectal and white blood cell GST activities. 
Haplotypes for GSTP1 polymorphisms were estimated using the Hplus 
program version 2.5, available online (Fred Hutchinson Cancer Research Center. 
Hplus. http://qge.fhcrc.org/hplus). The GSTP1 g.217G>A, g.227G>A and g.272C>G 
variant nucleotides were not linked and were therefore investigated separately. 
Inclusion of the GSTP1 c.313A>G polymorphism (corresponding to genomic 
position 1377) in haplotype estimation resulted in 6 haplotypes, the two most 
common were: GGG-A (44.2%) and AGC-G (30.5%). All statistical analyses were 
performed using SAS software, version 9.1 (SAS institute, Cary, NC). 
 
RESULTS 
Table 1 shows the distribution of general characteristics and consumption of fruit 
and vegetable subtypes between groups of lower and higher rectal GST activity 
within the study population. Rectal GST activity was lower with higher age, longer 
duration of ex-smoking, and the presence of hemorrhoids and diverticula. In the 
higher rectal GST activity group, there were more Alliaceae consumers.  
In table 2 the GST genotypes and phenotypes are presented for the rectal GST 
activity groups and for the total population. Rectal GST activity was higher with 
presence of the GSTP1 272G- and 313A-alleles. All GST isoenzyme levels were 
higher with higher total rectal GST activity, GSTM2 and GSTP1 most pronounced. 
GSTP1 was the most abundant rectal GST enzyme measured, GSTA the least 
abundant. Interindividual variation in GST M1, M2, T1, A and P1 isoenzyme levels 
was about 10, 15, 7, 17 and 13-fold, respectively. Total GST activities in leukocytes 
and lymphocytes were higher with higher total rectal GST activity, though not 
significantly in lymphocytes. The interindividual variation in the GST activity 
measures was about 4-fold. The correlations between rectal and white blood cell 
GST activities were 0.41 between rectal and leukocyte, 0.35 between rectal and 
lymphocyte, and 0.41 between leukocyte and lymphocyte GST activity, p<0.001 for 
all coefficients.  
Rectal GST isoenzyme levels in relation to genetic variation. GST 
polymorphisms were associated with the levels of their isoenzymes (not in table); 
presence or absence of the GSTM1 gene resulted in GSTM1 levels of 2150±1148 and 
0 ng/mg protein and for the GSTT1 gene corresponding GSTT1 levels were 
4646±2466 and 0 ng/mg protein. GSTA level differed significantly between GSTA1 
g.-69C>T genotypes (Figure 1); The CC genotypes had the highest (762±413 ng/mg, 
median value 677), the CT genotypes an intermediate (378±264 ng/mg, median 
value 368) and the TT genotypes no detectable GSTA level (p<0.001). The GSTP1 
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level appeared to be higher among individuals with a GSTP1 313 variant G-allele: 
the 313GA and 313GG genotypes had 772 (p=0.17) and 1440 (p=0.088) ng/mg 
protein higher GSTP1 levels compared to the AA genotype, respectively. The 
GSTP1 217GA genotype also showed a borderline significantly higher GSTP1 level 
(1026 ng/mg, p=0.072) compared to the 217 GG genotype. There was no association 
between GSTP1 level and the GSTP1 227 or 272 variants. 
 
 Table 1: General study population characteristics by rectal GST activity
Characteristic 
Rectal total GST activity 
(nmol DNP-SG/min.mg protein)a 
  ≤ median,  n=46 >median, n=46 
General characteristics mean±sd or n 
Age years 51±14 42±11** 
Sex male 20 19 
Education low/high 9, 19 7, 21 
Smoking 
 
never 
current/ ex 
17 
6, 23 (quit: 19±11 yrs) 
19 
12, 15 (quit: 10±10 yrs)* 
BMI  25.3±4.4 26.0±4.8 
Medical factorsb  n 
Family history cancer (colorectal) 27 (2) 20 (4) 
Indication for 
endoscopyc 
 
 
blood loss per anum 
abdominal pain 
different defecation 
pattern 
21 
15 
15 
 
23 
15 
14 
 
Endoscopy 
characteristicsd 
 
 
 
outpatient clinic (A/B) 
morning/afternoon 
hemorrhoids 
diverticula 
adenoma(s) 
41/5 
24/22 
13 
11 
3 
36/10 
24/22 
5* 
3* 
8 
Intake of fruit and vegetable subtypese p50 (p25-p75); no. of consumers 
Vegetables, g/day totalf 117 (77-168) 40 100 (51-219) 39 
 Alliaceae 11 (5-38) 13 27 (15-33) 23* 
 Apiaceae 33 (5-50) 10 49 (12-110) 15 
 Brassicaceae 43 (22-86) 16 40 (24-82) 13 
 Compositae 38 (23-75) 21 39 (19-90) 16 
 Curcubitaceae 47 (25-51) 16 30 (22-75) 13 
 Solanaceaef 40 (29-95) 16 34 (18-55) 14 
 other 60 (17-109) 8 80 (73-101) 9 
Fruits, g/day total 138 (70-265) 34 85 (44-185) 36 
 citrus 68 (55-120) 14 55 (30-131) 12 
 citrus juice 203 (88-303) 12 125 (60-165) 7 
amedian value on which groups are based: 214 nmol/min.mg protein 
bsource: medical record and self-reported 
cmost common; more than one possibility per individual 
dbowel preparation, day before: 17:00 hrs: 2 laxatives (10 mg), 20:00 hrs microlax enema (5 ml), in clinic B 2x different  
preparation 
*<0.05; **<0.001 (χ2 or fisher depending on cell numbers for proportions; wilcoxon for non-normally distributed variables; t-test
for normally distributed variables) 
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Figure 1: Rectal GSTA level by GSTA1 g.-69C>T genotype
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Footnote:  
Boxes and bars represent the interquartile range and the median value,  
respectively; Whiskers represent distance to the smallest and largest sample 
value, excluding outliers; open circles represent values of 1.5-3 box lengths. 
Table 2: GST genotype and phenotype characteristics of the total study population and by  
rectal GST activity 
 
Rectal total GST activity 
(nmol DNP-SG /min.mg protein)a   
  ≤ median, n=46  > median, n=46  total population 
Genotyping results  n  % 
GSTM1 gene deletion  
(gene present/absent) 20 / 26 23 / 22  48 / 52% 
GSTT1  gene deletion  
(gene present/absent) 34 / 12 39 / 7  89 / 21% 
GSTA1  g.-69>T (CC/CT/TT) 20 / 23 / 3 11/ 28 / 7  33 / 55 / 12% 
GSTP1  g.217G>A (GG/GA/AA) 
g.227G>A (GG/GA/AA) 
g.272C>G (CC/CG/GG) 
c.313A>G (AA/AG/GG)b 
13 / 26 / 7 
33 / 10 / 3 
13 / 30 / 3 
13 / 25 / 8 
19 / 20 / 7 
38 / 8 / 0 
8 / 27 / 11* 
25 / 18 / 3*  
34 / 51 / 15 % 
78 / 19 / 3% 
22 / 63 / 15% 
41 / 47 / 12% 
Enzyme measurementsc     
GST isoenzyme level, rectum ng/mg protein 
M1 929 ± 1354 1091 ± 1311  1010 ± 1328 
M2 1119 ± 598 1533 ± 623**  1326 ± 642 
T1 3221 ± 2707 4152 ± 3031  3647 ± 2906 
A 427 ± 265 505 ± 485  473 ± 388 
P1 5584 ± 2264 7300 ± 2510***  6442 ± 2529 
GST activity nmol DNP-SG/min.mg protein 
rectum 173 ± 30a 258 ± 47a  216 ± 58 
leukocytes 118 ± 32 146 ± 39*  134 ± 38 
lymphocytesd 119 ± 28 131 ± 31  125 ± 30 
amedian value on which groups are based: 214 nmol/min.mg protein 
bcorresponds to genomic position 1377 
cfor rectal tissue, sample storage time until homogenation and refreezing was 9.4±5.0 for lower than and 5.6±3.0 months  
for higher than median GST activity; for white blood cells this was 8.2±5.0 for lower than and 4.4±3.0 months for higher  
than median GST activity 
done outlier deleted 
*<0.05; **<0.01, ***<0.001  (χ2 or fisher depending on cell numbers for proportions; wilcoxon for non-normally distributed  
variables; t-test for normally distributed variables)  
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Rectal GST isoenzyme levels in relation to fruit and vegetable consumption. 
Citrus fruit and juice consumption combined was positively associated with 
GSTM1 level (Table 3). Total vegetable consumption and consumption of Apiaceae 
were inversely associated with GSTM2 level. Consumption of Alliaceae was 
associated with higher GSTT1 level. There was no significant association between 
fruit or vegetable consumption and GSTA level. However, when the GSTA1 g.-
69C>T genotype was added to the GSTA-fruit and vegetable models, GSTA level 
was significantly higher among consumers of Solanaceae: +152 ng/mg protein 
(p=0.024), and Cucurbitaceae: +152 ng/mg protein (p=0.035), compared to non-
consumers (data not shown in table). Consumption of Alliaceae and Cucurbitaceae 
was positively associated with GSTP1 level (Table 3). This higher GSTP1 level was 
most pronounced for the GSTP1 272CC genotype: +3758 ng/mg protein (p=0.0039) 
with Alliaceae consumption and +2340 ng/mg protein (p=0.074) with 
Cucurbitaceae consumption; similar results were observed for the 227GA 
genotype, but this did not reach statistical significance. There was no such 
difference when stratifying for the GSTP1 g.217G>A or c.313A>G genotypes.  
Rectal and white blood cell total GST activity in relation to genetic variation. 
Rectal GST activity. The polymorphisms in GSTM1, GSTT1 and GSTA1 did not 
affect rectal GST activity significantly (Table 4). Rectal GST activity did differ 
significantly between GSTP1 c.313A>G genotypes; the 313AG and GG genotypes 
had 36 and 67 nmol/min.mg protein lower rectal GST activities than the AA 
genotype, respectively. The GSTP1 272GG genotypes showed significantly higher 
rectal GST activity, likely because all 272GG individuals were GSTP1 313AA. The 
GSTP1 g.217G>A and g.227G>A polymorphisms did not affect rectal GST activity 
significantly.  
White blood cell GST activity. In leukocytes, the GSTM1 deletion polymorphism 
was associated with a 28 nmol/min.mg protein lower GST activity (Table 4). As in 
rectum, the GSTP1 313G-variant showed lower activity in leukocytes, but this was 
not statistically significant. The GSTP1 272CG genotype was significantly inversely 
associated with leukocyte activity, which was in contrast to its effect on rectal GST 
activity. In lymphocytes, the GSTP1 c.313A>G polymorphism showed a similar 
trend as in rectum: the 313AG and 313GG genotypes had 17 and 35 nmol/min.mg 
protein lower GST activity than the 313AA genotype, respectively. The GSTP1 
217GA genotypes had significantly lower and the GSTP1 227GA genotypes had 
significantly higher lymphocyte GST activities than their homozygous wildtypes 
(GSTP1 217GG and 227GG, respectively). 
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Rectal and white blood cell total GST activity in relation to fruit and 
vegetable consumption.  Rectal GST activity. There was no statistically significant 
association between fruit and vegetable consumption on the two days prior to 
sigmoidoscopy and rectal GST activity (Table 5). However, when stratifying for the 
GSTM1 deletion polymorphism, there was a significant difference in rectal GST 
activity between those who did and did not report fruit consumption of any kind 
among GSTM1 null individuals (+43 nmol/min.mg protein, p=0.019, data not in 
table), which was not observed among GSTM1 positive individuals (-1.5, p=0.95). 
Also, when adding the GSTP1 c.313A>G polymorphism to the rectal GST activity 
and fruit and vegetable models, there was a significant difference between 
consumers and non-consumers of Alliaceae with respect to total rectal GST activity 
(+24 nmol/min.mg protein, p=0.031).  
White blood cell GST activity. Consumption of citrus juice was slightly inversely 
associated with leukocyte GST activity, and consumption of Alliaceae and 
Cucurbitaceae positively (Table 5). Lymphocyte GST activity appeared to be 
slightly positively associated with citrus fruit consumption.  
Table 4: Rectal and white blood cell GST activity (in nmol DNP-SG/min.mg protein) by GST genotype 
 Rectal total GST activity  White blood cell total GST activity 
   Leukocytes  Lymphocytes 
Genotype 
 
n 
92 
reference mean* 
+/- difference  
(95% CI) 
p-
value  
n 
75 
reference mean* 
+/- difference 
(95% CI) 
p-
value  
n 
93a 
reference mean*  
+/- difference  
(95% CI) 
p-
value 
GSTM1 deletion 
 
gene present 
gene absent 
43 
49 
218 
-4.4 (-27, 19) 
 
0.71 
 34 
41 
149  
-28 (-44, -11) 
 
0.001 
 45 
48 
128 
-3.8 (-16, 8.7) 
 
0.55 
GSTT1 deletion 
 
gene present 
gene absent 
73 
19 
219 
-12 (-40, 16) 
 
0.39 
 61 
14 
135 
-3.2 (-26, 19) 
 
0.78 
 74 
19 
126 
-0.61 (-16, 15) 
 
0.94 
GSTA1 g.-69C>T 
 
 
CC 
CT 
TT 
31 
51 
10 
201 
+23 (-1.2, 48) 
+28 (-12, 68) 
 
0.062 
0.16 
 22 
42 
11 
127 
+11 (-9.0, 31) 
+6.9 (-21, 35) 
 
0.28 
0.63 
 31 
51 
11 
127 
-1.9 (-16, 12) 
-6.0 (-28, 16) 
 
0.79 
0.58 
GSTP1 g.217G>A 
 
 
 
GSTP1 g.227G>A 
 
 
 
GSTP1 g.272C>G 
 
 
 
GSTP1 c.313A>G 
 
 
GG 
GA 
AA 
 
GG 
GA 
AA 
 
CC 
CG 
GG 
 
AA 
AG 
GG 
32 
46 
14 
 
71 
18 
3 
 
21 
57 
14 
 
38 
43 
11 
230 
-21 (-46, 3.9) 
-23 (-58, 11) 
 
216 
+10 (-18, 38) 
-61 (-124, 2.8) 
 
200 
+14 (-13, 41) 
+45 (8.4, 82) 
 
241 
-36 (-59, -13) 
-67 (-100, -33) 
 
0.098 
0.18 
 
 
0.48 
0.061 
 
 
0.30 
0.017 
 
 
0.002 
0.000 
 22 
42 
11 
 
62 
12 
1 
 
15 
49 
11 
 
27 
41 
7 
139 
-12 (-32, 7.7) 
+13 (-14, 41) 
 
130 
+20 (-3.2, 44) 
+44 (-33, 121) 
 
153 
-24 (-46, -2.2) 
-20 (-49, 9.4) 
 
144 
-16 (-35, 2.8) 
-13 (-45, 19) 
 
0.23 
0.34 
 
 
0.090 
0.26 
 
 
0.032 
0.18 
 
 
0.094 
0.48 
 31 
48 
14 
 
73 
17 
3 
 
21 
58 
14 
 
38 
44 
11 
135 
-14 (-28, -0.43) 
-13 (-32, 5.7) 
 
123 
+17 (1.2, 33) 
-0.67 (-36, 34) 
 
126 
-3.3 (-18, 12) 
+12 (-8.2, 33) 
 
138 
-17 (-30, -4.8) 
-35 (-54, -17) 
 
0.043 
0.17 
 
 
0.036 
0.97 
 
 
0.66 
0.24 
 
 
0.007 
0.000 
*adjusted for age, sex, sample storage time  
a1 outlier deleted 
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Similar to observations in rectal biopsies, lymphocyte GST activity among 
GSTM1 null individuals who reported fruit consumption was higher compared to 
those who did not (+18, nmol/min.mg protein p=0.068), and this was not observed 
among GSTM1 positive individuals (-16 nmol/min.mg protein, p=0.28); In 
leukocytes, GST activity among GSTM1 null and positive individuals with fruit 
consumption was +17 (p=0.13) and -5.1 (p=0.76), respectively. The difference in 
rectal GST activity, observed with Alliaceae consumption when the GSTP1 
c.313A>G polymorphism was added to the statistical model, could also be seen in 
lymphocytes: +13 nmol/min.mg protein (p=0.045) and became slightly more 
pronounced in leukocytes: +17 nmol/min.mg protein (p=0.076).  
 
 
Table 5: Rectal and white blood cell total GST activity (in nmol DNP-SG/min.mg protein) by recent fruit and vegetable  
consumption (yes or no) 
   Rectal total GST activity  White blood cell total GST activity 
     Leukocytes  Lymphocytesa 
 
Consumptionb 
 
 
 
n 
90 
reference mean* 
+/- difference 
(95% CI) 
 
p-
value  
n 
73 
reference mean* 
+/- difference 
(95% CI) 
 
p-
value  
n 
91 
reference mean* 
+/- difference 
(95% CI) 
 
p-
value 
Total fruit 
 
no 
yes 
 20 
70 
209 
+22 (-5.5, 50) 
 
0.12 
 19 
54 
133 
+5.7 (-15, 26) 
 
0.58 
 20 
71 
124 
+5.4 (-12, 22) 
 
0.51 
Citrus fruit 
 
no 
yes 
 64 
26 
223 
+5.8 (-21, 32) 
 
0.66 
 51 
22 
136 
+0.61 (-20, 22) 
 
0.95 
 65 
26 
125 
+13 (-2.2, 27) 
 
0.095 
Citrus juice 
 
no 
yes 
 71 
19 
227 
-17 (-45, 10) 
 
0.21 
 54 
19 
140 
-18 (-37, 1.0) 
 
0.063 
 70 
21 
129 
-9.3 (-24, 5.8) 
 
0.23 
Total vegetables 
 
no 
yes 
 11 
79 
222 
+2.9 (-33, 39) 
 
0.88 
 10 
63 
135 
+0.93 (-26, 28) 
 
0.95 
 12 
79 
119 
+9.5 (-10, 29) 
 
0.34 
Alliaceae 
 
no 
yes 
 54 
36 
218 
+15 (-9.0, 38) 
 
0.22 
 41 
32 
129 
+16 (-2.3, 33) 
 
0.086 
 56 
35 
124 
+7.5 (-6.1, 21) 
 
0.27 
Apiaceae 
  
no 
yes 
 65 
25 
226 
-5.8 (-31, 20) 
 
0.65 
 51 
22 
135 
+2.2 (-17, 21) 
 
0.82 
 65 
26 
125 
+8.5 (-5.8, 23) 
 
0.24 
Brassicaceae 
 
no 
yes 
 61 
29 
228 
-11 (-36, 13) 
 
0.36 
 46 
27 
136 
-0.65 (-19, 18) 
 
0.94 
 62 
29 
128 
-2.6 (-17, 11) 
 
0.71 
Cucurbitaceae 
 
no 
yes 
 61 
29 
222 
+8.2 (-17, 33) 
 
0.52 
 49 
24 
131 
+18 (-0.10, 37) 
 
0.051 
 62 
29 
126 
+5.7 (-8.4, 20) 
 
0.42 
aone outlier deleted 
bon (one of) the two days before specimen collection 
*adjusted for age, sex, sample storage time, smoking 
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DISCUSSION  
The results from this human observational study confirm that both genetic 
variation and recent consumption of fruits and vegetables influence the GST 
enzyme system. The GSTM1, GSTT1 and GSTA1 g.-69C>T polymorphisms clearly 
affected their respective isoenzyme levels. Consumption of specific fruits and 
vegetables was also associated with differences in specific rectal GST isoenzyme 
levels; GSTM1 level was higher among consumers of citrus, GSTM2 level was 
lower among total vegetable and Apiaceae consumers, GSTT1 level was higher 
among consumers of Alliaceae, and GSTP1 level was higher among consumers of 
Alliaceae and Cucurbitaceae. The consequences for the rectal GST activity are not 
obvious; activity was most affected by the GSTP1 c.313A>G polymorphism, 
whereas fruit and vegetable consumption in itself did not seem influential. GST 
activity in white blood cells did appear to be affected by fruit and vegetable 
consumption to some extent, and next to GSTP1 polymorphisms also by the 
GSTM1 deletion genotype.  
We will first discuss the polymorphisms, and then fruit and vegetable 
consumption, in relation to GST phenotype.  
In our population, the GSTA1 g.-69C>T polymorphism affected rectal GSTA 
enzyme level, which is consistent with knowledge about the functionality of the 
polymorphism30. GSTA level as measured by us, consists of GSTA1 and GSTA2 
protein. As we observed GSTA levels of zero (among the GSTA1 -69TT-genotypes), 
the expression of the GSTA2 subunit was apparently below detection in these 
subjects. Possibly, the reversed co-expression between GSTA1 and GSTA2, as 
reported for liver26, does not operate in the colorectal area. The GSTP1 c.313A>G 
polymorphism did not have a clear relationship with its enzyme level, but clearly 
affected rectal total GST activity. It leads to an amino acid change, with 
consequences for substrate binding and thermal stability, i.e. lower GSTP1 
activity19, 31. The abundance of GSTP1 enzyme in the rectum, in combination with 
the lower activity of the variant GSTP1 protein, explains the great influence of the 
GSTP1 c.313A>G polymorphism on total GST activity in the rectum. The effect of 
the other GSTP1 polymorphisms may be related to the GSTP1 c.313A>G 
polymorphism, as the 313A-allele occurred most frequently with the 272G-allele, 
and the 313G-allele with the 217A-allele. However, a larger population should be 
genotyped for more definitive answers concerning their linkage.  
Consumption of different types of fruits and vegetables appeared to influence 
rectal individual GST isoenzyme levels, while it did not seem to influence rectal 
total GST activity. In the literature, several GST protein phenotypes and fruit and 
vegetable subtypes have been investigated, in different tissues. Most studies have 
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focussed on Brassicaceae11, 13, 14, 16, 17, 32-34: higher levels of GSTA11, 13-15 and GSTP111, 
and higher total GST activity17 and GSTM activity15 have been reported. We 
observed higher GSTM1 levels in rectum among Brassicaceae consumers (~30%, 
not significant), but a significant positive effect of Brassicaceae consumption on 
GST isoenzyme levels or GST activity was not seen. Lampe et al. also studied 
Alliaceae and Apiaceae vegetables; After Alliaceae supplementation, they observed 
higher GSTM activity15. In our study, individuals who consumed Alliaceae had 
significantly higher GSTT1 and GSTP1 level. The latter is in contrast with Wark et 
al. who, also from observational data, noted downregulation of rectal GSTP1 with 
higher Alliaceae consumption35. After Apiaceae supplementation, Lampe et al. 
observed lower serum GSTA levels15. They have also reported decreased CYP1A2 
activity with Apiaceae consumption36. In our study, rectal GSTM2 appeared to be 
downregulated by Apiaceae. There are indications from cell studies that 
phytochemicals from Apiaceae and Brassicaceae downregulate certain enzymes37, 
38. Also, we observed lower GSTP1 levels with total vegetable consumption, to a 
level of about 85% of those who did not consume any vegetables on one of the two 
days before endoscopy; This effect appeared to be due to Apiaceae and 
Brassicaceae vegetables. A similar decrease in GSTP1 level was noted in 
lymphocytes by Persson et al. after a mixed vegetable diet, containing Apiaceae 
and Brassicaceae39. Overall, inconsistencies concerning the effect of fruit and 
vegetable consumption on GST phenotype remain. Differences in study results 
may be related to study design (intervention versus observational), time frame and 
method of food consumption measurement (food frequency questionnaire versus 
food record), coding of consumption (yes/no vs high/low or continuous), type of 
tissue that was sampled, or laboratory methods. In general, studies are small, and 
only few have taken genetic variation into account. 
Our a priori calculation of power and sample size required for comparison of 
phenotype by genotype groups was based on data by Coles et al.26 and Siegel et 
al.40. We estimated that a total group of 100 subjects and differing genotype 
frequencies would yield a power of >75% to detect relevant protein differences 
between at least two of the three genotype groups. To uncover the interplay 
between several different exposures and genes, however, larger studies are 
needed. As sampling of rectal material is invasive and impractical, blood GST 
activity could be a useful surrogate measure. We therefore compared white blood 
cell and rectal GST activity, but the correlation between the two was low. Despite 
earlier reports33, 41, blood may not be a good surrogate tissue. Possibly, taking 
genotype into account improves its value.  
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The study population consisted of individuals undergoing sigmoidoscopy for 
diagnostic reasons. Possible disadvantages are presence of colorectal 
abnormalities, bowel preparation, and lower food consumption. Colorectal 
abnormalities (i.e. diverticula, hemorrhoids, and adenomas) were minor however, 
and though their distribution over the GST activity median-based groups was 
different, they did not influence statistical models. Bowel preparation for 
endoscopy may have affected phenotype, by itself or by lowering absorption and 
delivery of (non)nutrients to the rectal crypts. If it did, subjects at least were 
affected similarly, as preparations were similar. Subjects were not restricted in their 
food consumption, but energy intake was relatively low (7930 ± 2136 kJ/day), as 
was vegetable intake, which may have resulted in relatively low amounts of 
inducer. The purpose of our food record was to estimate actual and not habitual 
consumption, because induction of GST enzymes occurs rapidly, in a matter of 
hours to days after consumption of the inducer17, 34, 42.  
Assessment of polymorphisms was reproducible, and distributions of the 
GSTM1, GSTT1, GSTA1 g.-69C>T and GSTP1 c.313A>G polymorphisms were 
similar to previous findings43, 44. The distribution of the other GSTP1 
polymorphism are not easily compared to that of the multi-ethnic population on 
the NCBI SNP-website (www.ncbi.nlm.nih.gov/SNP, accessed September 19th 
2006). 
Interindividual GST expression was highly variable in our study, which is in 
line with other reports3. Between studies, reported GST isoenzyme levels7, 35, 45 also 
vary, as do GST activities11, 12, 33, 35, 41, 46, 47. This may be related to the method of total 
protein measurement, by which GST measures are normalised; these are known to 
recover different amounts of protein48, 49. It may also be related to differences in 
population characteristics, such as genetic differences, age, sex, smoking or dietary 
habits.  
A general point of attention is the substrate used to measure GST activity, 
which was CDNB, as in most studies. The different GST enzymes contribute 
differently to its metabolism: the order of highest to lowest specific activity is 
GSTM2, GSTM1, GSTP1, GSTA, whereas GSTT1 has no activity for CDNB1. Total 
GST activity is an important measure for generic carcinogenic substrates. But, if not 
all GST isoenzymes or only those with lower specific activity are affected by a 
polymorphism or fruit and vegetable consumption, an effect may be difficult to 
visualize. It may, however, still be relevant, because numerous substrates are 
specifically metabolized by individual GST isoenzymes (e.g. N-acetoxy PhIP by 
GSTA1)2, 3.  
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The results of the present study contribute to a better understanding of both 
possibilities and limitations for food mediated health effects. When investigating 
GST phenotype, genotype needs to be taken into account. White blood cell total 
GST activity may be unsuitable as a surrogate for rectal total GST activity. Thus, 
large and invasive studies are needed to evaluate the true effects of fruits and 
vegetables on rectal GSTs in human populations.  
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ABSTRACT 
The possible interplay between cruciferous vegetable consumption, functional 
genetic variations in glutathione-S-transferases (GST) M1, T1, P1 and A1, and 
colorectal adenomas, was investigated in a Dutch case-control study. The GSTM1 
and GSTT1 deletion polymorphisms, and single nucleotide polymorphisms in 
GSTP1 (A313G) and in GSTA1 (C-69T) were assessed among 746 cases with 
colorectal adenomas ever in their lives and 698 endoscopy-based controls without 
any type of colorectal polyps. High and low cruciferous vegetable consumption 
was defined based on a median split in the control group. High consumption was 
slightly positively associated with colorectal adenomas, odds ratio (OR) 1.15, 95% 
confidence interval (CI) 0.92-1.44. For GSTP1, a positive association with higher 
cruciferous vegetable intake was only apparent in individuals with the low activity 
GSTP1 genotype (GG genotype, OR 1.94; 95% CI 1.02-3.69). This interaction was 
more pronounced in men, with higher age and with higher meat intake. The 
GSTA1 polymorphism may have a modifying role as well: the OR for higher intake 
compared to lower intake was 1.57 (0.93-2.65) for individuals homozygous for the 
low expression variant (TT genotype). This appeared to be stronger with younger 
age and higher red meat intake. Cruciferous vegetable consumption and the 
combined GSTA1 and GSTP1 genotypes showed a statistically significant 
interaction (p=0.034). The GSTM1 and GSTT1 genotypes did not seem to modify 
the association between cruciferous vegetable intake and colorectal adenomas. In 
conclusion: GSTP1 and GSTA1 genotypes may modulate the association between 
cruciferous vegetable intake and colorectal adenomas. 
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INTRODUCTION 
Diet and other lifestyle factors are thought to play a major role in the colorectal 
neoplastic process1, 2. Sporadic colorectal cancers arise from acquired DNA 
alterations which progressively facilitate uncontrolled cell growth, are 
predominantly epithelial and most are preceded by adenomas3.  
Consumption of vegetables of the family Cruciferae - in Western food patterns 
consisting mostly of the genus Brassica, including cabbage, cauliflower, Brussels 
sprouts and broccoli - has been associated with a decreased risk of colorectal 
adenomas and cancer4, though not consistently5-10. Cruciferous vegetables 
characteristically contain glucosinolates, phytochemicals that are hydrolyzed to the 
biologically active isothiocyanates (ITCs)11. ITCs demonstrate several anti-cancer 
properties, including induction of phase II biotransformation enzymes such as 
glutathione S-transferases (GSTs, EC 2.5.1.18)11, 12. Thus, they may enhance the 
detoxification and excretion of carcinogens and prevent alterations to the DNA13. 
In addition, ITCs are substrates for GSTs14-16 and thus GSTs contribute to the 
excretion of ITCs. The involvement of GSTs in ITC metabolism has led to the 
hypothesis that, through slower excretion of ITCs from the body in individuals 
with genetic variants associated with lower GST capacity, ITCs have more 
opportunity to exert their chemoprotective effects in these individuals17.  
Genetic polymorphisms that result in constitutively lower or absence of GST 
enzyme activity or expression are known for most GST isoforms18. Research has 
mostly focussed on the GSTM1 and GSTT1 deletion polymorphisms (“null”-
genotypes). These partial gene deletions result in absence of the GSTM1 or GSTT1 
enzyme, and occur among a range of 23-62% and 10-64% of the worldwide 
population, respectively19. A functional polymorphism resulting in a less active 
enzyme with lower thermal stability is known in the GSTP1 gene20. This A to G 
substitution at nucleotide position 313, changing an isoleucine to a valine amino 
acid, is present homozygously in 4-12% of the population21. GSTP1 is the most 
abundant GST iso-enzyme in the colon22. A variant haplotype resulting in 3-4 fold 
lower expression has been identified in the GSTA1 promoter23, and occurs 
homozygously in 2-14% of the population24. 
Some epidemiologic studies indicate an interplay between crucifer 
consumption and metabolism by GSTs. GSTT1-null subjects were found to have 
significantly lower urinary excretion of isothiocyanates relative to GSTT1-positive 
subjects in the Singapore Chinese Health Study25. In this cohort study, a 
significantly lower risk of colon cancer was observed among individuals without 
both the GSTM1 and GSTT1 genes who had high intakes of cruciferous vegetables, 
compared to those with low intakes; this was not seen among individuals with one 
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or both genes present26. In a UK case-control study, a significant inverse association 
between high versus low cruciferous vegetable consumption and colorectal cancer 
risk was observed among individuals with the GSTT1 null genotype as compared 
to those with one or both alleles present27. In the US, Lin et al. observed a lower 
risk of colorectal adenomas with higher consumption of cruciferous vegetables (in 
particular broccoli), which was statistically significant in individuals who lacked 
the GSTM1 gene only17. The aim of the present case-control analysis was to further 
explore the hypothesis that in individuals with lower imputed GST capacity (here: 
GSTM1 null, GSTT1 null, GSTP1 313 G and GSTA1 -69 T variants), higher 
cruciferous vegetable consumption is associated with a greater reduction of the 
risk of colorectal adenomas in a Dutch population.  
 
METHODS 
Population. Study design and population have been described before28, 29. Cases 
and controls were recruited among those undergoing endoscopy in 10 endoscopy 
outpatient clinics in the Netherlands between June 1997 and October 2002. 
Participants were informed of the study by endoscopy staff at the time of 
endoscopy or by mail at three-month intervals using endoscopy reports of all 
patients who had undergone endoscopy. All received the same information 
package. Eligibility criteria were: Caucasian, Dutch speaking, age 18-75 years at 
time of endoscopy, no hereditary colorectal cancer syndromes, no chronic 
inflammatory bowel disease, no history of colorectal cancer and no (partial) bowel 
resection. Cases had at least one histologically confirmed colorectal adenoma ever 
in their lives. Suitability of this case definition was confirmed by analyses restricted 
to cases who were first diagnosed at endoscopy of inclusion, yielding similar 
conclusions. Controls had no medical history of any type of polyp, confirmed by 
full colonoscopy (75%) or sigmoidoscopy combined with X-ray (10%). Fifteen 
percent of subjects did not have full visualisation of the colon, i.e. they had a 
sigmoidoscopy without X-ray or colonoscopy where the caecum was not reached. 
The study was approved by the Medical Review Boards of all participating 
hospitals and of Wageningen University. The overall response rate was estimated 
to be 55%, varying from 35% to 90% between outpatient clinics. The total study 
population consisted of 1477 participants (768 cases and 709 controls). All gave 
their written informed consent.  
Diet and other lifestyle factors. Dietary intake was assessed by a self-
administered food frequency questionnaire (FFQ) developed for the Dutch 
European Prospective Investigation Into Cancer (EPIC) cohort and processed using 
the Dutch food composition table30. Cruciferous vegetable consumption was 
60 Chapter 3 
 
calculated as the sum of raw and cooked crucifers. For cooked crucifers the 
frequency question was phrased ‘how often do you habitually consume Brussels 
sprouts, cauliflower, broccoli and (other) cabbage’, which covers the most 
commonly consumed cruciferous vegetables in the Netherlands. Frequency of 
cooked vegetable consumption could be indicated per day, week, month or year. If 
the sum of frequencies for the individual cooked vegetables was not equal to the 
question on total cooked vegetable consumption, the frequencies for individual 
vegetables were corrected proportionally30. Raw cabbage was measured as one of 
ten types of raw vegetables and frequency of consumption could be indicated 
always/most of the time, often, sometimes or seldom/never. Color photographs 
were included for 21 food items; cooked and raw crucifer portion size were 
estimated from a photograph containing cooked red cabbage and raw mixed salad, 
respectively. Frequencies and portion sizes were multiplied to obtain grams for 
each food item. The FFQ referred to habitual intake in the year preceding 
endoscopy or bowel problems. General lifestyle factors and disease-related issues, 
such as physical activity, smoking, self-reported family history of cancer and 
dietary changes due to bowel problems, were assessed by a self-administered 
questionnaire. Both FFQ and general questionnaire were handed at the time of 
endoscopy or sent within three months after endoscopy. Endoscopy-related and 
other medical information was abstracted from the patient’s medical record. 
Genotyping. EDTA treated whole blood was collected and stored at -20ºC 
until DNA extraction (QIAamp 96 DNA blood kit, Qiagen Inc.). An average DNA 
concentration of approximately 20 ng/μl was used for genotyping analyses. DNA 
was stored at 4ºC, in random order in 8*12 array banks. Samples were interspersed 
with water controls to check for cross-contamination. Laboratory staff was blinded 
for case-control status.  
The GSTM1 and GSTT1 deletion polymorphisms were determined using a 
general multiplex polymerase chain reaction (PCR) amplification method31. A ß-
globin gene fragment was present as a positive control. The GSTP1 A313G 
polymorphism was assessed by PCR amplification followed by RFLP according to 
Harries32. The GSTA1 C-69T polymorphism was determined by PCR-RFLP, 
according to Coles et al.23. They reported this SNP to be fully linked (in 55 liver 
samples) to a G to A substitution at position -52 in the promoter region23, which 
has been shown to be functional in cell studies33. In a subsample of 93 individuals 
we determined the nucleotide sequence of the relevant promoter region by strand 
termination sequencing, and also found that the C-69T SNP and the presumed 
functional G–52A SNP were in 100% linkage disequilibrium. Some modifications to 
the Coles’ PCR-RFLP protocol were made; Denaturing, annealing and elongation 
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times were set at 30, 30 and 45 seconds, respectively, and annealing temperature at 
61°C. In the RFLP, the Eam1104I restriction enzyme was used (Fermentas Inc.). 
Positive controls were included in the genotyping analyses. GSTP1 and GSTA1 
genotypes were in Hardy Weinberg Equilibrium among both controls and cases, as 
tested by a χ2 test. To test reproducibility, one row out of each DNA bank (8% of 
the population) was genotyped in duplo; reproducibility was 100%. 
Data analysis. Eighteen participants (11 cases, 7 controls) were excluded 
because blood was unavailable or the amount of DNA insufficient and therefore all 
polymorphism results were absent. Fifteen patients (11 cases, 4 controls) were 
excluded because of incomplete data on vegetable consumption. This resulted in a 
final population of 746 cases and 698 controls.  
Cruciferous vegetable intakes were dichotomized by a median split based on 
the distribution in the control group. Conventional logistic regression was used to 
calculate odds ratios and 95% confidence intervals, using a single reference group 
(low GST capacity variant and low crucifer intake).  
Evaluated as possible confounders of the relation between median split 
cruciferous vegetable intake and colorectal adenomas were: consumption of fruit, 
vegetables minus crucifers, meat; intake of energy, folate, calcium, dietary fibre, 
vitamin C, coffee, alcohol, and saturated fat; physical activity, use of NSAIDs, 
smoking, education, hormone replacement therapy, body mass index, abdominal 
problems, defecation problems and self-reported family history of colorectal 
cancer. Folate intake, age (four categories) and sex changed the β-estimate by 35%, 
20% and 20%, respectively, and were included in the model. Energy intake did not 
affect the estimates, but was included for comparability with other studies. 
The p-value for interaction was calculated by χ2 test comparing the –2 log 
likelihood (-2LL) values of the models with and without crucifer-by-genotype 
interaction term(s). P-values lower than 0.05 were considered statistically 
significant. Genotypes were considered individually and in combinations; 
grouping rationales were: correspondence with the literature (GSTM1/T1), high 
colonic gene expression (GSTP1/T1), high hepatic gene expression (GSTA1/M1), 
and posterior combination of most promising separate genotypes (GSTP1/A1). 
The crucifer-by-genotype interaction was further studied in strata of age 
(higher and lower than 55 years), sex, smoking (ever and never) and meat 
consumption (fresh red and processed, higher and lower than median intake). 
Stratifying rationales were: indication from the literature for a possible 
modification by age34 and sex35, and our hypothesis that individuals with high 
exposure to (pro)carcinogens from meat and cigarettes may benefit most from low 
activity GST variants in combination with high cruciferous vegetable intake. For 
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comparison, the cruciferous vegetable median split based on population controls 
was maintained. Sex-specific median cut-off points yielded similar estimates as 
population-based medians, to enable comparison we present the latter.  
Statistical analyses were performed using SAS software, version 9.1 (SAS 
Institute, Cary, NC). 
 
RESULTS  
Table 1 shows the characteristics of the study population. The control group 
included more women than the case group. Cases were older and more often 
smokers. Controls more often had defecation problems or other abdominal 
complaints than cases. Cases, on the other hand, more often experienced rectal 
bleeding and more often had a history of endoscopy and came for surveillance. 
Cases consumed more cruciferous vegetables and total vegetables than controls, 
and had a higher alcohol intake. The distribution of GST variants did not differ 
between cases and controls. 
In table 2, the associations between cruciferous vegetable intake, GST 
polymorphisms and colorectal adenomas are presented. Consumption of 
cruciferous vegetables was slightly positively associated with colorectal adenomas. 
A positive association with higher cruciferous vegetable intake was more obvious 
for the GSTP1 low activity genotype (GG) and GSTA1 low expression genotype 
genotype (TT). The combination of GSTP1 and GSTA1 genotypes showed a 
statistically significant interaction with cruciferous vegetable consumption; 
adenoma risk was higher with high cruciferous vegetable intake for subjects with 
one or both of the low capacity genotypes (GSTP1 GG or GSTA1 TT), but not for 
subjects with both high capacity variants (GSTP1 AA and GSTA1 CC). In the low 
crucifer group, the high capacity variants appeared to have a higher adenoma risk 
than the low capacity variants. GSTM1 and GSTT1 deletion polymorphisms did 
not seem to affect the association between cruciferous vegetable intake and 
colorectal adenomas.  
When, instead of a median split, we used tertiles of cruciferous vegetable 
intake, the high crucifer intake*low GSTP1 activity (GG) variant and high crucifer 
intake*low GSTA1 expression (TT) variant still had the highest adenoma risk: OR 
1.52 (95% CI 0.70-3.28, p value for interaction 0.081), and 2.27 (1.21-4.24, p=0.054), 
respectively. Cruciferous vegetable consumption expressed as a continuous 
variable showed significant interaction with the GSTA1 variants (p=0.030). 
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Table 1: Population characteristics
 
Characteristic 
Cases 
n=746 
Controls 
n=698 
General   
Sex % female 46.5 61.8 
Age (mean±sd)  years 59.0±10.1 51.5±13.6 
Smoking status % ever 66.8 55.3 
BMI (mean±sd)  26.1±3.9 25.5±4.1 
Physical activity % low 38.2 33.2 
Regular NSAID use 
(≥12/yr) 
% yes 
 
26.7 
 
29.7 
 
Education % lowa 35.9 33.0 
Medical, % yes   
Family history of colorectal cancer 23.2 20.0 
Abdominal complaints  
Defecation problems 
Blood loss per anum 
Surveillance/follow-up 
34.0 
25.7 
30.6 
48.0 
59.0 
43.4 
18.9 
6.1 
Dietary intake, median (10-90 percentile)  
Energy  kJ/d 8394 (5889-11800) 8113 (5452-11808) 
Cruciferous 
vegetables           
g/wk 
freq/wk 
137 (41-322) 
0.9 (0.3-1.9) 
129 (32-289) 
0.8 (0.2-1.7) 
Total vegetablesb      
g/d 
freq/wk 
114 (69-180) 
7.0 (4.6-11.5) 
109 (68-169) 
7.0 (4.7-11.0) 
Total fruit 
 
g/d 
freq/wk 
127 (18-367) 
7.0 (1.0-21.0) 
125 (27-350) 
7.0 (1.5-21.0) 
Folate  μg/d 194 (139-272) 185 (131-260) 
Dietary fibre g/d 23 (15-32) 23 (15-32) 
Total meat  
g/d 
freq/wk 
107 (40 – 177) 
14.5 (5.9-31.0) 
102 (35 – 172) 
14.0 (5.4-29.9) 
Fresh red meat       
 
g/d 
freq/wk 
60 (16 – 100) 
4.3 (1.7-6.0) 
53 (13 – 96) 
4.2 (1.6-6.1) 
Processed meat        
 
g/d 
freq/wk 
30 (6 – 75) 
9.2 (1.03-25.4) 
29 (5 – 73) 
8.4 (1.09-24.1) 
Alcohol  g/day 9 (0-42) 4 (0-31) 
Coffee cups/day 4 (2-7) 4 (0-8) 
Genotype distribution, %   
GSTM1 
GSTT1  
GSTP1 
GSTA1 
present/null 
present/null     
AA/AG/GG 
CC/CT/TT 
48.6/51.4 
82.0/18.0 
42.5/45.3/12.2 
33.8/47.9/18.3 
45.9/54.1 
81.8/18.2 
42.8/45.3/11.9 
34.8/47.1/18.1 
aprimary school or lower vocational training only 
bdefinition of total vegetables includes non-starch legumes (string beans and peas) and excludes potato
and vegetable juice 
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Table 2: Interplay between cruciferous vegetable intake (g/wk), GST genotypes, and the risk of colorectal  
adenomas 
 
n  
(cases/controls) 
Age + sex adjusted OR (95% CI) 
p for interactiona 
 Multiple adjusted*  OR (95% CI) 
p for interactiona 
Crucifer intakeb 
 
≤ 129 
g/wk 
> 129  
g/wk 
≤ 129  
g/wk 
> 129  
g/wk 
 ≤ 129  
g/wk 
> 129  
g/wk 
All genotypes 336/349 410/349 1 1.22 (0.98-1.52)  1 1.15 (0.92-1.44) 
Individual genotypesc       
GSTM1 
null 
present 
 
168/185 
166/163 
 
213/192 
194/157 
 
1 
1.09 (0.79-1.49) 
 
1.18 (0.87-1.59) 
1.39 (1.01-1.89) 
  
1 
1.09 (0.80-1.50) 
 
1.12 (0.83-1.53) 
1.30 (0.94-1.79) 
   0.72 0.81 
GSTT1 
null 
present 
 
62/61 
272/287 
 
71/66 
336/283 
 
1 
0.97 (0.64-1.46) 
 
1.13 (0.68-1.88) 
1.20 (0.80-1.80) 
  
1 
0.99 (0.65-1.49) 
 
1.08 (0.64-1.80) 
1.15 (0.76-1.73) 
   0.75 0.79 
GSTP1 
dGG 
AG 
AA 
 
34/43 
151/169 
148/137 
 
56/40 
183/147 
166/162 
 
1 
1.22 (0.72-2.07) 
1.43 (0.84-2.43) 
 
2.06 (1.09-3.89) 
1.61 (0.95-2.71) 
1.39 (0.82-2.34) 
  
1 
1.22 (0.72-2.06) 
1.40 (0.82-2.39) 
 
1.94 (1.02-3.69) 
1.50 (0.89-2.55) 
1.30 (0.76-2.20) 
   0.10 0.11 
GSTA1 
dTT 
CT 
CC 
 
53/63 
166/169 
113/117 
 
82/63 
187/160 
136/126 
 
1 
1.26 (0.81-1.97) 
1.19 (0.75-1.91) 
 
1.67 (1.00-2.81) 
1.42 (0.91-2.21) 
1.39 (0.87-2.21) 
  
1 
1.24 (0.79-1.95) 
1.17 (0.73-1.88) 
 
1.57 (0.93-2.65) 
1.32 (0.84-2.06) 
1.30 (0.82-2.08) 
   0.42 0.43e 
Genotype combinations  
GSTM1/T1 
both null 
M1 or T1 null 
both present 
 
30/33 
170/180 
134/135 
 
32/36 
220/186 
155/127 
 
1 
1.18 (0.67-2.07) 
1.16 (0.66-2.06) 
 
1.15 (0.56-2.35) 
1.37 (0.79-2.39) 
1.53 (0.86-2.71) 
  
1 
1.21 (0.69-2.12) 
1.20 (0.67-2.11) 
 
1.11 (0.54-2.29) 
1.33 (0.76-2.32) 
1.46 (0.82-2.59) 
   0.86 0.91 
GSTP1/A1 
P1 GG and/or A1 TT 
remaining genotypes 
P1 AA and A1 CC 
 
81/100 
196/211 
54/38 
 
129/94 
216/196 
60/59 
 
1 
1.23 (0.85-1.77) 
1.71 (1.00-2.92) 
 
1.87 (1.23-2.84) 
1.37 (0.95-1.99) 
1.33 (0.81-2.16) 
  
1 
1.22 (0.84-1.77) 
1.69 (0.99-2.88) 
 
1.76 (1.16-2.69) 
1.28 (0.88-1.87) 
1.24 (0.76-2.03) 
   0.033 0.034 
GSTA1/M1 
A1 CT/TT and M1 null 
A1 CC and M1 null 
A1 CT/TT and M1 pres 
A1CC and M1 pres 
 
118/127 
49/58 
100/104 
64/59 
 
143/125 
66/67 
124/98 
69/59 
 
1 
0.93 (0.58-1.50) 
1.03 (0.70-1.52) 
1.11 (0.70-1.74) 
 
1.18 (0.82-1.70) 
1.05 (0.67-1.64) 
1.38 (0.94-2.02) 
1.33 (0.85-2.09) 
  
1 
0.94 (0.58-1.51) 
1.04 (0.70-1.54) 
1.10 (0.70-1.74) 
 
1.12 (0.78-1.62) 
1.03 (0.66-1.60) 
1.30 (0.88-1.91) 
1.25 (0.79-1.97) 
   0.96 0.98 
GSTP1/T1 
P1 AG/GG and T1 null 
P1 AA and T1 null 
P1 AG/GG and T1 pres 
P1 AA and T1 pres 
 
35/35 
27/26 
149/176 
120/111 
 
45/34 
26/32 
194/153 
137/130 
 
1 
1.03 (0.49-2.18) 
0.88 (0.51-1.52) 
1.10 (0.63-1.93) 
 
1.36 (0.69-2.68) 
0.91 (0.44-1.89) 
1.30 (0.76-2.22) 
1.08 (0.62-1.88) 
  
1 
0.99 (0.46-2.09) 
0.89 (0.51-1.53) 
1.09 (0.62-1.92) 
 
1.26 (0.64-2.49) 
0.87 (0.41-1.81) 
1.23 (0.71-2.11) 
1.01 (0.58-1.76) 
   0.34 0.37 
*adjusted for age (in 4 categories: <45, <55, <65, <75 y), sex, energy intake (kJ/d) and folate intake (g/d) 
acalculated as the LR test comparing the models with and without crucifer-by-genotype interaction terms 
bmean cruciferous vegetable intake was 73.1±36.3 g/wk and 70.3±36.6 g/wk for cases and controls, respectively, in the lower-than-median intake 
group; and 242.5±108.4 g/wk and 230.3±109.2 g/wk, respectively, in the higher-than-median intake group 
cnumbers do not always add up to numbers under ‘all genotypes’ due to missing genotype-data (M1,T1: 6; P1:8; A1:9) 
dleast active/expressed variant(s)  
ewhen cruciferous vegetable intake is considered as a continuous variable, crucifer*genotype interaction is significant, p=0.030 
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About half (n=394) of all cases did not have a history of colorectal polyps. Analyses 
restricted to these newly diagnosed cases yielded similar conclusions, with more 
pronounced results for GSTP1 and GSTA1 genotypes; for GSTP1, the OR for high 
crucifer intake*GSTP1 GG-genotype was 2.90 (95% CI 1.32-6.39; p value for 
interaction 0.029); for GSTA1, the OR for high crucifer intake*GSTA1 TT-genotype 
was 1.92 (1.03-3.58, p= 0.17); and for the combined GSTA1 and GSTP1 genotypes, 
the p value for interaction was 0.0023, with an OR of 2.31 (1.40-3.84) for the high 
intake*low GST capacity combination. Median intake of cruciferous vegetables 
among incident cases was slightly, but not statistically significantly, lower than 
intake among prevalent cases (143 vs.135 g/week, p=0.48). 
In fifteen percent of our controls a full visualisation of the colon was not 
accomplished. However, restriction to controls with full visualisation (n=591) 
yielded similar results as analyses including all controls (data not shown). 
Further evaluation in strata of age and sex showed differences in colorectal 
adenoma risk (table 3). GSTP1 genotypes and cruciferous vegetable intake showed 
a statistically significant interaction in the higher, but not in the lower age category; 
The GSTA1 genotype showed a near-significant interaction with cruciferous 
vegetable medians in the lower age category, only. In men, but not in women, 
there was statistically significant interaction between the GSTP1 genotype and 
cruciferous vegetable intake. Noteworthy in this respect is the lower prevalence of 
the GSTP1 GG genotype in men: 10.2% (cases 10.6%, controls 9.7%) versus 13.6% 
for women (cases 14.0%, controls 13.3%) (p=0.054). The overall colorectal adenoma 
risk (without genotype stratification) with higher cruciferous vegetable 
consumption appeared higher in men. In individuals with a positive family history 
of colorectal cancer, prevalence of the GSTA1 low expression genotype (GSTA1 TT) 
was significantly lower than in individuals without a positive family history of 
cancer (13.5% vs. 19.1%, p=0.027).  The overall colorectal adenoma risk with higher 
cruciferous vegetable consumption was higher in individuals with a positive 
family history: OR 1.83 (1.12-3.01). Unfortunately, power was too low for gene-
environment analyses in separate strata of family history.  
In strata of possible environmental exposure to carcinogens (table 4), the 
higher risk with higher cruciferous vegetable intake associated with the low 
activity GSTP1 variant appeared more pronounced in subgroups of higher (red 
and processed) meat consumption and slightly in non-smokers. For GSTA1, results 
appeared more pronounced in the higher red meat subgroup. 
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 Table 4: Interplay between cruciferous vegetable intake (g/wk), GSTP1 and GSTA1 genotype, and the risk  
of colorectal adenomas in subgroups of meat consumption and smoking 
   
n 
(cases/controls) 
OR (95% CI)* 
p for interactiona  
n 
(cases/controls) 
OR (95% CI)* 
p for interactiona 
Crucifer intakeb 
  
≤ 129 
g/wk 
> 129 
g/wk 
≤ 129
g/wk 
> 129
g/wk  
≤ 129
g/wk 
> 129
g/wk 
≤ 129
g/wk 
> 129 
g/wk 
RED MEATc  ≤53 g/d > 53 g/d  
All genotypes  161/173 161/176 1 0.93 (0.66-1.30) 175/176 249/173 1 1.36 (1.00-1.86) 
GSTP1 
 
 
dGG 
AG 
AA  
17/19 
65/85 
78/69 
26/24 
68/77 
65/75 
1 
1.05 (0.48-2.28) 
1.33 (0.61-2.89) 
1.44 (0.58-3.61)
0.97 (0.44-2.11) 
1.08 (0.49-2.38)  
17/24
86/84 
70/68 
30/16
115/70 
101/87 
1
1.39 (0.67-2.89) 
1.34 (0.63-2.82) 
2.67 (1.07-6.69) 
2.04 (0.98-4.22) 
1.48 (0.72-3.04) 
    0.56  0.22 
GSTA1 
 
 
dTT 
CT 
CC  
29/30 
86/87 
46/56 
28/33 
64/76 
67/67 
1 
1.12 (0.59-2.12) 
0.85 (0.43-1.70) 
1.05 (0.48-2.28)
0.78 (0.40-1.51) 
1.04 (0.53-2.02)  
24/33
80/82 
67/61 
54/30
123/84 
69/59 
1
1.41 (0.74-2.67) 
1.66 (0.86-3.22) 
2.36 (1.14-4.87) 
2.01 (1.07-3.77) 
1.66 (0.86-3.24) 
   0.30 0.16 
PROCESSED MEATe ≤ 29 g/d   > 29 g/d  
All genotypes  156/160 189/189 1 0.96 (0.69-1.33)  180/189 221/160 1 137 (1.00-1.88) 
GSTP1 
 
 
dGG 
AG 
AA  
19/18 
73/68 
62/74 
28/24 
79/89 
79/76 
1 
1.11 (0.51-2.40) 
0.87 (0.40-1.89) 
1.23 (0.50-3.03) 
0.81 (0.38-1.75) 
1.03 (0.48-2.22)  
15/25 
78/101 
86/63 
28/16 
104/58 
87/86 
1 
1.42 (0.68-2.98) 
2.24 (1.05-4.75) 
3.25 (1.27-8.30) 
2.87 (1.35-6.10) 
1.66 (0.79-3.49) 
    0.32 0.0016 
GSTA1 
 
 
dTT 
CT 
CC  
23/33 
82/79 
48/48 
42/36 
81/87 
63/66 
1 
1.69 (0.88-3.25) 
1.47 (0.72-2.97) 
1.85 (0.88-3.89) 
1.30 (0.68-2.51) 
1.38 (0.70-2.72)  
30/30 
84/89 
65/69 
40/27 
106/74 
73/60 
1 
0.94 (0.50-1.75) 
1.00 (0.53-1.91) 
1.41 (0.67-2.98) 
1.36 (0.72-2.54) 
1.27 (0.66-2.43) 
     0.14 0.92 
SMOKING   Never    Ever  
All genotypes  102/146 146/165 1 1.19 (0.82-1.73) 234/202 264/184 1 1.16 (0.87-1.55) 
GSTP1 
 
 
dGG 
AG 
AA  
12/18 
48/76 
40/53 
24/15 
54/72 
66/78 
1 
1.14 (0.48-2.71) 
1.27 (0.52-3.09) 
3.32 (1.16-9.53) 
1.17 (0.49-2.78) 
1.34 (0.57-3.15)  
22/25 
103/93 
108/84 
32/25 
129/75 
100/84 
1 
1.28 (0.65-2.50) 
1.46 (0.74-2.85) 
1.44 (0.64-3.26) 
1.79 (0.91-3.50) 
1.30 (0.66-2.57) 
     0.12f 0.29 
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dTT 
CT 
CC  
14/24 
57/71 
29/52 
31/30 
65/80 
48/55 
1 
1.45 (0.64-3.29) 
0.96 (0.41-2.27) 
2.16 (0.88-5.30)
1.25 (0.56-2.75) 
1.45 (0.64-3.32)  
39/39
109/98 
84/65 
51/33
122/80 
88/71 
1
1.16 (0.67-2.01) 
1.32 (0.74-2.35) 
1.37 (0.71-2.64) 
1.45 (0.81-2.53) 
1.26 (0.71-2.23) 
     0.14  0.59 
*adjusted for age (in 4 categories: <45, <55, <65, <75), sex, energy intake and folate intake 
acalculated as the LR test comparing the models with and without crucifer-by-genotype interaction terms 
bmean cruciferous vegetable intake was 73.1±36.3 g/wk and 70.3±36.6 g/wk for cases and controls, respectively, in the lower-than-median intake group; and 
242.5±108.4 g/wk and 230.3±109.2 g/wk, respectively, in the higher-than-median intake group 
cfresh red meat consumption defined as sum of pork, beef and unclassified (non-organ) meats; consumption  in the lower and higher category was 28.7±15.2 g/d 
and 82.1±21.2 g/d,respectively 
dleast active/expressed variant(s) 
fp-value Lemeshow goodness-of-fit test: 0.049 
eprocessed meat defined as preserved and ready-to-eat meat products; consumption in the lower and higher category was 13.7±8.2 g/d and 57.8±32.7 g/d, 
respectively 
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DISCUSSION 
In this endoscopy-based case-control study of colorectal adenomas, the GSTP1 
A313G and GSTA1 C-69T single nucleotide polymorphisms appear to modify the 
association between cruciferous vegetable consumption and colorectal adenoma 
risk, though with results that contradict our hypothesis that low capacity GST 
genotypes benefit (most) from higher consumption: compared with the low 
crucifer consumption*low GST capacity variant combination, the highest adenoma 
risk was observed in the high crucifer consumption*low GST capacity variant 
combination.  
There was no indication for an interplay between cruciferous vegetable 
consumption and GSTM1 or GSTT1 deletion polymorphisms in this population. 
Our study has strengths and weaknesses. The response rate was about 55%, 
and varied rather widely by clinic, depending on local recruitment factors. 
However, selection procedures were identical for cases and controls, reducing the 
possibility for differential selection bias. Unfortunately we do not have sufficient 
data on patients not participating in the study to further evaluate the possible 
selection bias due to non-response. Our control group underwent endoscopy, 
mostly because of bowel problems, and as such may not be fully representative of 
the average individual without adenomas in the population. Therefore, risk 
estimates cannot be extrapolated to the general population inadvertently. 
However, adenomas are fairly prevalent in the population and often do not give 
symptoms36. Thus, the fact that our control status was defined by endoscopy can be 
seen as an advantage. Full visualisation of the colon was achieved for most 
controls and restriction of analyses to this group did not change results. Combined 
with the fact that adenomas were histologically confirmed, case-control 
misclassification is unlikely. Bowel complaints may lead to change in food habits. 
Only few participants, however, indicated an increase in vegetable intake (16 cases, 
18 controls) or a decrease in cabbage intake (8 cases, 4 controls) specifically. 
Exclusion of these participants from analyses did not change our conclusion. 
Excluding those with bowel problems weakened results for GSTP1, strengthened 
results for GSTA1 and yielded similar results for the GSTP1/A1 combination, 
though statistical significance was lost due to small numbers.  
Our case group consisted of new as well as previously diagnosed cases. 
Restriction of analyses to new cases did not change our conclusions and thus 
information bias due to differences in recall of dietary habits and/or time span of 
adenoma diagnosis and related surveillance is likely to have been limited. 
Information on reproducibility and validity of our cruciferous vegetable 
measurement is not available and we cannot rule out some degree of exposure 
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misclassification. For total vegetables, the reproducibility was 0.76 and 0.65 for 
men and women, respectively, and relative validity was 0.38 and 0.31 for men and 
women, respectively, which is in the range of estimates that others find for FFQs30. 
Genotype misclassification is assumed to be low, as measurement and scoring was 
blind, negative and positive controls were included and duplos were assessed with 
excellent reproducibility. The genotypes are sufficiently prevalent and the study 
population sufficiently large to render power adequate for most of the analyses. 
Concluding: our study has many strengths, yet risk of selection and 
information bias remains a point of attention in case-control studies. Bias cannot be 
ruled out in the explanation of our finding of a slightly higher adenoma risk with 
higher cruciferous vegetable consumption. However, we add to an existing 
literature, of both case-control and cohort studies, in which increased risks, 
significant and non-significant, of colorectal adenomas or cancer with higher 
intakes of cruciferous vegetables have been reported5-8, 10. Unlike these studies, we 
also incorporated genetic polymorphisms in our design.  
We hypothesized that inherited decreased GST-capacity, which presumably 
results in a longer biological half-life of phytochemicals from cruciferous 
vegetables, may confer increased chemopreventive potential when these 
vegetables are consumed at higher levels. Other studies preceded ours: for the 
GSTM1 and/or GSTT1 deletion genotypes, lower colorectal adenoma17 and cancer26, 
27, 34 risks were observed with higher cruciferous vegetable intake. In the case-
control study by Lin et al., however, the observed decreased risk of colorectal 
adenomas with higher cruciferous vegetable intake in GSTM1 null subjects did not 
apply to all types of crucifers (i.e. not to cabbage, cauliflower or Brussels sprouts), 
but was restricted to broccoli17. We were unable to separate crucifer type, but we 
generated toplists of cruciferous vegetables in the 1998 Dutch National Food 
Consumption Survey37 and found that broccoli contributed only about 8% to the 
total amount of crucifers by weight. The cruciferous vegetable contributing most in 
this population was cauliflower (about 30%). Interestingly, in some of the 
aforementioned other studies reporting increased risk, cauliflower and cabbage 
contributed 97% to cruciferous vegetable intake8, or the reported risk was for 
cauliflower and cabbage specifically5, 7. Cruciferous vegetables differ in their 
composition of glucosinolates38 and different (patterns of) consumption may be 
one reason why we were unable to reproduce the findings by Lin et al. in our 
population17. Lin et al. also investigated the GSTT1 genotype39, but without 
convincing results, whereas the interplay between cruciferous vegetables and GST 
genotypes reported by Turner et al. was limited to GSTT1 and could not be seen 
for GSTM127. The differential ITC excretion levels among individuals with different 
70 Chapter 3 
 
GSTT1 genotypes found by Seow25 was not replicated by Fowke et al. and both 
found urinary ITC levels unaffected by GSTM1 genotype25, 40. The use of genotype 
assays that are able to differentiate between the presence of one or two alleles41 
may help in creating a more consistent view concerning the modifying effects by 
GSTM1 and GSTT1 genotypes. 
For the GSTP1 A313G polymorphism, Fowke et al. found a significant positive 
trend between cruciferous vegetable intake and fasting first-morning urinary ITC 
excretion in the high activity GSTP1 AA genotype40. No association between 
urinary excretion of total ITC and the GSTP1 A313G genotype was observed by 
Seow et al.25, however, nor did they find an interplay between GSTP1 genotype, 
high cruciferous vegetable intake and colorectal cancer among Singapore 
Chinese26. It must be noted that the frequency of the GSTP1 313G allele among 
Asian subjects is low (3.5-5%), resulting in low power, and this may explain lack of 
association. The results of our study do not support the hypothesis that imputed 
decreased GSTP1 or GSTA capacity in combination with high crucifer intake 
protects against colorectal adenoma, but they may support an interaction between 
cruciferous vegetable consumption and these genotypes. Both the GSTP1 low 
activity variant (GG genotype) and the GSTA1 low expression variant (TT 
genotype) appeared to increase the risk of colorectal adenomas with higher 
cruciferous vegetable intake. This higher adenoma risk with a low capacity GST 
variant could reflect directly the slower processing of genotoxic compounds 
associated with cruciferous vegetable intake. Genotoxicity of glucosinolate 
breakdown products is supported by bacterial and cell assays42, 43. In the human 
situation, however, it is believed that a variety of mechanisms operate to prevent 
the genotoxic effects observed in vitro and that toxicity may therefore occur only at 
exposure doses exceeding human intake 100-fold44. However, this does suggest 
there is a certain dependency on a well functioning biotransformation system. An 
indirect possibility for a higher adenoma risk, that finds some support in human 
studies, is the prolonged stimulation of phase I enzymes, notably CYP1A2, by 
glucosinolate-derived (indole) ITCs that are metabolized by GSTs45-47. If this is not 
accompanied by sufficient conjugating activity, this might result in a net increased 
metabolic activation of (pro)carcinogens. In individuals carrying the two most 
active variants of the GSTA1 and GSTP1 gene homozygously, there is no indication 
of higher adenoma risk with higher crucifer intake, possibly suggesting that 
sufficient detoxification is provided by these high capacity variants. There does 
appear to be a genotype effect in the low cruciferous vegetable group. 
GSTs have overlapping substrate specificities18, and the iso-forms may interact. 
Ketterer and coworkers suggested a link between GSTA and GSTM1: GSTA 
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sequesters ITC-conjugates and converts them slowly back to the active ITC15, 48, but 
only in the GSTM1 null individual; in the GSTM1-positive individual, excretion is 
favored. It is possible then, that a higher availability of GSTA, as partly determined 
by GSTA1 C-69T genotype, might result in a higher amount of conservation, 
especially in GSTM1 null individuals. We found no evidence for an interplay 
between the GSTM1 and GSTA1 genotypes in our study. GSTM1 and GSTA are 
expressed at a low level in the colon22, but are highly expressed in the liver49. They 
are relevant for the colon because glucosinolate metabolites are also delivered to 
the colonic crypts via the colonic blood supply, after absorption from the small 
intestine and passage through the liver50. The combined genotypes of the genes 
most expressed in the colon, i.e. GSTP1 and GSTT1, also did not show a clear effect 
on the association between colorectal adenomas and crucifer intake.  
GSTs have dual roles in relation to glucosinolates: apart from their 
metabolizing roles, a number of GSTs, e.g. GSTP1 and GSTA1, appear to be 
inducible by glucosinolate breakdown products35, 51. Although in the GSTA1 gene 
no electrophile responsive element or xenobiotic responsive element has been 
found, other transcription factor binding sites have been identified. The differential 
expression of the GSTA1 genotypes defined by the C-69T substitution has been 
attributed to alteration of the binding of the ubiquitously expressed transcription 
factor Sp133. The glucosinolate-derived indole ITC indol-3-carbinol (I3C) may 
influence this binding, demonstrating the complicated nature of the GST-
glucosinolate relation52.  
Our subgroup analyses showed differences in subgroups of age, sex, meat 
consumption and smoking, which we may not be able to fully disentangle from 
one another. They may be due to chance. Glutathione availability decreasing with 
age may play a role53. Generation and sex may influence dietary habits. Also, GST 
responses to cruciferous vegetable diets may differ between men and women35. N-
acetoxy PhIP, one of the most important (pro)carcinogens in cooked meat, is 
metabolized by GSTα and to a lesser extent by GSTP154 and thus subjects with low 
capacity variants may be less equipped to detoxify55, 56. If slower processing of 
glucosinolate-derived compounds leads to prolonged phase I activation, then 
subjects with low capacity GST variants and higher exposure to (meat) carcinogens 
may be burdened even more by these carcinogens. Similarly, GSTP1 is involved in 
the detoxification of polycyclic aromatic hydrocarbons (PAHs) present in cigarette 
smoke and a potential by-product of meat processing. Slattery et al. also reported a 
modifying role for smoking and suggested smoking may influence the balance of 
phase II and phase I biotransformation enzymes4, but how this applies to our 
results is not clear.   
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We conclude that genetic variation in the GSTP1 and the GSTA1 gene may 
modulate the relation between cruciferous vegetables and colorectal adenomas. In 
this population, the advantage of hypothetical prolonged stimulation of phase II 
enzymes may not outweigh the disadvantage of lower GST enzyme capacity. 
Further research may explore the specific effects of the different cruciferous 
vegetable types. Phenotyping of phase I enzymes (e.g. CYPs) in relation to phase II 
GST polymorphisms or proteins may shed more light on the balance between 
phase I bioactivation and phase II detoxification of (pro)carcinogens. Also, genetic 
variation in GST inducibility (i.e. in regulatory sequences) may be taken into 
account. 
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ABSTRACT 
NAD(P)H:quinone oxidoreductase (NQO1) is an inducible detoxification enzyme 
relevant for colorectal cancer biochemoprevention. We evaluated the influence of 
recent fruit and vegetable (F&V) consumption and polymorphisms in NQO1 and 
transcription factor NFE2L2 on rectal NQO1 phenotype and also whether white 
blood cell (WBC) NQO1 activity reflects rectal activity. Among 94 sigmoidoscopy-
patients, we assessed F&V consumption by dietary record and determined the 
NQO1 c.609C>T and g.-718A>G and NFE2L2 g.-650C>A, g.-684G>A and g.-686A>G 
polymorphisms. NQO1 mRNA level was measured in rectal biopsies, NQO1 
activity in rectal biopsies and WBC. Consumption of F&V did not yield higher 
mRNA level or activity, but rather appeared to have a repressive effect. Rectal 
activity was higher among NQO1 609CC-genotypes as compared to 609CT-
genotypes (p<0.0001; 609TT-genotypes were absent), whereas mRNA was higher 
among 609CT-genotypes (p<0.001). mRNA and activity correlated among NQO1 
609CC-genotypes (r=0.50, p=0.0001) but not among 609CT-genotypes (r=0.14, 
p=0.45). The NFE2L2 -684A-allele was associated with higher mRNA levels 
(p=<0.05). The other polymorphisms did not affect phenotype significantly. WBC 
and rectal activity did not correlate. In conclusion, genetic variation, especially the 
NQO1 609C>T polymorphism, is a more important predictor of rectal NQO1 
phenotype than F&V consumption. WBC NQO1 activity is not a good surrogate for 
rectal activity. 
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INTRODUCTION  
NAD(P)H:quinone oxidoreductase (NQO1; EC 1.6.5.2) is involved in the 2-electron 
reductive biotransformation of quinones, which are highly reactive molecules with 
carcinogenic potential1. Quinones have important roles in cellular respiration and 
are ubiquitous in nature2. Epithelial tissues, such as of the digestive tract, produce 
relatively high levels of NQO1 protein, which is thus readily available to act on 
quinones entering the body3, 4. NQO1 detoxifies or activates the toxic action of a 
quinone depending on the stability of the hydroquinone that is formed1. Despite its 
contrasting potential, increasing the NQO1 capacity is expected to overall inhibit 
carcinogenesis. Besides facilitating the excretion of exogenous quinones, a role for 
NQO1 has been proposed in antioxidant protection through reduction of 
endogenous quinones and prevention of one-electron redox cycling thus inhibiting 
formation of DNA-damaging reactive oxygen species5, and in stabilization of the 
major tumor suppressor gene p535. Sufficient NQO1 capacity, both constitutive 
and induced, is therefore important for protection against quinone-type 
carcinogens and oxidative stress. 
The human NQO1 gene is inducible6-8. An electrophile-responsive element 
(EpRE), wich mediates the regulation of many detoxifying enzymes, has been 
identified in its 5’-flanking region9. EpRE mediated upregulation of protective 
biotransformation enzymes, by plant food components such as isothiocyanates, 
flavonoids, carotenoids, sulfides and phenols, can contribute importantly to 
prevention of carcinogenesis10, 11. This may be especially true for colorectal cancer, a 
common and possibly largely preventable form of cancer12.  
The effect of dietary inducers may be dependent on genetic makeup. In the 
coding region of the NQO1 gene, two functional polymorphisms are known, of 
which one occurs relatively frequently. This C to T sequence variation at cDNA 
position 609 exists with an allele prevalence of ~20% in Caucasians to ~50% in 
Asians13, 14. It  results in lower NQO1 protein stability and enzymatic activity in 
heterozygotes and its absence in homozygotes for the variant15-19. Some studies 
have reported an increased risk of colorectal tumors associated with the NQO1 
609T allele20, 21. Possibly, NQO1 609C>T heterozygotes can compensate for the 
disadvantage of their dysfunctional allele by consuming NQO1 inducers, and thus 
enhance overall NQO1 capacity by increasing expression of the functional allele. 
Polymorphisms that affect NQO1 regulation also may exist; in the regulatory 
region of the NQO1 gene itself, or in the gene encoding the transcription factor 
NFE2L2 (nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2) which 
acts through the EpRE and is important in the transcriptional activation of the 
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NQO1 gene22, 23. These polymorphisms may act constitutively or their effect may be 
modulated by consumption of dietary inducers.  
In an endoscopy-based population, we investigated the influence of short-term 
fruit and vegetable consumption and genetic variation in NQO1 and NFE2L2 on 
rectal NQO1 mRNA expression and NQO1 enzymatic activity. Furthermore, we 
investigated whether NQO1 activity in white blood cells reflects activity in rectal 
tissue and could serve as surrogate endpoint. 
 
METHODS 
Study population. The study population has been described before24. In short, 
participants were recruited in two outpatient endoscopy clinics in the Netherlands 
from patients scheduled for a sigmoidoscopy, between January 2003 and June 2004. 
Eligibility criteria were: age between 18 and 75 years, Caucasian, no chronic 
inflammatory bowel disease (past or present), no inflammation in the distal colon 
at the time of endoscopy, no sporadic colorectal cancer (past or present), and no 
bowel resection. Forty-five percent of invited patients agreed to participate (n=105). 
Of these, 11 were excluded because inclusion criteria were not met posteriorly. 
This resulted in a final study population of 94 individuals. The study was 
approved by the Medical Review Boards of both hospitals. All participants gave 
their written informed consent.  
Medical, dietary and lifestyle information. Medical information was recorded 
from the endoscopy request form, endoscopy report and, if available, PA report. 
Participants kept a 3-day dietary record, the third day ending at the time of 
endoscopy. All records were checked for quality and completeness by the same, 
trained dietician of the division of Human Nutrition of Wageningen University. 
Processing into food quantities and coding was done according to the most recent 
standard manual on food portions and household measures and the Dutch Food 
Composition Table25, 26. Conversion into amounts of nutrients was done using the 
VBS Food Calculation System27. Fruits were subdivided in citrus and non-citrus 
fruits, vegetables in botanically defined subgroups: Alliaceae (e.g. garlic, leek), 
Apiaceae (e.g. celery, carrot), Brassicaceae (e.g. cauliflower, broccoli), Compositae 
(e.g. endive, lettuce), Cucurbitaceae (e.g. zucchini, cucumber), Solanaceae (e.g. bell 
pepper, tomato; potato not included), and a restgroup. 
General lifestyle information was collected through a semi-structured 
questionnaire containing questions about age, sex, weight, height, smoking habits, 
medication, disease and family history of cancer. 
Specimen collection and preparation. Biopsies. Flexible sigmoidoscopy was 
performed with the patient in left lateral decubitus position. Biopsies 
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(approximately 20 mg each) were taken from normal rectal mucosa at a distance of 
5 to 15 cm from the anal verge. For every subject, two biopsies were collected in 
RNA stabilization solution (RNAlater, Qiagen Benelux B.V., Venlo, The 
Netherlands). All were snap-frozen in liquid nitrogen. Blood. Blood (3 x 9 ml) was 
drawn shortly after endoscopy by venipuncture in Vacuette EDTA K3 Tubes 
(Greiner Bio-One, Alphen a/d Rijn, the Netherlands). Leukocytes, lymphocytes and 
buffy coat DNA samples were isolated as described before24. Sample storage. Rectal 
biopsies were stored intact at -80°C for 7.5±4.5 months after tissue sampling until 
homogenation and refreezing; NQO1 enzymatic activity was then measured 
within 1 month and NQO1 mRNA levels within 2 months. White blood cell pellets 
were stored intact at -80°C for 6.3±4.5 months after blood sampling until 
preparation and refreezing. NQO1 activity was then measured within 1 month. 
Laboratory assays. Genotyping. DNA samples were stored at 4ºC in 8x12 array 
banks with negative controls. Nomenclature of sequence variation is according to 
recent consensus28, but after first mention is made this is abbreviated in the text by 
omitting ‘c.’ or ‘g.’. 
The NQO1 c.609C>T polymorphism (16; position 609 relative to the 
transcription site of GenBank Accession number J03934) was assessed by PCR-
RFLP, with an internal check on digestion (all experimental details available on 
request). NQO1 609C>T genotyping was performed in duplicate and found to be 
100% reproducible. It was not in Hardy-Weinberg Equilibrium (HWE): χ2: 4.26, p-
value: 0.039. However, as our genotyping assay has an internal check on complete 
digestion and was 100% reproducible, we think this statistical deviation from HWE 
is probably due to a coincident absence of T-homozygotes where three TT-
genotypes were expected based on HWE (had there been one TT-genotype, the p-
value would have been >0.05). 
The  NQO1 g.-718G>A regulatory polymorphism, -718 relative to the 
transcription initiation site (or -829 relative to the translation start) of GenBank 
Accession number M81596, genotyped by pyrosequencing the region -725 to -717 
of NQO1. We selected this SNP because it was found to have the highest frequency 
in our sequence survey of  ~1100 bp of the NQO1 regulatory region upstream of 
the transcription initiation site among 96 individuals (unpublished results). The 
NQO1 -718G>A genotyping was performed in duplicate and found to be 100% 
reproducible, and was in HWE (χ2: 0.32, p-value: 0.57).  
The NFE2L2 (also known as Nrf2) polymorphisms reported by Yamamoto et 
al.29, g.-650C>A, g.-684G>A and g.-686A>G relative to the transcription initiation 
site of GenBank accession number AC079305 (g.-733C>A, g.-767G>A and g.-
769A>G, respectively, relative to the translation start of this accession number) 
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were determined by pyrosequencing. The region -686 to -677 of NFE2L2 was 
analyzed in order to genotype the -686A>G and -684G>A polymorphisms, and the 
region -651 to -646 in order to genotype the -650C>A polymorphism. Genotyping 
of all three NFE2L2 polymorphisms was performed in duplicate. One subject could 
not be genotyped unambiguously for the -686A>G and -684G>A polymorphisms, 
while another subject could not be genotyped unambiguously for the -650C>A 
polymorphism. These subjects were excluded from the respective analyses. The 
other measurements were 100% reproducible. All NFE2L2 polymorphisms were in 
HWE (650: χ2 0.76, p=0.38; 684: χ2=0.37, p=0.54; 686: χ2=1.16, p=0.28).  
mRNA assays. Rectal biopsies stored in RNAlater were homogenized on ice 
using a frozen (-20°C) pestle and subsequently mixed with 1 ml Trizol Reagent 
(Invitrogen, Breda, The Netherlands). Samples were disintegrated further by 
passage through one or more syringe needles with decreasing diameter (minimal 
diameter 0.8 mm). Total RNA was subsequently purified by a standard 
chloroform-phenol extraction method30. RNA concentration was measured 
spectrophotometrically at 260 nm, and the samples were stored at -80°C until 
reverse transcription (RT-)PCR using 1-2 μg of total RNA and Moloney murine 
leukemia virus (MMLV) reverse transcriptase (Invitrogen) according to the 
manufacturer’s instructions. NQO1 expression was quantitated by real-time PCR 
using a SYBR green-based method and using β-actin as a reference. PCR 
amplification was performed at least in 3-fold. Measurement was not successful for 
two subjects. NQO1 mRNA levels were expressed as the NQO1:β-actin ratio.  
Protein assays. Protein was isolated from rectal biopsies, leukocytes and 
lymphocytes as described before24. Total protein was measured using the Pierce 
bicinchoninic acid (BCA) protein assay reagent kit (Pierce Rockford, IL, USA) and 
BSA as a standard, following manufacturer’s instructions. To determine NQO1 
enzymatic activity, the dicoumarol inhibitable reduction of 2,6-
dichlorophenolindophenol (DCPIP, Sigma Aldrich, Zwijndrecht, The Netherlands) 
was measured spectrophotometrically at 600 nm, as described by Benson et al.31, 
with minor modifications32. Measurements were performed in duplicate. NQO1 
enzymatic activity was normalised to protein content, and expressed as nmol 
DCPIP reduced/min/mg protein. 
Statistical analyses. Excluded from their respective analyses were subjects 
with: no dietary information (2), no rectal biopsies (2), no mRNA measurement (2), 
extreme mRNA level (1; NQO1:β-actin ratio of 100.4 x 10-3), extreme lymphocyte 
enzyme activity (1; 106 nmol/min/mg protein), and different bowel preparation, 
which was accompanied by high rectal NQO1 activities (1). Thus, in relation to 
mRNA level and enzymatic activity, 87 and 90 subjects, respectively, were 
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available for genotype analyses and 85 and 88, respectively, for fruit/vegetable 
consumption analyses.  
The statistical differences in NQO1 mRNA level and in NQO1 activity were 
evaluated between groups based on population characteristics (table 1), 
consumption of fruits and vegetables (yes/no, tables 2 and 4) and genotype (table 
3). Non-parametric testing (Wilcoxon, Kruskal Wallis, savage) was performed, 
because these methods remain valid for small and skewed sample sizes. A two-
sided probability of < 0.05 was considered statistically significant and <0.10 as a 
signal for possible association. Cells with 1 subject (NQO1 -718 AA, and NFE2L2 -
650 AA and -684 AA) were not included in the test.  
In addition, we explored possibly confounding factors for associations between 
fruits and vegetables and NQO1 phenotype using linear regression models. Out of 
the variables age, sex, BMI, mean energy intake, education, time of endoscopy, 
clinic, sample storage time, smoking, family history of colon cancer, presence of 
polyps, meat consumption, and coffee consumption, the following univariately 
showed an association with NQO1 phenotype with a significance of p=0.10 or less: 
endoscopy time and meat consumption for NQO1 mRNA and smoking and 
sample storage time for NQO1 activity. Smoking and storage time affected some 
fruit/vegetable β-estimates by >10%, and were included in the activity models. 
Endoscopy time and meat consumption did not affect β-estimates and were not 
included in the mRNA models. Statistical interaction was measured by the 
addition of a genotype*consumption product term. For power reasons, total fruit 
and total vegetable consumption groups were based on a median-split of the 
average intake in g/day here. 
Spearman correlation coefficients were calculated to evaluate the association 
between rectal NQO1 mRNA level and NQO1 activity, and between rectal and 
white blood cell NQO1 activities. 
Haplotypes were estimated for NQO1 and NFE2L2 using the Hplus program 
version 2.5, available online (Fred Hutchinson Cancer Research Center Hplus. 
http://qge.fhcrc.org/hplus. The coding and regulatory NQO1 variants were never 
found to be linked, and neither were the three NFE2L2 variants. Variants of both 
the genes occurred together infrequently. Therefore, all SNPs were analyzed 
separately. 
All statistical analyses were performed using SAS software, version 9.1 (SAS 
institute, Cary, NC). 
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RESULTS  
Population characteristics. The general and medical characteristics of the 
population and their relationships with NQO1 mRNA level and NQO1 enzymatic 
activity are presented in table 1. Total population mean rectal NQO1:β-actin mRNA 
ratio was 10.2 x 10-3 ± 5.3 x 10-3 (median value 9.4) and mean rectal NQO1 activity 
was 97 ± 47 nmol DCPIP/min/mg protein (median value 89). NQO1 mRNA level 
was lower among those undergoing endoscopy in the morning and NQO1 activity 
was higher among those with adenomas, both borderline significantly.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 First, the influence of recent fruit and vegetable consumption on NQO1 
mRNA level and NQO1 activity (not considering genotype) is presented, then the 
influence of genetic polymorphisms in NQO1 and NFE2L2 on these parameters are 
described, followed by their possible interaction in determining NQO1 phenotype. 
Table 1: Rectal NQO phenotype by general study population characteristics
 
Characteristic 
 
 
Total 
 
 
Rectal NQO1:β-actin 
mRNA ratio 
 
median x 103a 
Rectal NQO1 activity 
(nmol DCPIP/ 
min/mg protein)  
median 
  n=92 n=87 n=90 
General characteristics   9.4a, b 89b 
Age <49.3/>49.3 yearsc  46/46 8.6 / 9.8 88 / 93 
Sex male/female  39/53 8.5 / 9.5 89 / 89 
Education low/high  17/41 7.9 / 9.5 84 / 90 
Smoking never/current/ex  37/18/3 8.2 / 10.5 / 9.7 88 / 94 / 89 
BMI <24.7/>24.7c  46/46 9.5 / 8.6 85 / 92 
Medical factorsd     
Family history 
 
cancer 
colorectal cancer 
yes/no 
yes/no 
48/43 
7/85 
8.5 / 9.8 
7.9 / 9.5 
90 / 87 
85 / 89 
Indication for 
endoscopye 
 
 
blood loss per anum 
abdominal pain 
different defecation 
pattern 
yes/no 
yes/no 
yes/no 
 
44/48 
30/62 
30/62 
 
8.5 / 9.8 
8.8 / 9.5 
9.8 / 9.1 
 
84 / 93 
89 / 88 
91 / 89 
 
Endoscopy  characteristicsf     
Outpatient clinic A/B  79/13 9.4 / 8.1 88 / 94 
Endoscopy time morning/afternoon  48/44 8.4 / 10.6* 85 / 89 
Macroscopic 
view 
 
hemorrhoids 
diverticula 
adenoma(s) 
yes/no 
yes/no 
yes/no 
17/74 
13/78 
10/81 
9.7 / 9.4 
9.7 / 9.4 
10.3 / 9.4 
90 / 89 
84 / 89 
102 / 88* 
ae.g., 9.4 means a NQO1:β-actin mRNA ratio of 0.0094 
bmean ± sd: 10.2 ± 5.3 and 97 ± 47 for mRNA and activity, respectively 
cmedian split; age: mean±sd = 46.5±13.8; BMI: mean±sd = 25.5±4.6 
dsource: medical record and self-reported 
ethe three most common indications are shown; more than one possibility per individual 
fbowel preparation, day before: 17:00 hrs: 2 laxatives (10 mg), 20:00 hrs microlax enema (5 ml) 
*p<0.10 (the difference between the characteric-groups was tested by Wilcoxon test) 
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Rectal NQO1 phenotype by fruit and vegetable consumption. Mean total fruit 
and mean total vegetable consumption among consumers on the 2 days preceding 
endoscopy was 144 ± 116 and 128 ± 89 g/day, respectively (table 2). Total 
consumption of fruits (yes/no) was not significantly associated with rectal NQO1 
mRNA or NQO1 activity. Vegetable consumers did appear to have lower NQO1 
mRNA levels. Consumption of Compositae (yes/no) was inversely associated with 
NQO1 mRNA level (table 2); mean NQO1:β-actin mRNA ratio was 2.7 x 10-3 (95% 
confidence interval (CI): 0.45 x 10-3 , 5.0 x 10-3 ) lower among consumers as 
compared to non-consumers. Consumption of Apiaceae (yes/no) was inversely 
associated with rectal NQO1 activity. Adjusted for smoking and sample storage 
time, it was 23 nmol DCPIP/min/mg protein (95% CI: 1.4, 45) lower among 
consumers as compared to non-consumers (data not in table).  
Table 2: Rectal NQO1 phenotype by fruit and vegetable consumption (yes/no) 
Consumption 
 
 
 
n 
Intake, g/daya
 
mean ± sd 
(median) 
 
 
n 
Rectal NQO1:β-actin
mRNA ratio 
 
mean ± sd (median) x103b 
 
 
n 
Rectal NQO1 activity 
(nmol DCPIP/ 
min/mg protein) 
mean ± sd (median) 
Total population 88 225 ± 159 (200) 85 10.2 ± 5.3 (9.4)b 88 97 ± 47 (89) 
Total fruit 
 
No 
Yes 
20 
68 
- 
144 ±  116 (120) 
20 
65 
10.8 ± 4.3 (10.2) 
10.1 ±  5.6 (9.4) 
20 
68 
105 ± 59 (93) 
94 ± 43 (88) 
Citrus fruitc 
 
No 
Yes 
62 
26 
- 
84 ± 59 (60) 
61 
24 
10.1 ± 5.4 (8.7) 
10.8 ± 5.3 (10.1) 
62 
26 
100 ± 52 (90) 
89 ± 33 (83) 
Total vegetablesd 
 
No 
Yes 
10 
78 
- 
128 ±  89 (113) 
10 
75 
13.3 ± 8.8 (11.8) 
9.9 ± 4.6 (9.4)** 
10 
78 
94 ± 42 (85) 
97 ± 48 (89) 
Alliaceae 
 
No 
Yes 
52 
36 
- 
28 ±  28 (21) 
51 
34 
10.3 ± 6.0 (9.4) 
10.3 ± 4.4 (9.1) 
52 
36 
93 ± 46 (86) 
103 ± 50 (90) 
Apiaceae 
 
No 
Yes 
63 
25 
- 
50 ± 43 (44) 
61 
24 
10.5 ± 5.5 (9.4) 
9.8 ± 5.1 (9.1) 
63 
25 
103 ± 53 (89) 
81 ± 26 (86)* 
Brassicaceae 
 
No 
Yes 
60 
28 
- 
53 ± 38 (40) 
58 
27 
9.9 ± 5.6 (8.6) 
11.2 ± 4.7 (10.0) 
60 
28 
96 ± 51 (88) 
98 ± 38 (91) 
Compositae 
 
No 
Yes 
51 
37 
- 
50 ± 37 (38) 
50 
35 
11.4 ± 5.7 (10.3) 
8.7 ± 4.4 (8.2)** 
51 
37 
98 ± 44 (88) 
96 ± 52 (89) 
Cucurbitaceae 
 
No 
Yes 
59 
29 
- 
44 ± 30 (40) 
58 
27 
10.7 ± 5.8 (9.6) 
9.4 ± 4.1 (8.5) 
59 
29 
94 ± 47 (88) 
102 ± 48 (93) 
Solanaceae 
 
No 
Yes 
58 
30 
- 
53 ± 45 (34) 
57 
28 
10.7 ± 5.7 (8.7) 
9.5 ± 4.5 (9.5) 
58 
30 
101 ± 49 (89) 
88 ± 44 (81) 
aaverage intake on the 2 days preceding endoscopy, 2 food records missing 
be.g., 10.3 means a NQO1:β-actin mRNA ratio of 0.0103 
cresults are similar for combined group of citrus fruit and juice; juice consumption among 21 consumers: 176 ± 117 g/d  
ddoes not include potato 
**p<0.05, *p<0.10 (the difference between the yes vs no consumption groups was tested by Wilcoxon and Savage test) 
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Rectal NQO1 phenotype by NQO1 and NFE2L2 genotype. The NQO1 609CT 
genotypes showed a higher NQO1 mRNA level than the 609CC genotypes (figure 
1a, table 3); the mean difference in NQO1:β-actin mRNA ratio amounted to 3.9 x  
10-3 (95% CI: 1.7 x 10-3, 6.1 x 10-3). NQO1 activity was lower among NQO1 609CT 
genotypes as compared to 609CC genotypes (figure 1b, table 3); the mean 
difference amounted to 39 nmol DCPIP/min/mg protein (95% CI: 21, 58). The 
NQO1 mRNA level, but not NQO1 activity, was higher among the NFE2L2 -684GA 
genotypes than among the -684GG genotypes (table 3), the two genotypes showing 
a difference of 2.6 x 10-3 (95% CI:  0.034 x 10-3, 5.1 x 10-3). The NQO1 -718 G>A 
regulatory polymorphism and other NFE2L2 polymorphisms did not affect rectal 
NQO1 mRNA level or NQO1 activity significantly (table 3).  
 
Table 3: Rectal NQO1 phenotype by NQO1 and NFE2L2 genotype 
 
Genotype 
 
 
Total 
 
n 
 
 
 
n 
Rectal NQO1:β-actin 
mRNA ratio 
 
mean±sd (median) x103a 
 
 
n 
Rectal NQO1 activity 
(nmol DCPIP/ 
min/mg protein) 
mean±sd (median) 
All genotypes 92  87 10.2 ±5.3 (9.4) a 90 97±47 (89) 
NQO1  
c.609C>T 
 
CC 
CT 
TT 
59 
33 
0 
 55 
32 
0 
8.8 ± 4.3 (7.9) 
12.7 ± 6.0 (11.2)** 
- 
58 
32 
0 
110 ± 51 (96) 
72 ± 23 (73)*** 
- 
NQO1  
g.-718G>A 
 
GG 
GA 
AA 
78 
13 
1 
 74 
12 
1 
10.6 ± 5.6 (9.5) 
8.1 ± 2.8 (8.0) 
6.2 
77 
12 
1 
93 ± 42 (88) 
113 ± 73 (92) 
144 
NFE2L2 
g.-650C>A 
 
CC 
CA 
AA 
79 
11 
1 
 76 
9 
1 
10.2 ± 5.3 (9.1) 
10.0 ± 5.7 (9.5) 
11.7 
77 
11 
1 
98 ± 46 (89) 
78 ± 25 (84) 
198 
NFE2L2 
g.-684G>A 
 
GG 
GA 
AA 
67 
23 
1 
 63 
22 
1 
9.5 ± 5.5 (8.4) 
12.1 ± 4.2 (13.1)* 
15.2 
66 
22 
1 
97 ± 48 (89) 
94 ± 48 (86) 
93 
NFE2L2 
g.-686A>G 
 
AA 
AG 
GG 
35 
47 
9 
 31 
46 
9 
9.8 ± 4.6 (9.5) 
10.4 ± 5.8 (8.6) 
11.1 ± 5.5 (9.7) 
33 
47 
9 
85 ± 37 (84) 
103 ± 46 (93) 
107 ± 79 (80) 
ae.g., 10.2 means a NQO1:β-actin mRNA ratio of 0.0102 
*p<0.05, **p<0.001, ***p<0.0001 (the difference between genotypes was tested by Wilcoxon test for two groups and  
Kruskal Wallis test for three groups; cells with 1 observation were not included in the test) 
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When stratified by the NQO1 609C>T polymorphism (table 4), the difference in 
NQO1:β-actin mRNA ratio between the NFE2L2 -684GA and GG genotypes was 
visible among the NQO1 609CC genotypes (2.9 x 10-3; 95% CI: 0.1 x 10-3, 5.6 x 10-3; 
non-parametric test p=0.059) and not among the 609CT genotypes (0.85 x 10-3; 95% 
CI: -4.1 x 10-3, 5.8 x 10-3), but this was not a significant interaction (p for interaction 
= 0.42). The lack of association between the NFE2L2 -684G>A polymorphism and 
NQO1 enzymatic activity remained after stratification by the NQO1 609C>T 
polymorphism. There also were no significant differences with regard to NQO1 
phenotype between the NQO1 -718 G>A genotypes or the other NFE2L2 genotypes 
after stratifying for the NQO1 609C>T genotype.  
Overall, the Spearman correlation coefficient between rectal NQO1 mRNA 
level and NQO1 activity was 0.14 (p=0.20). The strength of this correlation differed 
by NQO1 609C>T genotype. Among NQO1 609CC genotypes, the Spearman 
correlation coefficient between NQO1 mRNA level and NQO1 activity was 0.50 
(p=0.0001) and among 609CT genotypes it was 0.14 (p=0.45). 
Figure 1: Rectal NQO1 phenotype by NQO1 c.609C>T genotype
 
 
 
Figure 1a: Rectal NQO1 mRNA level by  
NQO1 c.609C>T genotype 
 
 
 
Figure 1b: Rectal NQO1 enzymatic activity by 
NQO1 c.609C>T genotype 
Footnote 
Boxes and bars represent the interquartile range and the median value, respectively; Whiskers represent distance to  
The smallest and largest sample value, excluding outliers; ○ and * represent values of 1.5-3 and > box lengths from  
the box, resp. 
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Rectal NQO1 phenotype by total fruit and vegetable consumption and by NQO1 
and NFE2L2 genotype. Total fruit and vegetable consumption as divided in 
median groups was not statistically significantly associated with NQO1 mRNA 
level or NQO1 activity (table 5). No statistically significant differences were 
observed when taking genotype into account, with the exception of the NFE2L2 -
686A>G genotype in relation to NQO1 activity; High consumption of fruits and 
vegetables was associated with a lower NQO1 activity among the NFE2L2 -686AA 
and -686GG genotypes, but with a higher activity among the -686AG genotypes 
(table 5).  
When considering total fruit consumption only (data not in table), there was a 
significant statistical interaction between the NQO1 609C>T polymorphism and 
NQO1 mRNA level (p for interaction = 0.040); Among 609CC-genotypes, high 
consumption of fruit was associated with a 2.9 x 10-3 (95% CI 0.61 x 10-3, 5.2 x 10-3) 
lower NQO1:β-actin mRNA ratio as compared to low consumption. Among CT-
genotypes, the ratio was higher with high fruit consumption, but not significantly: 
1.7 x 10-3 (95% CI -2.7 x 10-3, 6.1 x 10-3).  
Total vegetable consumption only, as divided in median groups, was not 
associated with NQO1 mRNA level or NQO1 activity (data not in table), but there 
was statistical interaction between vegetable consumption and the NQO1 -718G>A 
polymorphism in NQO1 activity, showing similar data as for the total fruits and 
vegetable groups in table 5. Also, there was a borderline significant interaction 
between vegetable consumption and the NFE2L2 -650C>A polymorphism. Looking 
further into vegetable subtypes, consumption of Compositae (yes/no) was 
significantly inversely associated with rectal NQO1:β-actin mRNA ratio among 
NFE2L2 -650CC genotypes: -3.2 x 10-3 (95% CI -5.6 x 10-3, -0.78 x 10-3) as compared 
to non-consumption, but not among -650CA genotypes (2.0 x 10-3; -7.5 x 10-3, 11.5 x 
10-3; data not shown in table). Consumption of Compositae (yes/no) was 
significantly inversely associated with rectal NQO1 activity among NFE2L2 -
686AA genotypes: -31 nmol DCPIP/min/mg protein (95% CI -58, -5.0) as compared 
to non-consumption, but not among –686AG and GG genotypes: 5.4 (-24, 35) and 
8.0 (-19,35) nmol DCPIP/min/mg protein, respectively; data not shown in table). 
Results of interactions between genotypes and consumption of fruits and/or 
vegetables need to be considered with caution, as numbers are small and the 
influence of single observations can be quite high. 
 
NQO1, fruits and vegetables, and enzyme phenotype 89 
 
 
Ta
bl
e 
5:
 R
ec
ta
l N
Q
O
 p
he
no
ty
pe
 b
y 
fr
ui
t a
nd
 v
eg
et
ab
le
 c
on
su
m
pt
io
n 
(h
ig
h/
lo
w
) a
nd
 b
y 
N
Q
O
1 
an
d 
N
FE
2L
2 
ge
no
ty
pe
   
R
ec
ta
l N
Q
O
1:
β-
ac
tin
 m
R
N
A
 
ra
tio
 
 
R
ec
ta
l N
Q
O
1 
ac
tiv
ity
 
(n
m
ol
 D
C
PI
P/
m
in
/m
g 
pr
ot
ei
n)
 
Fr
ui
t &
 v
eg
et
ab
le
 
co
ns
um
pt
io
n 
 
G
en
ot
yp
e 
lo
w
 c
on
su
m
pt
io
na
 
(9
8±
62
 g
/d
, 1
01
 g
/d
) 
hi
gh
 c
on
su
m
pt
io
na
 
(3
58
±1
37
 g
/d
, 3
03
 g
/d
) 
 
lo
w
 c
on
su
m
pt
io
na
 
(9
8±
62
 g
/d
, 1
01
 g
/d
) 
hi
gh
 c
on
su
m
pt
io
na
 
(3
58
±1
37
 g
/d
, 3
03
 g
/d
) 
n 
m
ea
n±
sd
 
(m
ed
ia
n)
*1
0-
3b
 
n 
m
ea
n±
sd
 
(m
ed
ia
n)
*1
0-
3  
 
n 
m
ea
n±
sd
 
(m
ed
ia
n)
 
n 
m
ea
n±
sd
 
(m
ed
ia
n)
 
A
ll 
ge
no
ty
pe
s 
43
 
11
.0
 ± 
5.
8 
(1
0.
4)
b  
42
 
9.
5 
± 4
.8
 (9
.0
) 
 
44
 
10
4 
± 5
5 
(9
1)
 
44
 
89
 ± 
37
 (8
5)
 
N
Q
O
1 
 
c.
60
9C
>T
 
 
C
C
 
C
T TT
 
26
 
17
 
0 
9.
5 
± 4
.8
 (7
.8
) 
13
.3
 ± 
6.
5 
(1
3.
6)
 
- 
27
 
15
 
0 
8.
1 
± 3
.8
 (7
.9
) 
12
.0
 ± 
5.
5 
(9
.9
) 
- 
 
27
 
17
 
0 
12
5 
± 6
0 
(1
03
) 
72
 ± 
22
 (6
8)
 
- 
29
 
15
 
0 
99
 ± 
39
 (8
9)
 
71
 ± 
24
 (8
1)
 
- 
N
Q
O
1 
 
g.
-7
18
G
>A
 
 
G
G
 
G
A
 
A
A
 
38
 
5 1 
11
.2
 ± 
6.
1 
(1
0.
2)
 
9.
8 
± 1
.9
 (1
0.
8)
 
6.
2 
34
 
7 0 
10
.2
 ± 
5.
0 
(9
.5
) 
6.
9 
± 2
.9
 (7
.0
) 
- 
 
39
 
5 1 
99
 ± 
45
 (9
1)
 
14
8 
± 1
05
 (9
6)
 
14
4 
36
 
7 0 
88
 ± 
38
 (8
4)
 
88
 ± 
28
 (8
9)
 
- 
N
FE
2L
2 
 
g.
-6
50
C
>A
 
 
C
C
 
C
A
 
A
A
 
36
 
5 1 
11
.2
 ± 
5.
9 
(1
0.
6)
 
8.
9 
± 5
.7
 (7
.7
) 
11
.7
 
38
 
4 0 
9.
3 
± 4
.7
 (8
.6
) 
11
.3
 ± 
6.
2 
(1
0.
2)
 
- 
 
36
 
6 1 
10
6 
± 5
7 
(9
3)
 
83
 ± 
32
 (8
5)
 
19
8 
39
 
5 0 
92
 ± 
38
 (8
5)
 
73
 ± 
16
 (6
2)
 
- 
N
FE
2L
2 
 
g.
-6
84
G
>A
 
 
G
G
 
G
A
 
A
A
 
31
 
11
 
1 
10
.4
 ± 
6.
2 
(8
.6
) 
12
.4
 ± 
4.
4 
(1
4.
0)
 
15
.2
 
32
 
9 0 
8.
7 
± 4
.8
 (8
.3
) 
12
.7
 ± 
3.
9 
(1
2.
9)
 
- 
 
32
 
11
 
1 
10
3 
± 5
5 
(9
0)
 
10
9 
± 6
1 
(9
3)
 
93
 
34
 
9 0 
92
 ± 
40
 (8
5)
 
78
 ± 
22
 (8
4)
 
- 
N
FE
2L
2 
 
g.
-6
86
A
>G
 
 
A
A
 
A
G
 
G
G
 
14
 
27
 
2 
9.
9 
± 4
.8
 (1
0.
5)
 
11
.4
 ± 
6.
2 
(1
0.
4)
 
13
.8
 ± 
8.
6 
(1
3.
8)
 
16
 
18
 
7 
9.
7 
± 4
.7
 (9
.4
) 
9.
2 
± 5
.2
 (8
.2
) 
10
.3
 ± 
4.
9 
(9
.7
) 
 
14
 
28
 
2 
10
5 
± 4
3 
(9
2)
 
97
 ± 
49
 (8
9)
 
20
5 
± 1
45
 (2
05
) 
18
 
18
 
7 
68
 ± 
23
 (6
9)
 *  
11
4 
± 3
8 
(1
06
) 
79
 ± 
25
 (7
8)
 ^
 
a m
ed
ia
n 
va
lu
e 
on
 w
hi
ch
 lo
w
 a
nd
 h
ig
h 
fr
ui
t a
nd
 v
eg
et
ab
le
 c
on
su
m
pt
io
n 
gr
ou
ps
 a
re
 b
as
ed
: 1
99
.5
 g
; d
oe
s n
ot
 in
cl
ud
e 
ju
ic
e 
b e
.g
., 
11
.0
 m
ea
ns
 a
 N
Q
O
1:
β-
ac
tin
 m
RN
A
 ra
tio
 o
f 0
.0
11
 
* p
<0
.0
5 
(th
e 
di
ffe
re
nc
e 
be
tw
ee
n 
th
e 
hi
gh
 v
s l
ow
 c
on
su
m
pt
io
n 
gr
ou
ps
 w
as
 te
st
ed
 b
y 
W
ilc
ox
on
 te
st
) 
^ p
 fo
r i
nt
er
ac
tio
n 
<0
.0
1 
(c
al
cu
la
te
d 
as
 d
ep
ar
tu
re
 fr
om
 m
ul
tip
lic
at
iv
ity
 u
si
ng
 li
ne
ar
 re
gr
es
si
on
; e
nz
ym
at
ic
 a
ct
iv
ity
 w
as
 a
dj
us
te
d 
fo
r s
m
ok
in
g 
an
d 
sa
m
pl
e 
 
st
or
ag
e 
tim
e)
  
90 Chapter 4 
 
NQO1 activity in white blood cells. For comparison with rectal NQO1 activity, 
NQO1 enzymatic activity was also measured in total leukocytes (n=73) and in 
lymphocytes (n=91). It amounted to a mean of 19.9 ± 5.5 and 23.9 ± 5.8 nmol 
DCPIP/min/mg protein, respectively. There was no correlation between NQO1 
activity in rectal biopsies and NQO1 activity in total leukocytes (r=0.10, p=0.40), or 
lymphocytes (r=-0.02, p=0.88). This absence of correlation did not change when 
stratifying for the NQO1 609C>T polymorphism. There also was no correlation 
between total leukocyte and lymphocyte NQO1 activity (r=0.003, p=0.98).  
White blood cell NQO1 activity did not appear to be subject to the same 
genetic and/or exogenous influences as rectal NQO1 activity. There was no 
influence from recent fruit and vegetable consumption on lymphocyte activity and 
only consumption of Alliaceae was positively associated with leukocyte activity 
(non-parametric p=0.0425; adjusted β-estimate 2.15 nmol DCPIP/min/mg protein 
(95% CI -0.18, 4.47). The NQO1 609CT genotypes had somewhat lower NQO1 
activity in leukocytes and lymphocytes than the CC genotypes, but the difference 
was not significant: -1.8 (95% CI -4.1, 0.52) and -1.03 (-3.49, 1.45) DCPIP 
nmol/min/mg protein, respectively. 
 
DISCUSSION 
In this endoscopy-based population genetic variation, in particular the NQO1 
609C>T polymorphism, appeared more relevant for rectal NQO1 mRNA level and 
NQO1 enzymatic activity than fruit and vegetable consumption. White blood cell 
NQO1 activity did not reflect rectal activity. 
Consumption of fruits and vegetables did not show the expected positive 
association with NQO1 phenotype, but rather there appeared to be an inverse 
association with NQO1 mRNA and NQO1 activity. With regard to specific 
subtypes, consumption of Compositae (yes vs no) was associated with lower rectal 
NQO1 mRNA level and consumption of Apiaceae (yes vs no) was associated with 
lower rectal NQO1 activity. One factor that may play a role here is the relatively 
high content of pro-vitamin A carotenoids of Apiaceae and Compositae33. These 
can be metabolised to retinoic acid (RA), which was found to have a repressive 
effect on GSTP1 expression, mediated by an AP-1-binding site (TGACTCA) in the 
GSTP1 regulatory region34. An AP-1 sequence is also embedded in the NQO1 
EpRE22 and this AP-1 sequence was shown to be functional, since it was found to 
bind transcription factor AP-135 leading to repression of NQO1 transcription36. 
Moreover, the expression of GSTA and GSTM2 protein, which both have an AP-1 
binding site in their regulatory region37 was also found to be diminished upon 
Apiaceae consumption24, 38. Therefore, AP-1 binding site-mediated repression of 
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NQO1 transcription by RA may play a role in the observed inhibitory effect of 
Apiaceae and Compositae on NQO1 mRNA transcription and NQO1 enzyme 
activity. 
Consumption of known inducers of human NQO1 mRNA or NQO1 protein, 
such as Allium or Brassica vegetables6, 39, 40, was not significantly associated with 
higher NQO1 mRNA expression and/or NQO1 activity, although individuals who 
consumed Brassica vegetables did show higher NQO1 mRNA levels. The purpose 
of our food record was to estimate actual consumption on the two days prior to 
endoscopy (and not habitual consumption), because the transcriptional process 
occurs rapidly, in a matter of hours to days after consumption of the inducer6, 41 
and therefore the time window should have been sufficient to show any possible 
effects of the measured fruit and vegetable consumption. Perhaps, their inducing 
effects are overruled by other components of the total diet. Because of our 
observational design, most subjects were exposed to more than one type of fruit or 
vegetables. However, as we eat total diets and not components, this does reflect 
relevant exposure. Fruit intake was similar to and vegetable intake and percentage 
of vegetable consumers somewhat lower than that reported in the 1998 Dutch 
National Food Consumption Survey, a 2-day dietary record among representatives 
of the Dutch population42. Possibly, the exposure to some fruit and vegetable 
components was too low to show significant differences in NQO1 phenotype. E.g., 
most intervention studies that show inducing effects of Brassica vegetables on 
NQO1 or GST (to which a similar mechanism applies) phenotype use doses of ~300 
grams6, 38, 43, 44. Altogether, our study results indicate a limited role for recent 
regular fruit and vegetable consumption in human NQO1 phenotype. 
A role for fruits and vegetables may also be overruled by the NQO1 609C>T 
polymorphism, which was the most significant determinant of both NQO1 mRNA 
expression and NQO1 activity. In this study, the genotype distribution of the 
NQO1 609C>T polymorphism was comparable to frequencies found in other 
Northern European studies45, 46. The distribution of the NQO1 -718G>A 
polymorphism was comparable to that reported on the NCBI-website under 
rs689457 for a population with European ancestry47. As far as we know, the 
distributions of the three NFE2L2 polymorphisms have not been reported before 
for a (Northern) European population.  
We confirmed, in rectal biopsies, that NQO1 activity is lower among NQO1 
609 heterozygotes. This is due to the C to T change leading to a proline to serine 
amino acid substitution, which results in rapid degradation of the variant protein 
and thus rapid loss of activity48. The correlation coefficient between NQO1 mRNA 
level and NQO1 activity was low. The lower enzymatic activity not preceded by 
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lower mRNA level among those with the NQO1 609T-allele partly explains this 
low correlation coefficient.  
Interestingly, while rectal NQO1 activity was lower, rectal NQO1 mRNA 
expression was higher among individuals with the NQO1 609CT-genotype as 
compared to the 609CC-genotype. A similar observation has been reported for 
lung tissue49. A kind of feed-back control of the possible physiological 
consequences of the non-functional NQO1 609T-allele, i.e. higher levels of 
oxidative stress, may play a role in this. This could result in increased activation of 
transcription factor NFE2L2, which is considered to be responsive to intracellular 
oxidative stress23 and the major transcription factor involved in EpRE-mediated 
NQO1 expression control.  
Another explanation for the higher mRNA expression with the NQO1 CT-
genotype could be the existence of a uninducible C-allele, as proposed by Begleiter 
et al. based on studies of human tumor cell lines using 1,2-dithiol-3-thione (D3T), a 
known synthetic NQO1 inducer naturally occurring in e.g. cruciferous vegetables. 
Some NQO1 609CC cell lines in their studies were not inducible by D3T and in 
some NQO1 609CT cell lines there was induction of variant protein (i.e. encoded by 
the T-allele), only50. This phenomenon could also obscure an association between 
plant food inducers and activity. However, so far, a common genetic difference in 
the NQO1 promoter causing a clear difference in NQO1 regulation has not been 
identified, neither in a subsequent study by Begleiter et al.51 nor by our work.   
The correlation between NQO1 mRNA and NQO1 activity was low, also 
among the NQO1 609CC genotypes (r=0.50). It is important to consider both 
mRNA and activity, and their determinants, because mRNA is the first measure of 
induction, but activity is ultimately the more functional parameter for health. For 
practical reasons, biopsies for the mRNA and protein measurements were sampled 
and processed separately. The possible differences in sampling may have 
contributed to the low mRNA – activity correlation3. A regulatory mechanism that 
could further explain the low correlation between NQO1 mRNA and NQO1 
activity is alternative splicing. This is a common process in higher eukaryotes and 
may serve as a control mechanism for NQO1 expression52. One specific 
alternatively spliced transcript lacks exon 4, which contains the quinone binding 
site, and therefore lacks activity53, 54. It has been associated with the low-frequency 
NQO1 465C>T polymorphism (~5%) at position -3 before the 5’-splice site of intron-
414, 52. We did not discriminate between variant and full-length transcripts in our 
mRNA assay, and thus cannot quantitate the effect of its presence in our 
population. In the study by Szarka et al., its contribution differed between 
individuals, but in general was not high in colon mucosa55.  
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 There may be a functional role for genetic variation in transcription factor 
NFE2L2. The NFE2L2 -684G>A polymorphism was positively associated with 
rectal NQO1 mRNA expression (though this was not translated into a difference in 
activity) and warrants further investigation. Due to the relatively strong influence 
of the NQO1 609C>T polymorphism and lower power when stratifying for this 
polymorphism, a role for NFE2L2 polymorphisms in NQO1 phenotype is difficult 
to evaluate. Another complicating matter is that the functioning of the protein that 
regulates NFE2L2 activity (Keap1) could also be subject to genetic variation56. 
Altogether, this multitude of factors illustrates the complexity and diversity of 
cancer-biochemopreventive pathways.  
Although sample size was small for detecting more complex interactions, our 
study’s power was on average (with group sizes varying) >85 %  to detect a 50% 
difference in NQO1 phenotype. As no experimental data are available concerning 
the functionality of the NQO1 regulatory region and the NFE2L2 polymorphisms 
in rectal enzyme phenotype, their reported interactions need to be regarded with 
caution. Of course, with multiple comparisons there is also a risk of chance 
findings. To elucidate the determinants of rectal NQO1 activity, larger studies, at 
least stratified for the NQO1 609C>T polymorphism and discriminating between 
differences in exposure to inducers and repressors, are needed. 
Because rectal sampling is invasive and impractical, and because activity (and 
not mRNA level) eventually is the most relevant endpoint when considering 
protection against cancer, we examined if NQO1 activity in white blood cells may 
be a good surrogate for rectal activity. This does not appear to be the case. 
O’Dwyer et al. observed a close correlation for NQO1 mRNA expression between 
peripheral mononuclear cells and sigmoid samples, and conclude that colonic 
NQO1 gene expression can be monitored by using peripheral mononuclear cells8. 
However, NQO1 mRNA level does not necessarily predict NQO1 protein level or 
activity. The lack of correlation between white blood cell and rectal NQO1 activity 
in our study may reflect the complexity of influences (both genetic and exogenous) 
on the resulting NQO1 capacity in different parts of the body. 
Overall, the results of the present study demonstrate that both rectal NQO1 
mRNA level and NQO1 enzymatic activity are influenced most by the NQO1 
609C>T polymorphism. The NFE2L2 -684G>A polymorphism possibly affects 
NQO1 mRNA expression. Recent fruit and vegetable consumption may repress 
rather than induce rectal NQO1 phenotype. White blood cell NQO1 activity is not 
a good surrogate parameter for rectal NQO1 activity. Thus, to better understand 
the effects of fruits and vegetables in the large intestine, genetic variation needs to 
be taken into consideration in larger, tissue-specific studies.  
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ABSTRACT  
Both environment and genetics contribute to the pathogenesis and prevention of 
colorectal neoplasia. NAD(P)H:quinone oxidoreductase (NQO1) is a detoxification 
enzyme that is polymorphic and inducible. We investigated interactions between 
lifestyle factors and polymorphisms in NQO1 and its key regulatory transcription 
factor NFE2L2 in colorectal adenoma risk. The NQO1 c.609C>T and g.-718A>G and 
NFE2L2 g.-650C>A, g.-684G>A and g.-686A>G polymorphisms were determined 
among 740 Dutch adenoma cases and 698 endoscopy-based controls. Dietary 
intake was assessed by FFQ, other lifestyle information by questionnaire. The 
NQO1 609CT genotype was associated with a higher adenoma risk (OR 1.27, 95% 
CI 1.00-1.62) compared to the 609CC genotype, whereas the 609TT genotype was 
not (OR 1.03, 95% CI 0.56-1.88). The higher risk with the NQO1 609CT-genotype 
was seen among smokers (OR 1.96, 95% CI 1.40-2.76), but not among non-smokers 
(OR 0.91, 95% CI 0.62-1.35; interaction p=0.030). Fruit and vegetable consumption 
did not protect smokers from adenomas and did not interact with the NQO1 
609C>T polymorphism or the NFE2L2 polymorphisms. A higher adenoma risk 
seen with high fruit and vegetable consumption among NQO1 -718GG genotypes 
was absent among -718GA genotypes (interaction p=0.071). Gene-gene interactions 
were observed between the NQO1 609C>T and NFE2L2 -686A>G polymorphisms 
(interaction p=0.056) and between the NQO1 -718 G>A and NFE2L2 -650C>A 
polymorphisms (interaction p=0.013). In conclusion: the NQO1 609CT genotype is 
associated with increased adenoma risk among smokers, which is not diminished 
by high fruit and vegetable consumption. The observed gene-gene interactions 
may point to a role for NFE2L2 polymorphisms in NQO1-related adenoma 
formation.
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INTRODUCTION 
Both environmental and genetic factors contribute to the pathogenesis as well as 
prevention of human colorectal neoplasia. The colorectal area is exposed to a wide 
variety of carcinogens and protective compounds. An important biotransformation 
enzyme, that may play a role in the detoxification of dietary and other carcinogens, 
is NAD(P)H:quinone oxidoreductase (NQO1, EC 1.6.5.2)1.   
NQO1 is subject to genetic variation2. Two functional single nucleotide 
polymorphisms (SNPs) have been reported: the 609 C to T substitution with a 
prevalence ranging from ~20% in Caucasians to ~50% in Asians and the 465 C to T 
substitution with low prevalence2. The 609C>T SNP translates into an amino acid 
change and results in loss of enzyme activity3-5. Its consequences for colorectal 
cancer risk are not clear. A meta-analysis of 6 studies (5 in Caucasians and 1 in 
Asians) concluded that the heterozygous genotype (609CT) was associated with a 
modestly higher colorectal cancer risk (OR 1.15)6. The homozygous variant 
genotype (609TT), however, was not significantly associated with cancer risk and 
even appeared to be protective in Asians6. With respect to colorectal adenomas, 
intermediates in colorectal carcinogenesis, an increased risk has been reported with 
the 609CT genotype only in one study7 and with the 609TT genotype only in 
another study8. 
Environmental exposure to anticarcinogens and procarcinogens is relevant for 
the risk assessment of the NQO1 609C>T SNP. NQO1 may play a role in the 
colorectal biotransformation of cigarette smoke7-10, alcohol7, meat11 and may be 
inducible by coffee, polycyclic aromatic hydrocarbons (PAHs) and various other 
environmental compounds12-14. Also, NQO1 is thought to be inducible by various 
fruit and vegetable components12-16. High exposure to inducers such as fruits and 
vegetables could be beneficial for individuals with the NQO1 609CT genotype as it 
may upregulate their one functioning (C) allele, without concomitant 
(pro)carcinogen exposure. The relation between the NQO1 609C>T SNP and high 
fruit or high vegetable consumption in colorectal cancer risk has rarely been 
investigated, however, and a risk difference between NQO1 609 coding region 
variants has not been observed11. In this respect, the regulatory region of the NQO1 
gene is also relevant, as it contains sequences such as the electrophile responsive 
element (EpRE) through which inducers act to promote transcription. So far no 
genetic variation has been described in the EpRE of the NQO1 gene, but 
polymorphisms may exist in other NQO1 regulatory region nucleotide sequences, 
which may also turn out to be functional. EpRE-controlled transcription involves 
binding of transcription factor nuclear factor (erythroid-derived 2)-like 2 (NFE2L2, 
also known as Nrf2). For the NFE2L2 gene, SNPs have also been reported17, but 
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little is known about their functionality in human populations. These SNPs may 
influence the regulation of NQO1 and could thus affect NQO1-related differences 
in adenoma risk.  
The aim of this study was to explore the associations between genetic variation 
in NQO1 and NFE2L2, exposure to environmental factors (i.e. cigarette smoking, 
meat consumption and alcohol consumption) and the possible beneficial role of 
fruit and vegetable consumption, in colorectal adenoma risk. 
 
METHODS 
Population. Study design and population have been described before18, 19. Cases 
and controls were recruited among those undergoing endoscopy in 10 endoscopy 
outpatient clinics in the Netherlands between June 1997 and October 2002. 
Eligibility criteria were: Caucasian, Dutch speaking, age 18-75 years at time of 
endoscopy, no hereditary colorectal cancer syndromes, no chronic inflammatory 
bowel disease, no history of colorectal cancer and no (partial) bowel resection. 
Most common endoscopy indications were bowel discomfort, change in defecation 
pattern, anal bleeding or, for cases, follow-up after earlier adenoma. Cases had at 
least one histologically confirmed colorectal adenoma ever in their lifetime. 
Controls had no medical history of any type of polyp, confirmed by full 
colonoscopy (75%) or sigmoidoscopy combined with X-ray (10%). Fifteen percent 
of subjects did not have full visualisation of the colon, i.e. they had a 
sigmoidoscopy without X-ray or colonoscopy where the caecum was not reached. 
The study was approved by the Medical Review Boards of all participating 
hospitals and of Wageningen University. The overall response rate was estimated 
to be 55%, varying from 35% to 90% between outpatient clinics. The total study 
population consisted of 1477 participants (768 cases and 709 controls). All gave 
their written informed consent.  
Diet and other lifestyle factors. Dietary intake was assessed by a self-
administered food frequency questionnaire (FFQ) developed for the Dutch 
European Prospective Investigation Into Cancer cohort and processed using the 
Dutch food composition table20. Frequency of consumption could be indicated per 
day, week, month or year. Portion sizes were estimated from color photographs. 
Frequencies and portion sizes were multiplied to obtain grams for each food item. 
Total vegetable consumption was calculated as the sum of raw and cooked 
individual vegetables and total fruit consumption as the sum of individual fruits 
and corrected proportionally to the frequency reported on total vegetables and on 
total fruits20. Total vegetables and total fruits were summed into one variable to 
reflect the composite exposure to its many phytochemicals. Total meat 
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consumption was calculated according to Linseisen et al.21 as the sum of fresh meat 
(among which fresh red meat) and processed meat; Fresh red meat was defined as 
beef, pork and other; Processed meat was defined as cold/sandwich meats, sausage 
and meat snacks. Alcoholic beverages were divided in beer, white wine, red wine, 
ports and liquors, and ethanol consumption was measured as the number of 
glasses multiplied by its ethanol content (~ 10 grams). Coffee consumption was 
measured as the number of cups consumed. The FFQ referred to habitual intake in 
the year preceding endoscopy or bowel problems. General lifestyle factors, such as 
smoking behaviour, were assessed by a structured self-administered questionnaire. 
Both FFQ and general questionnaire were handed at the time of endoscopy or sent 
within three months after endoscopy. Endoscopy-related and other medical 
information was abstracted from the patient’s medical record. 
Genotyping. EDTA treated whole blood was used for DNA extraction 
(QIAamp 96 DNA blood kit, Qiagen Inc.). DNA was stored at 4ºC in 8*12 array 
banks with negative controls. Laboratory staff was blinded for case-control status. 
Nomenclature of sequence variation is according to recent consensus22, but after 
first mention is made this is abbreviated in the text by omitting ‘c.’ or ‘g.’. 
The NQO1 c.609 C>T SNP3 (position according to GenBank Accession number 
J03934) was assessed by PCR-RFLP with an internal check on digestion. PCR was 
performed with the ‘NQO1 cod-fw’ and ‘NQO1 cod-rv’ primers (table 1), Super 
Taq DNA polymerase (HT Biotechnology, Sphaero Q, Gorinchem, the 
Netherlands), and annealing at 60°C. The resulting amplicon was digested with 
HinfI (Fermentas GmbH, St. Leon-Rot, Germany), which yielded fragments of 273, 
119 and 23 base pairs (bp) for the C-allele, and fragments of 151, 122, 119 and 23 bp 
for the T-allele.  
Table 1: NQO1 and NFE2L2 PCR and (pyro)sequencing primers 
Name Sequence (5’ → 3’) Method Measurement 
NQO1 cod-fw 
NQO1 cod-rv 
TGA GAA GCC CAG ACC AAC TT 
GAA GGA AAT CCA GGC TAA GGA PCR-RFPL c.609C>T 
NQO1 reg-fw 
NQO1 reg-rv 
NQO1 pyrosequencing 
TTT TTC AGT ACA GAC GGG GCT TC 
Biotin-GGC TGG TGT GGA GAT AGC AGT TA 
GTG AGC CAC CGC GCC Pyrosequencing 
 
 
g.-718G>A 
NFE2L2 fw 
NFE2L2 rv 
NFE2L2 pyrosequencing 1 
NFE2L2 pyrosequencing 2 
ATA CTG ACC ACT CTC CGA CCT AA 
Biotin-GTG GGG GGG GCT AAA GAT 
CGT GGG AGT TCA GAG G 
GAA CAC GAG CTG CCG 
Pyrosequencing
 
 
 
g.-684G>A and g.-686A>G  
g.-650C>A 
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The NQO1 regulatory SNP, g.-718G>A relative to the transcription initiation site 
(or -829 relative to the translation start) of GenBank Accession number M81596 and 
known under NCBI rs689457, was genotyped by pyrosequencing. We selected this 
SNP because it was found to have the highest frequency in our sequence survey of  
~1100 bp of the NQO1 regulatory region upstream of the transcription initiation 
site among 96 individuals (unpublished results). PCR was performed with ‘NQO1 
reg-fw’ and ‘NQO1 reg-rv’ primers (table 1), Super Taq DNA polymerase, and 
annealing at 61°C. The resulting 181 bp amplicon was used for a forward directed 
pyrosequencing analysis; primer ‘NQO1 pyrosequencing’ (table 1) was used to 
analyze the region -725 to -717 of NQO1 in order to genotype the -718G>A 
polymorphism.  
The NFE2L2 SNPs reported by Yamamoto et al.17, g.-650C>A, g.-684G>A and 
g.-686A>G relative to the transcription initiation site of GenBank accession number 
AC079305 (g.-733C>A, g.-767G>A and g.-769A>G, respectively, relative to the 
translation start of this accession number) were determined by pyrosequencing. 
PCR was performed with ‘NFE2L2 fw’ and ‘NFE2L2 rv’ primers (table 1), Super 
Taq DNA polymerase, and annealing at 58°C. The resulting 241 bp amplicon was 
used for two forward directed pyrosequencing analyses; primer ‘NFE2L2-
pyrosequencing 1’ (table 1) was used to analyze the region -686 to -677 of NFE2L2 
in order to genotype the -686A>G and -684G>A polymorphisms, and primer 
‘NFE2L2-pyrosequencing 2’ (table 1) was used to analyze the region -651 to -646 of 
NFE2L2 in order to genotype the -650C>A polymorphism. 
NQO1 and NFE2L2 genotypes were in Hardy Weinberg Equilibrium among 
both controls and cases, as tested by a χ2 test, with a possible exception for the 
NQO1 -718 SNP, where χ2 for cases was 3.04, p=0.081.  
To test reproducibility, one row out of each DNA bank (8% of the population) 
was genotyped in duplicate; Four subjects could not be genotyped unambiguously 
for NFE2L2, the other measurements were 100% reproducible. 
Statistical analysis. Fifteen individuals (11 cases, 4 controls) were excluded 
because of incomplete data on vegetable consumption. Twenty-four participants 
(17 cases, 7 controls) were excluded because blood was unavailable or the amount 
of DNA insufficient and therefore all genotyping results were absent. This resulted 
in a final study population of 1438 (740 cases and 698 controls). Additional 
individuals missing SNP data as a result of insufficient DNA varied from 1 (NQO1 
-718) to 17 (NFE2L2 -684).  
Haplotypes for NQO1 and NFE2L2 were estimated using the Hplus program 
version 2.5, available online (Fred Hutchinson Cancer Research Center. 
http://qge.fhcrc.org/hplus.) The two NQO1 variants never occurred together on the 
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same allele, and neither did the three NFE2L2 variants. In further statistical 
analysis, genotypes were therefore considered individually. Also, pairwise (and for 
power reasons not higher order) combinations were made. Case-control 
comparisons were made using conventional logistic regression. Odds ratios (ORs) 
and 95% confidence intervals (95% CIs) were calculated using the most common 
homozygous genotype as a reference group. Literature indicates that the NQO1 
609 CT and TT genotypes respond differently biologically6 and therefore they were 
not grouped together, despite low power for the TT genotypes. SNPs were 
analyzed in relation to adenoma risk in strata of other SNPs and strata of the 
following dietary and other lifestyle exposures that may influence NQO1: 
consumption of vegetables and fruits, meat (and subtypes), alcohol and coffee, and 
smoking. Smoking was defined as never or ever smoking. In addition, duration of 
smoking and number of cigarettes was evaluated, based on the (most equal) 
median split in controls. Consumption of fruits, vegetables, meat, alcohol (all in 
g/d) and coffee (freq/d) was divided into tertiles based on the distribution in the 
control group. For the analysis of higher order interactions, exposures were 
dichotomized, based on the median value of the control group. The reference 
group was the most common homozygous genotype in combination with low 
exposure. The p-value for interaction was calculated by χ2 test comparing the –2 
log likelihood (-2LL) values of the models with and without genotype-by-genotype 
or exposure-by-genotype interaction term(s). P-values lower than 0.05 were 
considered statistically significant. For reasons of power, the interaction analyses 
were restricted to individuals with the homozygous common and heterozygous 
genotypes, with the exception of the NFE2L2 -686 SNP. Trend analysis was 
performed by substituting continuous values with the three control median values 
of the tertiles. Reported p-values are Wald χ2 test p-values. Evaluated as possible 
confounders for smoking/dietary exposure-adenoma associations, which always 
included age (< and > 55 years) and sex (male/female), were: indication for 
endoscopy (bowel complaints, family history; yes/no), education 
(low/medium/high), smoking (never/ever; for dietary exposures), total energy 
intake (kJ/d), consumption of coffee (freq/d), alcohol, total meat, red meat, 
processed meat, total vegetables, cruciferous vegetables, total fruit and citrus fruit 
(all in g/d). Alcohol consumption affected the OR for number of cigarettes by more 
than 10% and was included in the smoking models and, for comparison, also in 
fruit and vegetable models.  
Statistical analyses were performed using SAS software, version 9.1 (SAS 
Institute, Cary, NC).  
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To complement traditional analysis, we used a multifactor dimensionality 
reduction (MDR) approach23: a nonparametric method for detecting and 
characterizing nonlinear interactions. Two analyses were performed, using the 
MDR sofware available through www.epistasis.org (version 1.0.0): one containing 
all NQO1 and NFE2L2 SNPs and total fruit and vegetable consumption in tertiles, 
and one containing the additional attributes smoking (ever/never) and alcohol 
(median-split).  
 
RESULTS 
Characteristics of the study population are described in table 2, more elaborate 
descriptions can be found in previous reports19, 24, 25. Controls were younger, more 
often female and more often underwent endoscopy for reasons of bowel problems 
than cases. Cases were more often smokers and had a higher alcohol intake than 
controls.  
 
Table 2: Selected population characteristics
abowel discomfort and defecation problems 
bmissing information on endoscopy indication: 9, missing information on ever/never smoking: 9  
cdoes not include potato 
Characteristic Cases (n=740) Controls (n=698) 
General/medical  Median (p10-p90) 
Age years 60 (44-72) 52 (33-69) 
Sex % female 46 62 
Endoscopy indication 
 
% bowel 
complaintsa, b 47 77 
Smoking 
% everb 
duration 
number/day 
67 
30 (12-45) 
15 (4-25) 
56 
22 (8-40) 
15 (5-25) 
Dietary    
Total fruits & vegetables 
total vegetablesc 
total fruits 
Total meat 
fresh red 
processed 
Alcohol 
Coffee 
Energy 
g/day 
g/day 
g/day 
g/day 
g/day 
g/day 
g/day 
freq/day 
kJ/day 
277 (120-492) 
114 (69-180) 
127 (18-367) 
107 (40-178) 
60 (16-100) 
30 (6-75) 
9 (0-42) 
4 (2-7) 
8378 (5885-11804) 
260 (119-476) 
109 (68-169) 
125 (27-350) 
102 (35-172) 
53 (13-96) 
29 (5-73) 
4 (0-31) 
4 (0.4-8) 
8113 (5452-11808) 
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The NQO1 609CT genotype was associated with a slightly higher colorectal 
adenoma risk (OR 1.27, 95% CI 1.00-1.62; table 3), and a similar observation was 
made for the NFE2L2 -686AG genotype (OR 1.19, 95% CI 0.94-1.50; table 3), but not 
for the other SNPs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was a borderline significant interaction between the NQO1 609C>T  and 
the NFE2L2 -686A>G SNP (p for interaction=0.056). The higher adenoma risk 
associated with the NQO1 609CT genotype appeared to be absent in combination 
with the NFE2L2 -686AA genotype (table 4). Risk was somewhat higher for the 
NQO1 609CT and NFE2L2 -686AG genotype combination (OR 1.56, 95% 1.09-2.22; 
table 4) and, though with low power, was highest for the NQO1 609TT and NFE2L2 
-686GG genotype combination (OR 6.84, 95% CI 0.79-59.6; table 4). Results of 
haplotype analysis including the SNPs in both genes also pointed to a possible 
interaction between NQO1 and NFE2L2 (data not in table). The combination of the 
NQO1 609T and NFE2L2 -686G variant nucleotides and wild-type nucleotides for 
the 3 other SNPs was statistically significantly associated with higher adenoma risk 
as compared to the combination of all five wild-type nucleotides: OR 1.72 (95% CI 
1.18-2.49), with a frequency of 8.74% among cases and 5.10% among controls 
Table 3: NQO1 and NFE2L2 genotyping results and adenoma risk
Genotypea 
  
Cases (n=740)  Controls (n=698)   
% n  % n  OR (95% CI)* 
NQO1 
c.609 C>T 
 
CC 
CT 
TT  
64.0 
32.6 
3.4 
472 
240 
25  
70.2 
26.5 
3.3 
490 
185 
23  
1 (ref)b 
1.27 (1.00-1.62) 
1.03 (0.56-1.88) 
NQO1  
g.-718 G>A 
 
GG 
GA 
AA  
79.0 
20.4 
0.5 
584 
151 
4  
78.2 
20.5 
1.3 
546 
143 
9  
1 (ref) 
1.01 (0.77-1.32) 
0.51 (0.15-1.77) 
NFE2L2  
g.-650 C>A 
 
CC 
CA 
AA  
81.5 
17.5 
1.0 
596 
128 
7  
81.4 
17.8 
0.7 
566 
124 
5  
1 (ref) 
1.01 (0.76-1.34) 
1.19 (0.36-3.92) 
NFE2L2  
g.-684 G>A 
 
GG 
GA 
AA  
75.5 
23.0 
1.5 
551 
168 
11  
77.4 
21.0 
1.6 
535 
145 
11  
1 (ref) 
1.14 (0.88-1.46) 
1.04 (0.43-2.50) 
NFE2L2  
g.-686 A>G 
 
AA 
AG 
GG  
43.0 
45.4 
11.6 
314 
332 
85  
45.6 
42.1 
12.3 
316 
292 
85  
1 (ref) 
1.19 (0.94-1.50) 
0.99 (0.69-1.40) 
*adjusted for age and sex 
amissing genotype results NQO1 c.609C>T: 3, g.-718A>G: 1, NFE2L2 g.-650C>A: 12, g.-684G>A: 17, g.-686A>G: 14 
bref abbreviates reference category 
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compared with the wild-type combination of 31.6% and 31.5%, respectively. There 
was no interaction between the NQO1 609C>T SNP and the other SNPs in 
adenoma risk. The NQO1 -718G>A SNP did interact with the NFE2L2 -650C>A 
SNP (p for interaction=0.013), the combined heterozygotes showing an increased 
adenoma risk (OR 1.77, 95% CI 0.98-3.19; table 4) compared with the reference 
group of combined common homozygotes. 
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Smoking (past or present) was associated with a higher adenoma risk (OR 1.43, 
95% CI 1.13-1.80; table 5). There was a significant interaction between smoking and 
the NQO1 609C>T SNP (p for interaction=0.030, table 5); The increased adenoma 
risk with the NQO1 609CT genotype was clearly present among smokers (OR 1.96, 
95% CI 1.40-2.76), but could not be seen among non-smokers (OR 0.91, 95% CI 0.62-
1.35). Duration of smoking was positively associated with colorectal adenoma risk 
(not in table). Among NQO1 609CC genotypes the OR was 0.97 (95% CI 0.69-1.37) 
for less than 22 years and 1.51 (95% CI 1.09-2.09) for more than 22 years of smoking 
and among 609CT genotypes these risks were 1.65 (95% CI 1.01-2.71) and 2.16 (95% 
CI 1.45-3.21), respectively, both compared with non-smoking 609CC-genotypes. 
Adenoma risk did not increase with increasing number of cigarettes. There was no 
interaction between the NQO1 -718G>A SNP and smoking.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Following up on the literature, we also evaluated consumption of alcohol, 
coffee and (total, red and processed) meat for a possible interaction with the NQO1 
609C>T SNP in colorectal adenoma risk. In this study, these factors did not interact 
significantly with the NQO1 609C>T SNP in colorectal adenoma risk. Alcohol 
consumption increased adenoma risk (data not shown in table) and this was 
additional to the effect of the NQO1 609C>T SNP: for the NQO1 609CC genotypes, 
the OR with the highest tertile of alcohol intake was 1.52 (95% CI 1.09-2.12) and for 
NQO1 609CT genotypes this was 1.82 (95% CI 1.19-2.80; p for interaction=0.70), 
both compared with the lowest tertile of intake and 609CC genotypes. Among 
smokers, the highest OR with the highest alcohol tertile was also observed among 
the 609CT genotypes: 1.98 (95% CI 1.08-3.65) versus 1.31 (95% CI 0.85-2. 40) for 
609CC genotypes, compared with the lowest tertile of alcohol intake (data not in 
Table 5: NQO1 polymorphisms, smoking and adenoma risk
Smoking Never Ever  
 
na 
(cases/controls) 
OR* (95% CI) 
 
n
(cases/controls) 
OR* (95% CI) 
 
p 
intb 
All genotypes 239/307 1 (ref)b 494/387 1.43 (1.13-1.80)  
NQO1  
c.609 C>T 
 
CC 
CT 
TT 
163/211 
67/88 
9/8 
1 (ref) 
0.91 (0.62-1.35) 
1.36 (0.50-3.72) 
306/276
172/96 
16/15 
1.24 (0.94-1.64) 
1.96 (1.40-2.76) 
1.06 (0.49-2.30) 
 
0.030 
 
NQO1  
g.-718 G>A 
 
GG 
GA 
AA 
191/234 
48/69 
2/4 
1 (ref) 
0.87 (0.57-1.34) 
0.76 (0.12-4.65) 
390/309
102/73 
2/5 
1.36 (1.05-1.76) 
1.52 (1.05-2.22) 
0.55 (0.10-3.00) 
 
0.37 
 
*adjusted for age, sex and alcohol consumption (g/d) 
anumbers do not always add up due to missing values 
bref abbreviates reference category, int abbreviates interaction 
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table). However, among non-smokers, the highest OR with the highest tertile of 
alcohol intake was observed among the NQO1 609CC genotypes: 1.92 (95% CI 1.11-
3.33, p for trend=0.025) versus 1.11 (95% CI 0.49-2.51) for 609CT genotypes, 
compared with the lowest tertile of alcohol intake. Interactions between the NQO1 
609C>T SNP and alcohol consumption among non-smokers and smokers did not 
reach statistical significance: p for interaction=0.25 and 0.15, respectively. 
High consumption of fruits and vegetables was associated with an increased 
adenoma risk: OR 1.36 (table 6). This was more associated with consumption of 
vegetables (OR for the highest vegetable tertile was 1.37, 95% CI 1.05-1.80), than 
with consumption of fruit (OR for the highest fruit tertile was 1.13, 95% CI 0.86-
1.48; data not shown in table). There was no significant interaction between the 
NQO1 609C>T genotype or the NFE2L2 genotypes and the consumption of fruits 
and vegetables, in adenoma risk (table 6). There was a weak suggestion for an 
interactive effect between the NQO1 -718G>A SNP and consumption of fruits and 
vegetables (p for interaction=0.071): the highest tertile of fruit and vegetable 
consumption was associated with a higher risk among -718GG genotypes (OR 1.58, 
95% CI 1.17-2.15) but not among -718GA genotypes (OR 1.05, 95% CI 0.67-1.66; 
table 6).  
High fruit and vegetable consumption was also not associated with a lower 
adenoma risk for smokers. Compared to non-smokers with the common NQO1 609 
variant (CC) and low fruit and vegetable intake (median-split), the highest 
adenoma risk was observed in smokers with the NQO1 609CT-genotype that had a 
high fruit and vegetable consumption (OR 3.01, 95% CI 1.78-5.10, data not in table).  
Our MDR analyses did not yield testing balance accuracies >0.55. With a cross 
validation consistency of 10/10, it did select the NQO1 609C>T and NFE2L2 -
686A>G SNPs, smoking and alcohol consumption as relevant variables. 
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DISCUSSION 
Our results confirm a role for the NQO1 609C>T SNP in colorectal tumor risk. The 
NQO1 609CT genotype, but not the 609TT genotype, was associated with a higher 
colorectal adenoma risk. The higher risk with the 609CT genotype was observed 
among smokers, but not among non-smokers. No such distinction was apparent 
for the 609TT genotypes. High consumption of fruits and vegetables did not 
protect those with the 609CT-genotype, but rather seemed to increase their risk 
further, especially among smokers. Interactions were observed between the NQO1 
609C>T and the NFE2L2 -686A>G SNPs, and between the NQO1 -718A>G and 
NFE2L2 -650A>C SNPs. 
The NQO1 609CT genotype, but not the 609TT genotype, was associated with 
an increased colorectal adenoma risk. This finding is in line with a meta-analysis of 
the association between the NQO1 609C>T SNP and colorectal cancer6, comprising 
6 studies26-31, which reported a significant slightly increased risk with the 609CT-
genotype, but not the 609TT-genotype. It is also supported by more recent results 
for high risk colorectal adenomas from the UK flexible sigmoidoscopy screening 
trial7. As the C to T substitution results in loss of NQO1 enzyme activity5, it is likely 
that the increased risk with the 609CT genotype relates to reduced detoxification. 
Lack of significance with the 609TT genotype may simply be due to the low 
prevalence of the 609TT genotype resulting in low power, though some studies of 
equal or smaller size do report an increased risk with the NQO1 609TT genotype 
(and not the CT genotype) in colorectal cancer26, 32 and adenomas8. It may also 
relate to underlying differences in exposure to (pro)carcinogens metabolized by 
NQO1 between the study populations. Exposure to (pro)carcinogens is relevant for 
the amount of detoxification needed by the NQO1 enzyme, but also for its 
potential role as activator of (pro)carcinogens13, 33. 
Tobacco smoke is one such relevant environmental exposure9, 10, being a source 
of the procarcinogen benzo(a)pyrene and its reactive benzo(a)pyrene quinone 
metabolites. NQO1 can specifically prevent formation of benzo(a)pyrene-quinone-
DNA adducts34. We report an interaction between smoking and the NQO1 609C>T 
SNP in adenoma risk, the risk being highest with the 609CT genotype among 
smokers, but absent among non-smokers. There was no indication for an altered 
risk with the 609TT genotype. Our finding is supported by an earlier observation 
of interaction between smoking and the NQO1 609C>T SNP in distal colorectal 
cancer28. In colorectal adenoma risk, similar interactions were also observed 
before7, 8, but these did not reach statistical significance. One of these adenoma 
studies did report a significant interaction when the CYP1A1 4889A>G SNP was 
included: the highest adenoma risk was observed among smokers with one or two 
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variants of both NQO1 609C>T and CYP1A1 4889A>G. Altogether, it is plausible 
that a mechanism associated with both smoking and the NQO1 enzyme adds to 
adenoma formation. In a separate study, we determined the NQO1 609C>T SNP 
and NQO1 enzymatic activity in rectal biopsies and also registered if subjects were 
current, ex or never smokers. Current smoking was associated with higher rectal 
enzymatic NQO1 activity than not smoking (144 and 96 nmol DCPIP/min/mg 
protein, respectively, p=0.0065) among NQO1 609CC-genotypes (n=59), but not 
among 609CT-genotypes (64 and 77 nmol DCPIP/min/mg protein, respectively, 
p=0.26; unpublished data). These data suggest that smokers with the 609CC-
genotype induce their already higher NQO1 detoxification capacity and that 
smokers with the 609CT-genotype might be faced with a double burden: their 
already lower detoxification capacity and lack of induction. It is currently unclear 
how the absence of a higher adenoma risk with smoking among the 609TT-
genotypes relates to this, as these subjects have no NQO1 detoxification capacity. 
Alternatively, they cannot bioactivate procarcinogens, such as nitrosamine in 
tobacco and this has been suggested as an explanation for a cancer-protective 
association with the 609TT genotype in Asians6. Another possibility is that total 
loss of activity is compensated by upregulation of other detoxification pathways, 
such as other quinone, carbonyl, and aldo-keto reductases35.  
Other relevant environmental exposures include consumption of alcohol and 
meat. A significant interaction has previously been reported between alcohol 
consumption and the NQO1 609C>T SNP, the 609CC genotypes having a higher 
adenoma risk with higher alcohol consumption7, but we could not confirm this in 
our total population. Alcohol consumption did appear to increase adenoma risk 
among non-smoking 609CC-genotypes, but among smokers adenoma risk was still 
highest among 609CT-genotypes. This may indicate that the effect of smoking is 
stronger than the effect of alcohol consumption in our population, allowing the 
latter to become visible only in non-smokers. With respect to meat intake, an 
earlier study observed the highest colorectal cancer risk for high red meat intake 
among individuals with imputed intermediate NQO1 enzymatic activity 
(consisting of the NQO1 609C>T and 465C>T SNPs), and the lowest risk among 
those with deficient enzymatic activity11. We could not confirm an interaction 
between the NQO1 609C>T SNP and red meat consumption. Consumption of 
barbecued or grilled meat, as a source of PAHs, would also be interesting in this 
respect, but in this population, the frequency of consumption was too low to 
investigate, i.e. only ~12% of cases and of controls had barbecued or grilled meat 
once a month or more. 
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We hypothesized that consumption of fruits and vegetables protects the 
colorectum against the NQO1 609CT genotype and against the deleterious effects 
of quinone-type (pro)carcinogens such as present in cigarette smoke. This did not 
appear to be the case in our population. Higher consumption of fruits and 
vegetables even increased the adenoma risk among the NQO1 609CT genotypes, 
especially in combination with smoking. Mechanistically, this could be related to 
the action of an unspecified component that is widely present in fruits and 
vegetables. For example, a significant interaction between tobacco use and intake 
of β-carotene in colorectal adenoma risk has been reported36, which consisted of a 
protective effect among non-smokers and an increased risk among ever smokers. 
In our study, there was no effect of β-carotene among non-smokers, but risk 
increased with the second and third tertile of β-carotene intake among smokers 
(data not shown). Interestingly, there was an increased adenoma risk with high 
fruit and vegetable consumption among NQO1 -718 GG genotypes and this was 
absent among those with the -718 GA genotype. It is not known whether this 
represents a truly functional consequence, e.g. because the SNP is part of a 
regulatory sequence mediating the effect of a fruit and vegetable constituent.  
It is also not yet known whether the SNPs in NFE2L2 have consequences for 
the functioning of NFE2L2, but the significant gene-gene interactions between the 
NFE2L2 and NQO1 SNPs in this study indicate their possible functionality in 
(NQO1-related) adenoma tumor risk. Transcription factor NFE2L2 regulates 
transcription of several genes containing EpRE enhancers in their regulatory 
region. In light of that role, functional phenotypic differences between the NFE2L2 
genotypes may have implications beyond the NQO1 enzyme and our findings 
need to be replicated in future studies including other enzymes.  
Our study has strengths and weaknesses. The development of colorectal 
tumors is a complex process. More than one enzyme and more than one exposure 
play a role and we attempted to take this into account within the limits of our 
study size. We considered coding and regulatory region SNPs in NQO1 and SNPs 
in the regulatory pathway of NQO1, as well as exposure to both proposed 
carcinogens and anticarcinogens. Exploration of three-way interactions with 
biological plausibility (such as smoking/fruits and vegetables/NQO1 SNP and 
smoking/alcohol/NQO1 SNP) can be seen as a strength, because this more closely 
represents real-life situations. However, as our study does not have enough power 
for three-way interactions, the analyses and their results should be interpreted as 
exploratory. Our genotyping assays were reproducible and the NQO1 609C>T 
genotype distributions in accordance with other northern European populations27, 
29, 37. As far as we know, the distributions of the three NFE2L2 SNPs have not been 
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reported for a (Northern) European population before. Our controls underwent 
endoscopy and this has the advantage of cases and controls being sampled from 
the same base population and of lower outcome misclassification because of 
verification of control status by endoscopy. Our positive association between fruit 
and vegetable consumption and adenomas requires further methodological 
consideration. In general, measurement of fruits and vegetables is difficult. 
Reproducibility of the FFQ was ~0.70 for vegetables and ~0.65 for fruits38. Validity 
relative to twelve 24hr recalls was ~0.35 for vegetables and ~0.60 for fruits38. These 
correlations are low, but no exception for FFQs20. They indicate that some degree of 
misclassification, especially for vegetables, may have occurred39, but not to a 
greater extent than in other studies. Cases may have overreported their fruit and 
vegetable intake due to knowledge of adenoma status. Controls, being endoscopy-
based and having a higher prevalence of bowel discomfort than cases, may have 
avoided intake of certain vegetables such as cabbage. We judge both types of bias 
unlikely, however, because adenoma patients do not receive dietary advice on 
fruits and vegetables in the Netherlands, earlier analyses restricted to new cases 
did not change conclusions18 and only very few subjects have reported a change in 
vegetable intake due to bowel problems18. Bias may have been introduced due to 
non-response, but unfortunately we do not have sufficient data on patients not 
participating in the study to further evaluate a possible bias due to non-response or 
due to differences in outpatient clinic. Thus, we cannot fully rule out the possibility 
that selection bias, a problem often encountered in case-control studies, is one 
explanation why we see an increased adenoma risk with fruits and vegetables in 
this study. However, bias most likely is no explanation for differences in adenoma 
risk between genotypes.  
In conclusion, smokers with the NQO1 609CT genotype have a higher 
colorectal adenoma risk and this is not counteracted by a high fruit and vegetable 
consumption. The regulatory NQO1 SNP and the NFE2L2 SNPs may also have 
modifying roles in colorectal tumor formation. As the NQO1 609C>T SNP 
demonstrates, it may not always be legitimate to group heterozygotes and 
homozygous variants together and genotypes should be placed in the context of 
polymorphisms in other genes and exposure to dietary and other lifestyle factors. 
This requires very large-scale epidemiologic studies. These studies, aided by 
human mechanistic and intervention studies, will need to confirm the role of the 
SNPs and also further evaluate the role of fruits and vegetables in this. 
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PREAMBLE 
The role of fruit and vegetable consumption and individual genetic variation in 
regulatory and coding DNA sequences of the glutatione S-transferase (GST) and 
NAD(P)H:quinone oxidoreductase (NQO1) detoxification enzymes was 
investigated in relation to GST and NQO1 enzyme level and activity, and in 
relation to colorectal adenoma risk.  
In the previous chapters, the background and rationale of the studies were 
described, and the methods and results were discussed by detoxification system 
(GSTs and NQO1) and endpoint (enzyme phenotype and colorectal adenomas).  
In this chapter, the findings are integrated, placed in a broader context of 
concepts and methodology, and their implications are discussed. The focus of the 
chapter will be on the concept of polymorphism functionality, interpreted from 
and structured into a molecular, physiological and epidemiological perspective, 
with emphasis on the latter perspective. Finally, a societal perspective is reflected 
upon, and some suggestions for future research are made. The chapter starts with a 
brief recapitulation of the main findings. 
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MAIN FINDINGS 
The main findings are summarized by detoxification system and by endpoint, 
below and in table 1. It is based mostly on the polymorphisms for which some 
knowledge concerning their functionality was already available. An elaborate 
summary can be found in addendum I.  
In general, regulatory SNPs in GSTA1, GSTP1 and NQO1 with convincing 
differences in their responsiveness to fruit and vegetable intake were not found.  
GSTs: rectal enzyme phenotype. The most important determinant of rectal 
GST activity was the GSTP1 313A>G polymorphism, GST activity being lower with 
the 313 G variant. Overall, fruit and vegetable consumption was not associated 
with higher GST activity, but individual botanicals were associated with higher or 
lower levels of individual GST enzyme levels (e.g. Alliaceae and GSTP1 and 
Apiaceae and GSTM2, respectively). The correlation between rectal and white 
blood cell GST activities was low.  
GSTs: colorectal adenomas. High consumption of cruciferous vegetables 
appeared to increase adenoma risk among those with slower metabolizing GST 
variants, especially the combination of the GSTA1 -69 T and GSTP1 313 G variants, 
contrary to our hypothesis. The GSTM1 and GSTT1 genotypes, and cruciferous 
vegetable intake did not seem to interact with respect to colorectal adenomas.  
NQO1: rectal enzyme phenotype. The most important determinant of rectal 
NQO1 activity was the NQO1 609C>T polymorphism, NQO1 activity being lower 
with the 609 T variant. Overall, fruit and vegetable consumption was not 
associated with higher NQO1 activity, but rather with lower values, especially for 
the botanical subtype Apiaceae. NQO1 mRNA and NQO1 activity correlated 
among NQO1 609CC genotypes but not among CT genotypes. Rectal and white 
blood cell NQO1 activities did not correlate.  
NQO1: colorectal adenomas. The NQO1 609CT genotype was associated with 
an increased adenoma risk among smokers. Consumption of fruits and vegetables 
did not decrease this risk. NQO1 and NFE2L2 genotypes interacted in colorectal 
adenoma risk. 
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POLYMORPHISM FUNCTIONALITY IN RELATION TO FRUIT AND 
VEGETABLE CONSUMPTION AND DETOXIFICATION: SUBJECT MATTER 
AND METHODOLOGICAL CONSIDERATIONS FROM DIFFERENT 
PERSPECTIVES 
 
Here, the findings are discussed in light of the concept of polymorphism 
functionality, from a molecular, physiological, epidemiological and societal 
perspective. These perspectives represent and structure a continuum of integration 
levels of increasing complexity, through which the functionality of a 
polymorphism can persist. Functionality is broadly defined as the genetic 
difference having any consequence or not. An effect that persists through the 
higher integration levels is considered most relevant. The molecular, physiological 
and epidemiological perspectives start with a brief introduction and the position of 
relevant research questions. These are discussed with respect to content under the 
heading ‘Subject Matter’. Each perspective is bound by its available methodology, 
and this is accounted for under the heading ‘Methodology’. Subsequently, the 
societal perspective is addressed.  
The physiological and epidemiological perspectives are the core of this thesis, 
and the molecular and societal perspectives are touched upon to complement the 
continuum of integration levels on both sides. 
 
 
MOLECULAR PERSPECTIVE 
Definition. The molecular perspective is considered to include a comparison 
between different genotypes with respect to the organization of the DNA, the 
regulation of DNA transcription and environmental influences on this, and the 
biochemical properties of the proteins that are produced. 
Concept. In regulatory regions, a distinction can be made between genetic 
differences being functional in the absence or presence of environmental stimuli. 
On the one hand, genetic variation can have constitutive consequences, i.e. a basal 
difference in transcription rate. On the other hand, genetic variation can have 
consequences in response to environmental stimuli, e.g. a different induction 
effect. In our studies of colorectal cancer prevention, the main interest was in the 
latter mechanism, i.e. gene-fruit & vegetable interactions.  
Candidate genes. GSTA1, GSTP1 and NQO1 were selected as candidate genes, 
because they code for common biotransformation enzymes which metabolize 
carcinogens relevant for the colorectal area and because they have been reported to 
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be inducible in humans by consumption of fruits and vegetables (as explained in 
the Introduction).  
Study questions. One can ask the following questions fitting within the 
molecular perspective with regard to the GSTA1, GSTP1 and NQO1 genes: 
 
-------------------------------------------------------------------------------------------------------------- 
Q1) Have genetic variants been identified in the regulatory region? 
Q2) If so, do they confer different phytochemical-induced transcription levels? 
Q3)  If so, what is the combined effect of the identified regulatory region polymorphisms 
and known coding region polymorphisms on phenotype? 
Q4)  Do the known coding region genetic variants encode biotransformation enzymes 
which metabolize phytochemicals differently? 
-------------------------------------------------------------------------------------------------------------- 
 
MOLECULAR PERSPECTIVE: SUBJECT MATTER 
The search for polymorphisms in regulatory regions and the mechanistic 
assessment of their functionality was the subject of a complementary study 
(A.M.J.F. Boerboom, J.M.M.J.G. Aarts and I.M.C.M. Rietjens).   
Regulatory SNPs (Q1). The SNPs to be investigated further in relation to 
enzyme phenotype and adenoma occurrence ideally have mechanistic back-up of 
their functionality and occur with a frequency that would give these studies 
sufficient statistical power (the latter depends on many things, but a minimum 
requirement for the SNPs could be that they are ‘common’, i.e. with a minor allele 
frequency of more than 10%1). Only few polymorphisms were idenfied to occur at 
a frequency suitable for further studies. Of these, only one was in a regulatory 
region (NQO1) and three were in an intronic region (GSTP1). No SNPs were 
observed in the NQO1 and GSTP1 electrophile responsive elements (EpREs;  
GSTA1 is not known to contain an EpRE). Recently, SNPs in EpREs were reported 
to occur in other genes, but not in NQO1 and GSTP12. In the literature, functional 
haplotypes in the regulatory region have been reported in the GSTA1 gene3 and in 
the GSTP1 gene4. The haplotype in GSTA1 could be confirmed, the haplotype in 
GSTP1 could not. 
Functionality of regulatory SNPs (Q2 and 3). The studies concerning the plant 
component responsiveness or basal functionality of the polymorphisms were still 
on-going at the time this thesis was written and thus mechanistic back-up cannot 
be established at the time. A stable Hepa-1c1c7 luciferase reporter cell line 
containing the human NQO1 electrophile responsive element (EpRE) was 
developed5. This assay can be used to screen dietary constituents and to better 
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understand mechanistically their EpRE mediated gene transcription activation. The 
transfected construct can also be modulated to contain NQO1 promoter 
polymorphisms and can consequently be used to experimentally test differences in 
transcription activation between individual genotypes as well as between dietary 
constituents6.  
The GSTA1 regulatory region haplotype has been reported to have a different 
basal transcription rate6, as described in the Introduction. 
Functionality of coding SNPs (Q4). From the scientific literature, some GSTP1 
and NQO1 polymorphisms in coding regions, were already known. Their 
mechanistic functionality, i.e. a different substrate specificity for variants of 
GSTP17, 8 and NQO19, 10, has been described in the Introduction. With respect to 
GSTP1, there is not only a difference in substrate specificity for carcinogenic 
substrates, but also for supposed anticarcinogenic substrates such as glucosinolate-
derivatives11-13  The known functional coding variants were included for evaluation 
in our genotype-phenotype and case-control study.  
Future. Ideally, a number of (frequently occurring) regulatory SNPs would 
have been identified, their molecular functionality would have been known, and 
they would have been related to phenotypic outcomes on higher integration levels.  
For an example of such a multidisciplinary approach, see ref14. Unfortunately, this 
did not work out as such for our multidisciplinary project. The multidisciplinary 
approach is still deemed highly valuable, however. For the future, one 
improvement to the approach may be to allow for a (greater) time lag between the 
molecular work and the work on the higher integration levels. 
 
MOLECULAR PERSPECTIVE: METHODOLOGY  
Screening for promoter SNPs. Regions of the GSTA1, GSTP1 and NQO1 
promoters of 96 individuals (from the same base population as in subsequent 
studies) were sequenced. This number should suffice to identify SNPs occurring at 
frequencies relevant for further studies. It did not yield many frequently occurring 
SNPs, however. For the relevant DNA sequences and observed polymorphisms, 
see addendum II. There are a number of possibilities why other functional 
polymorphisms in regulatory regions were not found. If SNPs with regulatory 
potential exist, they may be outside the sequenced region, do not occur in our 
population or are missed in sequencing. Also, a gene may be affected by 
polymorphisms in transcription factors regulating it.  
Sequencing scope. Regulatory region SNPs could have been missed because 
sequencing did not cover a sufficiently large area. For NQO1, an upstream region 
of ~1100 bp from the transcription starting point was covered. In the NQO1 gene, 
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functional genetic variation within regulatory sequences has been suspected 
because of observed differences in transcription level15. However, lack of induction 
was reported not to be due to regulatory region genetic variation when ~2000 bp of 
NQO1 regulatory region from 6 cell lines were sequenced16. Based on the above, it 
is possible that common, functional SNPs are not present in the regulatory region, 
but more research is warranted.  
Functional SNPs could be present at large distance from the transcription 
starting point. The gene control region generally comprises several transcription 
factor binding sites that may influence (activate, repress) gene transcription and 
these could also be subject to the influence of fruit and vegetable components. 
 Also, other steps in the regulatory process can be influenced by genetic 
variation. The SNP at position +465 relative to the transcription starting site in the 
NQO1 gene is a good example of a functional SNP in an intronic sequence. It leads 
to alternative splicing, with consequences for the quinone binding site17. This 
particular polymorphism is infrequent, however, and thus not suitable for 
epidemiologic studies unless they are extremely large.  
Population. With regard to GSTP1, amplification of relevant GSTP1 promoter 
sequences by PCR repeatedly failed due to GC-rich areas and the promoter area to 
be sequenced was downsized. Eventually, a ~900 bp region was sequenced, 
reaching into the regulatory region to position -405 (acknowledgement Dr. M. 
Visker, dept. of Human Nutrition). Cauchi et al. reported a regulatory haplotype 
responsive to phytochemicals ex vivo after our data collection period was over, i.e. 
one homozygous and three heterozygous genotypes among 40 Caucasians4. Four 
of their SNPs, starting at position -282 relative to the transcription initiation site, 
were within the region that was sequenced in our population (for the relevant 
DNA sequences and observed polymorphisms, see addendum II). It is unclear why 
they were missed. 
Transcription factors. Variation may also occur in other, pathway-related 
genes. The most important regulatory factor for EpRE-related transcription, 
NFE2L2, has been reported to be polymorphic: three SNPs and a deletion 
polymorphism were found18. The SNPs were included in our investigations. 
Molecular studies investigating their functionality are lacking.  
 
MOLECULAR PERSPECTIVE: CONCLUSION 
At this point, it remains uncertain whether the GSTA1, GSTP1 and NQO1 genes 
contain regulatory polymorphisms with experimentally shown functional 
differences in relation to inducing fruit and vegetable components. New results are 
expected in this field in the near future.  
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PHYSIOLOGICAL PERSPECTIVE 
Definition. The physiological perspective is considered to include a comparison of 
enzyme levels and activities (phenotype) in tissues of individuals with different 
genotypes, and dietary and other environmental factors influencing this enzyme 
phenotype.  
Concept. Enzyme phenotyping can yield valuable information on 
biotransformation capacity and regulation of human carcinogen-metabolising 
enzymes, although it is labour-intensive and costly. The rationale behind 
measuring it is that the enzymes lower the levels of carcinogens in the tissues and 
cells by inactivating carcinogenic substances19. It gives more information on the 
actual level of protection compared to the molecular perspective. This is especially 
true when phenotyping is performed in the actual tissue of interest. When 
genotype-phenotype relations are established, it can also provide the rationale for 
using polymorphisms, as markers which are assessed relatively quickly and 
inexpensively, in epidemiological studies.  
SNP selection. SNPs were selected based on our own sequencing results 
(GSTP1 217G>A, 227G>A, 272C>G , NQO1 -718G>A SNP), based on molecular and 
phenotypic knowledge from the literature (GSTA1-69C>T, GSTP1 313A>G and 
NQO1 609C>T), and based on literature frequency reports (NFE2L2 -650C>A, -
684G>A, -686A>G SNPs).  
Study questions. The following questions fitting within the physiological 
perspective were asked with regard to GSTA1, GSTP1 and NQO1 phenotype: 
 
-------------------------------------------------------------------------------------------------------------- 
Q1) Do the genetic variants result in different protein or mRNA levels in rectum? 
Q2) Do the genetic variants result in different protein activity in rectum? 
Q3) Does consumption of fruits and vegetables, or their subtypes, result in different levels 
or activity of GSTA1, GSTP1 or NQO1 in rectum? 
Q4) Does an interaction exist between fruit and vegetable consumption and GSTA1, 
GSTP1 or NQO1 genetic variants in GSTA1, GSTP1 or NQO1 protein levels or 
activity in rectum? 
Q5) Does GST or NQO1 phenotype in blood reflect phenotype in rectum? 
-------------------------------------------------------------------------------------------------------------- 
 
PHYSIOLOGICAL PERSPECTIVE: SUBJECT MATTER 
Genotype – enzyme phenotype (Q1 and 2). SNPs with known functionality. The 
best-known polymorphisms in GSTA1, GSTP1 and NQO1 (GSTA1-69C>T, GSTP1 
313A>G and NQO1 609C>T) were clearly associated with a difference in enzyme 
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phenotype in the rectum, as had been described during and before our work, in 
different tissues (GSTA1:3, 20; GSTP1:21; NQO1: 22-25). For GSTA1, the difference was 
in the level of protein. For NQO1 and GSTP1, the difference was in enzymatic 
activity. For the latter, this was reflected in the total GST activity. GSTP1 protein 
level and NQO1 mRNA were measured to be able to determine a transcription 
effect, but the polymorphisms affecting the enzymatic functioning of the enzyme 
also seemed to affect transcription, in the opposite direction. Both the GSTP1 
313A>G and NQO1 609C>T polymorphisms resulted in lower activity, but their 
expression levels seemed to be higher. This shows that mRNA and protein levels 
bear a complicated relation to ultimate physiological functionality, i.e. the actual 
activity of the enzyme.  
SNPs with unknown functionality. The presence of the relatively strong 
differences between the GSTP1 313 and NQO1 609 genotypes makes detection of a 
difference on the enzyme level for the other polymorphisms more difficult. Their 
analysis can be stratified for the GSTP1 313 and NQO1 609 genotypes, but this 
reduces power. The GSTP1 intronic polymorphisms were not convincingly 
associated with GSTP1 level or total GST activity (chapter 2). The same applies to 
the NQO1 promoter polymorphism and NQO1 phenotype (chapter 4). The NFE2L2 
promoter polymorphisms may have some relation with NQO1 phenotype. The 
NFE2L2 -684G>A polymorphism was associated with higher NQO1 mRNA level, 
the difference between the NFE2L2 genotypes being most pronounced among 
those with the common homozygous NQO1 609CC genotype. The associations 
between the NFE2L2 polymorphisms and GST phenotypes were also evaluated. As 
the results have not been submitted to a scientific journal, they are included in 
addendum III. In short, the NFE2L2 -684GA genotype was associated with a higher 
GSTM1 level and total lymphocyte GST activity. The NFE2L2 polymorphisms did 
not significantly affect total rectal GST activity. So far, other studies investigating 
their physiological functionality have been limited to an observational study which 
concluded that the SNPs are associated with cellular indicators of gastric mucosal 
inflammation26, which shows the extensive role of NFE2L2 as a transcription factor. 
Fruits & vegetables – enzyme phenotype (Q3). Fruit and vegetable subtypes 
may contain components with opposing influences on colorectal enzyme 
phenotype.  
Induction. Allium consumption was associated with increased rectal GST 
protein levels, e.g. the level of GSTP1 and GSTT1. Thus, it may be relevant in 
colorectal cancer prevention27. For GSTP1 there is mechanistic support for an 
induction effect by Allium vegetables28.  Crucifers did not increase enzyme levels 
or activity, at least not statistically significantly. Several studies, however, have 
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shown higher GST capacity with higher crucifer intake29-31 32-36. Possibly here, type 
of crucifer also matters. Above-mentioned studies were performed with Brussels 
sprouts, broccoli and red cabbage. In the studies by Steinkellner and co-workers, 
there was no induction by broccoli and white cabbage37. In general, cauliflower is 
the main crucifer of consumption in the Netherlands, as a toplist of most 
frequently consumed vegetables in the 1998 Dutch National Food Consumption 
Survey showed (chapter 3). In our genotype-phenotype study, the order of highest 
to lowest crucifer consumption was cauliflower, white cabbage, Brussels sprouts, 
broccoli, traditional ‘potatoe-and-crucifer’ hodgepodge, pointed cabbage and 
radish (data not shown). In addition, dose and duration of exposure may also be 
associated with different mechanisms. Feedback mechanisms may be invoked. For 
example, in the Oltipraz trials, induction of GST and NQO activity was observed 
after a single dose, but the effect was lost after multiple doses38, 39.  
Repression. Total fruit and vegetable consumption was associated with lower 
total GST activity and GSTP1 level and total vegetables with lower NQO1 mRNA. 
Compositae consumption was associated with lower NQO1 mRNA and Apiaceae 
consumption with lower NQO1 enzymatic activity and lower GSTM2 level. Gene 
suppression by fruits and vegetables is biologically plausible. Persson et al. 
observed GSTP1 downregulation after three weeks of total vegetable intervention 
and speculated that this was compensatory, the result of increased external supply 
of antioxidants. An intervention study with polyphenol-rich fruit juices also 
showed GSTP1 protein downregulation, in leukocytes40. In vitro studies by Van 
Zanden41 en van Haaften42, 43 show that GSTP1 can be inhibited by the flavonoid 
quercetine and by tocopherols. Pro-vitamin A carotenoids may also have a 
repressive effect on both GSTP1 and NQO1 by the retinoic acid (RA)-AP-1 
mechanism discussed in chapter 4. Certain coumarins and flavones are competitive 
inhibitors of NQO1 activity that compete with NAD(P)H for binding to NQO144, 45 
44-48, resulting in lower activity. However, the latter type of inhibition could not be 
measured in our study (see Methods), and thus inhibition of enzymatic activity is 
therefore no explanation for our observation. It may nonetheless play a role in 
vivo. For example, a human intervention study found Apiaceae to inhibit CYP1A2 
activity, measured indirectly as urinary caffeine metabolite ratios49. Peterson et al. 
subsequently identified constituents in Apiaceae, certain furanocoumarins and 
flavonoids, likely to be responsible50.  
 Genotype – fruits & vegetables interaction in enzyme phenotype (Q4). Some 
examples were seen of fruit and vegetable consumption being associated with 
enzyme phenotype which appeared to differ among genotypes (chapter 2 and 4, 
see also Add I). However, our genotype-phenotype study remains exploratory in 
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this respect. For appropriate power, complex interactions involving several 
polymorphisms and several environmental influences require sample sizes that are 
hard to accomplish in enzyme phenotyping studies.  
Enzyme phenotype in rectum and white blood cells (Q5). The major 
polymorphisms for total GST activity and NQO1 activity in the rectum, the GSTP1 
313A>G and the NQO1 609C>T SNP, did not so much affect white blood cell total 
GST activity and NQO1 activity. This is likely the result of tissue specific 
expression. Different GSTs are expressed in different quantities in different 
tissues51 (resulting in tissue-specific susceptibility to genotoxicity). In addition, 
clear differences in GST expression have been found between different lineages of 
hematopoietic cells52 (which may the defence capability of cells from those 
lineages). In lymphocytes, as in rectum, GSTP1 is reported to be the most abundant 
isoenzyme52, 53. This probably explains why the difference in GST activity between 
the GSTP1 313A>G genotypes could also be seen in lymphocytes. GSTM1 is also 
thought to be important in lymphoid cells52. These polymorphisms were not seen 
to influence lymphocytes, but we did see an effect on leukocytes, which consist of 
~30% lymphoid cells. NQO1 is not highly expressed in blood cells. Besides genetic 
differences, tissues are supplied differently with diet-derived compounds. Blood is 
thus not a good surrogate tissue for rectal tissue and invasive studies taking 
biopsies remain necessary. An alternate explanation for lack of association between 
blood (both lymphocytes and leukocytes) and rectal tissue is that they represent 
different terms of exposure (short-term vs long-term). This would still mean they 
are not interchangeable (but could be complementary, depending on the research 
question to be answered).  
 
PHYSIOLOGICAL PERSPECTIVE: METHODOLOGY 
Assessment of enzyme phenotype. Enzyme levels are the result of many 
biological factors. Furthermore, the reproducibility and validity of the chosen 
phenotypic measurements need to be considered. Issues influencing internal and 
external validity discussed here are the use of specific chemicals, detoxification vs 
bioactivation (or: the paradigm that higher is better) the depth and localisation of 
rectal biopsy and reversible inhibition. 
Specific chemicals. Enzyme activity is not an absolute characteristic of a certain 
amount of a certain protein, but is relative to the substrate that is used. In the case 
of total GST activity, which consists of the sum of the activities of the GST 
subtypes, it is also determined by the relative substrate specificities of the 
contributing GST isoenzymes and the relative amounts in which they occur. The 
latter is tissue specific. Illustrating this, is a controlled feeding trial, where the 
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vegetable diets did not have an effect on GST activity in serum measured with 
CDNB as a substrate, but did affect GST activity measured with NBD-Cl as a 
substrate54. CDNB is a well-known generic substrate and was used in our studies 
for this reason. However, it may not best represent enzymatic activity towards, and 
thus protection against, all individual relevant carcinogens. Two examples by 
which this may affect our studies and other studies: GSTT1 has no metabolic 
activity for CDNB and GSTA1 relatively low activity. Firstly, if a substrate had 
been chosen to measure (total) GST activity that also allowed detection of GSTT1 
activity, then maybe a protective effect of Allium vegetables on total GST activity 
would have been shown in chapter 2, as opposed to only on GSTP1 and GSTT1 
protein levels. Secondly, GSTA1 is the only GST with high specificity for N-acetoxy 
PhIP, a dietary carcinogen that is very relevant for humans55 and CDNB will say 
relatively little about protection against this carcinogen. Using several substrates in 
measuring enzyme activity may thus yield valuable information. Despite substrate 
issues, enzymatic activity probably does represent a more relevant measure with 
regard to protection against carcinogens than enzyme levels.  
Enzyme activities and levels are commonly expressed by the amount of total 
protein to allow comparison between study subjects. As the methods to determine 
total protein are based on different chemical principles56-58, comparison between 
studies is not always possible. A different issue with respect to normalising to total 
protein is the possibility that other proteins are also affected by induction53. This 
will affect total protein, and thus the absolute degree of change in GST or NQO1 
level or activity may be attenuated by an accompanying change in total protein. 
For leukocytes, a solution is to measure by 106 cells instead of total protein40. 
Detoxification versus bioactivation. Measurement of phase II enzymes 
addresses only one side of the medal. For detoxification purposes it may be 
important to know if fruits and vegetables also affect phase I enzymes, which may 
activate (pro)carcinogens, and if polymorphisms exist in phase I enzymes that 
affect their capacity. Also, (the level of) exposure to (pro)carcinogens is important, 
and we attempted to take this into account in our case-control comparison by 
subgroup-analyses. Effects of (pro)carcinogen metabolism can also be measured 
and may give more insight in the functionality of the polymorphism. An example 
of this is the study by Hecht et al.59, in which vegetables were fed and in which 
(pro)carcinogen exposure (smoking) and a measure of consequence (NNK 
metabolites in urine) were taken into account.  
Depth and localisation of biopsy. Rectal biopsies may have contained not just 
epithelial tissue, but also underlying connective tissue and the ratio between the 
two tissue types may have varied between individuals due to random or 
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endoscopist-specific differences in biopsy depth. This is relevant, because NQO1 is 
not found in connective tissue. Sole presence of epithelial tissue could be checked 
under light microscopy, but this would preclude snap-freezing of samples and 
thus possibly affect enzyme activity. The ratio of mucus secreting goblet to 
absorptive cells increases toward the rectum. NQO1 expression is low in goblet 
cells compared to the absorptive cells. As biopsies were taken over a small distance 
of 10 cm, biopsy localisation probably did not affect comparability in our study, 
but may affect generalisability to the colon. The same is true for GSTs, their levels 
are also known to decrease towards the rectum. 
Reversible inhibition. A general drawback of measuring enzyme phenotype is 
that reversible inhibition (e.g. competition with NAD(P)H for binding to NQO1) 
cannot be measured in a cell lysate /ex vivo, because the inhibitory dietary 
compound will already have diffused away from the (NQO1) enzyme. However, it 
may still be relevant as a mechanism and have consequences for (NQO1) capacity. 
For some enzyme systems, it is possible to measure the consequences of inhibition 
somewhere further in the pathway, illustrated by the study measuring urinary 
cafeine metabolite ratios in CYP1A2 metabolism49.  
Assessment of fruit and vegetable consumption by food record. In the 
genotype-phenotype study, fruit and vegetable consumption was measured by 
food record. A food record is thought not to rely on memory and to be a specific 
reflection of actual intake60. Information on actual, and not habitual, consumption 
was desired in relation to enzyme phenotype for biological reasons, i.e. the 
pathway from consumption to expression and translation takes hours to a few 
days, known from cell studies and shown in human intervention studies29, 38. As 
not every fruit and vegetable subtype (for an overview of the botanicals and the 
individual subtypes that belong to the classes, see Addendum IV) is eaten by all 
study subjects within the days before endoscopy, exposed versus non-exposed 
groups can be formed. Two groups (yes and no consumption) were formed for 
practical reasons of power. Also it was expected that the difference of effect 
between no and any exposure is greater than between different levels of exposure. 
This may not be true for all vegetable subtypes or thresholds may exist at high 
doses. For example, an association suggesting an induction effect of cruciferous 
vegetables could not be demonstrated. Possibly, high doses such as used in 
controlled feeding trials are needed or an effect is confined to only some 
cruciferous vegetables and not others that are commonly eaten. Furthermore, a 
classification into botanically defined subtypes is only useful to some extent. In the 
context of this study, the classification should be able to show effects of 
phytochemicals that are mainly confined to these subtypes, but compounds that 
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are more widespread will need a different grouping or estimation from the total 
amount of fruits and vegetables that are consumed. Of course, intervention trials 
can give better answers with respect to underlying mechanisms and causality. In 
order to evaluate whether fruits and vegetables truly enhance the human 
detoxification system in vivo, a range of trials would have to be designed taking 
into account at least: different types of vegetables, doses, exposure times, phase II 
enzymes, phase I enzymes, polymorphisms, tissues and base line enzyme values. 
This is a true challenge. Also, studies would be needed to see under which 
circumstances increased detoxification capacity actually protects against cancer.  
Population. In the genotype-phenotype study, subjects came from a 
population that was referred to an endoscopy clinic. The exclusion criteria were 
intended to secure a study group with relatively normal mucosa. Yet there is still a 
chance that those with seemingly normal mucosa had an unmeasured underlying 
defect related to  GST and NQO1 enzymes which affected phenotype as compared 
to those from the general population. Genotype distributions were comparable to 
other populations, which can be interpreted as an indication that a normal fraction 
of the population was sampled with respect to GST and NQO1, although this is 
difficult to say in a population this size. There were no individuals with the low 
frequency NQO1 609TT genotype. This could be due to the relatively small sample 
size, may mean that homozygosity is related to the exclusion criteria, or it could 
even be the result of cross-contamination during DNA isolation.  
 
PHYSIOLOGICAL PERSPECTIVE: CONCLUSION 
GSTA1, GSTP1 and NQO1 contain polymorphisms with consequences for enzyme 
phenotype. Different botanicals may be capable of upregulating or downregulating 
enzyme phenotype. The effect of polymorphisms and fruit and vegetable 
consumption may be interactive, but this was not clearly shown. Measurements 
should be performed in the colorectum, white blood cells are not a good surrogate 
tissue. 
 
 
EPIDEMIOLOGICAL PERSPECTIVE 
Definition. The epidemiological perspective is considered to include a comparison 
of disease occurrence or intermediate clinical disease markers between groups of 
individuals with different genotypes, and dietary and other lifestyle factors 
influencing this. 
Concept. The conceptual framework of this perspective is that genetic 
susceptibility only matters in the presence of relevant environmental stimuli, i.e. 
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exposure to a relevant amount of carcinogens is needed for a genetic variant with 
lower detoxification potential to take effect and similarly, exposure to a relevant 
amount of anti-carcinogens is needed for a genetic variant with a higher induction 
potential of detoxification enzymes to take effect. Or in other words, from a 
consequential perspective: without exposure to carcinogens, there is no (visible) 
difference in toxicity; without exposure to anticarcinogens, there is no (visible) 
difference in protection capacity.  
SNP selection. In the epidemiological studies, the same SNPs were evaluated 
as were in the physiological studies (see p 7), with the exception of the GSTP1 
intronic SNPs.  
Study questions. The following questions fitting within the epidemiological 
perspective were asked with regard to an intermediate disease marker in the 
colorectal cancer pathway, adenomas: 
 
-------------------------------------------------------------------------------------------------------------- 
Q1) Is there an association between the polymorphisms and the occurrence of adenomas? 
Q2) Is there interaction between the polymorphisms and fruit and vegetable consumption 
in the occurrence of adenomas? 
-------------------------------------------------------------------------------------------------------------- 
 
EPIDEMIOLOGICAL PERSPECTIVE: SUBJECT MATTER 
Genotype – adenomas (Q1). As expected, the polymorphisms per se were not 
associated with a difference in adenoma risk, the NQO1 polymorphism being an 
exception because a substantial part of the study population consists of smokers 
and exposure to cigarette smoke is one important carcinogenic exposure to render 
the effect of the polymorphism visible.  
Genotype – fruits & vegetable interaction and adenomas (Q2). Higher intake 
of total fruits and vegetables or cruciferous vegetables was associated with an 
increased adenoma risk, as has been reported in some other populations before61-65, 
especially in those with genotypes conferring lower enzyme capacity. There are (at 
least) two conceivable biological explanations for this. One is, that fruits and 
vegetables may contain substances that increase the need for detoxification, which 
cannot be achieved sufficiently due to genetic predisposition. Another is that fruits 
and vegetables may contain substances that lower detoxification enzyme levels, 
which then reach critically low levels in those who are already genetically 
predisposed to lower levels.   
Starting with the latter explanation, vegetable constituents may lower the 
expression of GSTs and NQO1 (chapter 2 and 4). The tissue-specific distribution of 
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the enzyme and the sensitivity of the enzyme to the other carcinogens that the 
population is exposed to will then further determine the vulnerability of the tissue 
to develop cancer. Thus, e.g., GSTP1, which might be downregulated, will be 
important in the colorectal area because it is the most abundant GST there. An 
adenoma risk difference was seen with GSTP1 and GSTA1 polymorphisms, and 
not with GSTM1 and GSTT1 polymorphisms. It is possible that to a certain extent a 
lack of capacity of a biotransformation enzyme can be compensated for by another 
enzyme with respect to exposures that they are both sensitive to, either from its 
own family (eg other GSTs66) or from another family (e.g. other quinone 
reductases67). If true, genotype-phenotype relations are hard to establish.  
The other explanation mentioned above is that fruits and vegetables may 
contain substances that increase the need for detoxification. Fruit and vegetable 
constituents can induce phase I enzymes49, which may then activate carcinogenic 
metabolites68. But even the phase II GST and NQO1 systems are known to be active 
systems towards some specific chemical classes, i.e. they may sometimes result in 
the formation of active carcinogenic metabolites69. Thus, even when substances are 
supplied that monofunctionally induce phase II enzymes,  such as sulphoraphane 
from broccoli, there may still be a downside to inducing phase II enzymes and 
some authors warn against this70-72 or direct possible toxicity of naturally occurring 
plant components73-76.  
It is conceivable that a number of commonly consumed vegetable subtypes in 
the Netherlands express some of the above mentioned characteristics, as explained 
in chapters 3 and 5, which will become visible when detoxification capacity is 
already genetically lower. Along the same lines, the combination of fruit and 
vegetable consumption and smoking, i.e. a higher carcinogen load, was 
particularly unbeneficial.  
 
EPIDEMIOLOGICAL PERSPECTIVE: METHODOLOGY 
Colorectal adenomas. Adenomas are not carcinomas and most (85%) never will 
be77, 78. The unspecific nature of their relation to carcinomas may be seen as a 
disadvantage, because it may dilute the association with risk or preventive factors 
for cancer. On the other hand, they provide insight into the temporal relationship 
between exposure to fruits and vegetables and colorectal cancer60. Fruit and 
vegetable components may block or suppress carcinogenesis in many ways; by 
stratifying for GST and NQO1 genotype, we focussed on mechanisms related to 
their detoxification potential. Detoxification potential is probably most important 
in the first stages of carcinogenesis, where the multiple hits by carcinogens that 
increasingly disorganise the replication of the cell can still be prevented. If this 
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mechanism plays a role of importance, it is reasonable to assume it be visible on 
intermediate markers such as adenomas. Some subtypes of adenomas  (e.g. villous 
and large adenomas) are thought to confer a higher chance of carcinomas79, 80 and 
thus the dilution effect will be less. Unfortunately, because our research questions 
already required (multiple) stratification, there was no power for elaborate 
adenoma type subgroup analysis. 
 Assessment of fruit and vegetable consumption by FFQ. In the case-control 
study, fruit and vegetable consumption was measured by food frequency 
questionnaire (FFQ), with the purpose to estimate habitual intake in the period 
before the endoscopy of inclusion (controls) or before the occurrence of the first 
adenoma (cases). Fruit and vegetable consumption was measured as a summary 
variable to reflect total exposure to anticancer compounds, and also cruciferous 
vegetable intake was assessed.  
Recall bias. Cases consumed a (slightly) higher amount of vegetables than 
controls. A methodological explanation for this is information bias due to 
differential recall. Adenomas are reported to be mainly asymptomatic and thus the 
chance of a change in dietary habits due to symptoms is naturally small. It is 
possible that the recall of some cases was influenced because they knew the 
diagnosis before they filled out the questionnaire. This is probably limited, because 
gastroenterologists do not give dietary advice with respect to fruits and vegetables. 
Also, leaving recurrent cases out of statistical analyses in chapter 3 did not change 
conclusions, although this approach leaves in the new cases who filled out the FFQ 
after diagnosis and does not exclude some degree of recall bias. Controls may have 
been influenced by the presence of gastro-intestinal symptoms, causing them to 
start avoiding certain vegetables. Change of diet was, however, checked by our 
questionnaire, and only very few controls (or cases) responded affirmatively. 
Exposure misclassification. It has been argued that epidemiological studies do 
not find consistent associations with fruits and vegetables because of the 
considerable variation in bioactive content between the different plant cultivars 
and due to the many ways and conditions of processing, storage, and preparation81. 
The consequences of this uncertainty in intake on the outcome of epidemiologic 
cohort studies have been simulated by Monte Carlo simulations82. These 
simulations showed that even if one assumes a strong protective effect of 
glucosinolates in cruciferous vegetables (or any component in fruit and vegetables) 
against cancer, this effect would not be statistically significantly assessed in an 
epidemiologic study with food intake as the main input. Thus, this would 
attenuate a negative association towards null. However, it will not likely result in a 
spurious positive association and does not explain increased risk. So far, some food 
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frequency questionnaires have differentiated between raw and cooked vegetables, 
but production, processing, storage and preparation have not been incorporated 
yet. It is expected that future studies will attempt to take this into account. Also, 
precision can be gained through the field of biomarkers, as a more integrated 
measure of the actually consumed, absorbed and metabolised compound. Analysis 
of for example glucosinolates in blood plasma is becoming a more realistic support 
of dietary intake data83.  
Confounding. High cruciferous vegetable consumption may be indicative of 
some other component that is related to the consumption of crucifers but not the 
causal component in the adenoma risk increase (confounding). For example, it 
could be an indicator of the traditional dietary pattern consuming meat, potatoes 
and cooked vegetables (in which case glucosinolates would probably not be the 
culprit as their bioavailability is severely reduced by boiling84). It was evaluated 
statistically if total, red or processed meat and low education as a proxy for social 
status were confounders, which they were not by our standard of a 10% change in 
OR, making confounding less likely.  
Assessment of gene-environment interaction. A large amount of gene-
environment studies have been published in the cancer field over the past years85. 
Researchers have been guided through the design and analysis of gene-
environment studies in recent years86-90 and publication criteria have been 
suggested91-93. One, if not the most, important parameter in gene-environment 
studies, is the estimate of interaction. Interaction is usually defined as statistical 
interaction and assessed by parametric methods (linear and logistic regression) as 
the deviation from additivity or (most commonly) multiplicativity88. This is meant 
to be a reflection of biological interaction. However, biomolecular interactions do 
not always result in statistical interactions, and statistical interactions do not 
necessarily imply underlying biomolecular interactions and thus it is not always 
clear what a reported interaction, or lack of it, means94. Some authors propose a 
systems biology approach to obtain the relevant information to be able to 
mathematically model biomolecules with respect to interindividual phenotypic 
differences94. However, sporadic cancers may strongly be subject to chance and 
thus a deterministic approach attempting to accurately predict risk based on 
complete knowledge of genetic susceptibility, even if possible, may not be 
appropriate. 
A thorny issue in genetic association studies is the large number of 
polymorphisms under study by the scientific community in combination with the 
general reliance on significance levels of 5%95, 96. The probability that at least one 
study finds a ‘significant’ result is high96 and thus it is important that scientific 
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journals do not focus solely on ‘new’ findings. Studies investigating only few 
polymorphisms are being replaced by those evaluating large numbers of 
polymorphisms, and now chips of 384, 768, up to even 500.000 SNPs have become 
a possibility97. As with all ‘-omics’ data, the problem is analysing statistically these 
large numbers of polymorphisms98. The conventional parametric methods 
experience difficulty in dealing with the high risk of false positives when studying 
polymorphisms (multiple testing), with the large amount of genetic variation 
(high-dimensionality data), with clusters of genes underlying disease (genetic 
heterogeneity). A number of non-parametric methods have been developed, 
examples are MDR, GMDR, set association, random forests, neural networks. An 
introduction to these methods has been given by Heidema et al.99. At present, the 
best strategy may be to apply a combination of parametric and non-parametric 
methods and to seek replication of findings in different populations.  
Population. Group comparability. In epidemiology, important concepts in 
aiming to discover the determinants of human health and disease are population 
thinking and group comparisons. Case-control studies, retrospectively comparing 
exposures among those with and without the disease of interest, are prone to recall 
and selection bias. Recall bias was addressed under ‘assessment of fruits and 
vegetables’ and is not considered to be a great problem. Selection bias, 
however, may have occurred in the case-control study (as discussed in chapters 3 
and 5). Endoscopy controls more often experience bowel problems than cases, and 
this may be related to factors not truly related to absence of adenomas. Another 
possible source of selection bias is low response in some endoscopy-clinics. This 
option cannot really be excluded. An important question here is whether 
methodology can explain differences in ORs between genotypes. With respect to 
selection bias, it is thought that valid estimates of gene-environment interactions 
are still possible when the genotype does not influence selection conditional on 
exposure and disease status100, 101. In our case, it seems reasonable to assume that 
genotype did not influence participation in the study. Thus, interaction estimates 
may be more valid than main effects. 
Also, the proportion of men and women differed between cases and controls, 
which may be relevant as there are some indications that men and women differ in 
colorectal cancer etiology even though the incidence is approximately equal. 
Another possible problem is the age difference between cases and controls, which 
may have resulted in misclassification of outcome, because cases are on average 8 
years older than controls and this is a sufficient amount of time to develop an 
adenoma.  
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Generalisability. In our case-control study, controls may not be representative of 
‘all those without adenomas’ because of referral to outpatient clinics based on 
abdominal problems and possible difference with population controls on genetic 
and environmental factors that were not measured. However, it is likely that this is 
not related to our research questions. Advantage of our endoscopy controls is that 
the absence of polyps was checked. A random population sample undergoing 
endoscopy would be preferable, but this would be very invasive, financially 
unfeasible and possibly a problem ethically. Asymptomatic controls indicated for 
colorectal cancer screening would also be attractive controls if attendance rate is 
high. Preparations for a national colorectal cancer screening programme in the 
Netherlands are in an advanced stage102. Screening will have the secondary benefit 
of allowing the conduct of inherently methodologically better studies. 
 
EPIDEMIOLOGICAL PERSPECTIVE: CONCLUSION 
High fruit and vegetable consumption in combinations with low-capacity 
GSTP1/GSTA1 and NQO1 genetic variants may slightly increase colorectal 
adenoma risk. A GST or NQO1 genotype effect, if true, may exist in combination 
with certain fruit and vegetable subtypes only and one can speculate that this may 
be counteracted by a varied diet. Methodologically, it cannot be ruled out that 
fruits and vegetables actually confer some unfavourable effects in certain 
subgroups, but it also cannot be ruled out that some unknown confounding factor 
or selection bias plays a role. However, the study results do not support a 
protective effect from fruits and vegetables in our population.   
 
 
SOCIETAL PERSPECTIVE: A REFLECTION  
Definition. The societal perspective is considered to include a comparison of the 
general population and high-risk genotype subgroups as the subject of specific 
nutritional interventions with respect to public health and ethics. 
Concept. In the last decades, public health has largely been practiced from a 
population approach, as opposed to a high-risk approach. The rationale for this is 
that modest behavioural changes on a population level are likely to lead to a 
greater public health impact than larger behavioural changes restricted to a small 
high-risk group103, 104. The Human Genome Project (HGP), and the realisation that 
behavioural changes on a population level are hard to accomplish, has brought 
debate to this approach. The genomics- and related technologies have been rapidly 
finding their way into nutrition research105 and public health issues106, 107. One of the 
consequences for public health could be the adjustment of population dietary 
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recommendations based on genetic make-up108-110 or even population screening for 
those at high-risk111. Efforts are being made to establish and evaluate a systematic, 
evidence-based process for assessing genetic tests and other applications of 
genomic technology in transition from research to clinical and public health 
practice112. So far, these approaches have not been put into practise by public 
health professionals for combinations of common polymorphisms, chronic disease 
and dietary prevention measures. On an individual level, however, knowledge 
obtained in gene-diet studies has already been applied for purposes of individual 
genotype-based dietary counselling, so-called tailor-made diets or personalised 
nutrition. Several market parties offer genetic testing (including the GSTP1, M1 
and T1 polymorphisms) and subsequent dietary advice through the internet. This 
has raised concern for their consumers113, as its scientific basis is widely regarded 
as not sufficient yet114. Not only are there pragmatic and theoretical issues on the 
road to tailoring nutritional advice to high-risk groups or individuals based on 
genetic make-up for preventive purposes.  There are also a wide range of ethical, 
legal and social implications. 
Reflection. Below, some issues will be reflected upon with respect to the 
question whether is it sensible, in the prevention of colorectal cancer, to have fruit 
and vegetable advice based on high-risk genotype, compared to a no-genotype 
population approach. This will also be done with respect to the issue of ethical 
justifiability of high-risk genotypes. 
 
PUBLIC HEALTH IMPLICATIONS 
Theoretical issues. With respect to our studies and our detoxification systems, 
GSTs and NQO1, information that contributes to tailor-made dietary counseling on 
a genotype basis for colorectal cancer prevention was not delivered. In a larger 
picture, there is not yet sufficient scientific knowledge to know the holistic effect of 
fruits and vegetables, neither in the form of dietary patterns nor of separate fruit 
and vegetable constituents, on human biology. In vitro assays may show a 2-3 fold 
induction of a detoxification enzyme by a certain plant constituent, but the effect 
for whole individuals or populations is not known115 and should be carefully 
considered116. Fruits and vegetables contain an abundance of bioactive compounds 
(estimated number: >10.000) with possibly opposing effects. An enormous amount 
of enzymes play a role in carcinogenesis117, as well as an enormous amount of 
genetic variation in genes encoding these enzymes, and these all influence each 
other. Under the heading of ‘systems biology’, great research efforts are being 
made to elucidate the complex relationships between genotypes and phenotypes in 
an individual through a hierarchy of biochemical, metabolic and physiological 
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systems that are driven by biomolecular interactions (which has been termed 
‘epistasis’)94, 118-120. This will undoubtedly lead to new and better insights. However, 
it is not clear yet whether the holistic approach should be regarded as a solution or 
whether it suffers from an intrinsic problem; it is a very realistic scenario that in the 
end-conclusion will be that too many variables play a role to uncover the 
phytochemical-cancer associations in real human life for nutritional interventions 
directed at genotypes.  
 Pragmatic issues. Some authors are sceptical about the use of genomics in 
prevention, reasoning that if environmental influences can be modified, then 
genetic susceptibility looses relevance121-123.  A populations approach to prevention 
of highly modifiable disease will achieve a greater public health benefit than 
intervention targeted to high-risk groups on the basis of genotypes. However, the 
population strategy comes with the disadvantage of a small benefit for the 
individual (the so-called ‘Prevention Paradox’) and poor motivation104 . It has been 
proposed that knowledge of genetic make-up could be a stronger motivation for 
people to change to good nutrition behaviour. Incorporation of genetic 
susceptibility feedback has been evaluated in relation to smoking cessation124-126. 
Unfortunately, it did not have the desired behavioural change. This may also be 
true for nutrition behaviour127. One can speculate that different high-risk 
approaches are likely to produce different results, because they require a more 
rational or more emotional (e.g. in the case of a positive family history) weighing 
of costs and benefits of changing behaviour. More research into behavioural 
changes is needed. At the same time, we must not lose the ideals of changing 
society’s norms of behaviour (instead of only high-risk individuals).  More funds 
should be allocated to changing society’s infrastructure with respect to physical 
activity and the availability of (un)healthy food.  
Defining high-risk groups or high-risk individuals also has a range of social, 
legal and ethical implications. Below, some of the ethical implications are 
addressed. 
 
ETHICAL IMPLICATIONS OF INVESTIGATING INTERACTIONS BETWEEN DIETARY AND 
GENETIC FACTORS. (For a background related to the project described in this thesis, 
see addendum V). Early writings on the human genome project warned to take 
social, legal and ethical issues seriously and protested the low budget for exploring 
these128-130. According to one source, in 1989 we were "utterly unprepared to deal 
with issues of mandatory screening, confidentiality, privacy and discrimination.  
The genome project has been overhyped and oversold". Over ten years later these 
issues are still subject of concern131-133.  
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Many scenarios can be imagined with respect to preventive diets tailored to 
genotype information, with varying ethical (and legal and social) consequences, 
depending for example on how drastic the suggested dietary changes are, how 
great the estimated benefit is and whether the genetic test is on an individual, self-
initiated basis or part of a screening program. Let’s imagine that the scientific 
community has identified a set of genotypes so that: 
-those with set A benefit from regular consumption of vegetable subtype X 
with respect to colorectal cancer prevention (35% risk reduction) and  
-those with set B do not benefit.  
Now let’s reflect upon some of the ethical consequences, from a societal viewpoint. 
One obvious consequence is that the relation between food and health or disease is 
further complicated by medical terminology such as ‘lowered genetic 
susceptibility’, and will contribute further to the so called medicalisation of 
nutrition134. With an increasing number of available tests, less and less individuals 
will perceive themselves as healthy individuals. Also, including personal genetic 
information to preventive advice adds a new dimension of risk communication. 
Most challenging may be to explain to group B that eating vegetables (including 
vegetable X) may still help them to prevent other diseases than colorectal cancer. 
In our situation, the test is on the market. The choice, then, to obtain the test 
should be with the consumer. "Individuals are, ultimately, the best judges and 
guardians of their own interests" as formulated by J.S. Mill, a well-known 
utilitarian (1859, 'On Liberty'). This is essentially the concept of personal autonomy: 
the right of an individual to act freely. The importance of autonomy has been 
shown135-137 and as flourishing individuals better contribute to the general good, 
autonomy fits well within the utilitarian way of thinking.  For autonomous 
consumership to “work”, well-communicated, objective information is needed. The 
information flow is ever increasing, making it impossible for consumers to keep 
up. It has to be believed that individuals can actually absorb this information and 
base choices on it. This modern consumer-citizen may be an illusion, people may 
not use their autonomy optimally; But it would in general seem better that people 
made their decisions on the basis of knowledge rather than from ignorance.  
However, knowledge is not the only ingredient that individuals base choices 
on. There may be good reasons for not adhering to the advice, on different 
grounds. Consumption of food is a social event, as consumption and type of food 
are very much embedded in our family- and local environment. It gives shape to 
the identity of many individuals with certain convictions138. Tailoring food to the 
individual genetic make-up may divide families and social gatherings and distort 
the fulfilment of eating according to one's religious or other beliefs. On a different 
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level, some members of group A may have a genetically determined dislike for 
vegetable X139, 140. Once the test results are there, deliberately not complying to a 
diet may lead to feelings of guilt and unrest141, and thus to a diminishing of well-
being. This leads to issues whether non-complying individuals may be held 
accountable when they do get ill (e.g. by health insurance companies). Also, 
genetic knowledge may lead to some problems in families, because autonomy of 
one individual to know personal genetics may clash with a family member's 
autonomy not to know this.  
On the other hand, in western societies health is often considered a right, 
which is society’s responsibility. Yet it can be argued that consumers have a moral 
responsibility to make some sacrifices in order to lower the disease burden and 
maintain a social health care system based on solidarity. Blaming and sense of 
individual responsibility per se are acceptable, however it does not seem fair to 
preclude this to individuals with certain (unchangeable) genetic make-up. 
Adopting general nutrition and physical activity guidelines may suffice. 
Attention needs to be given to a big player in genetic testing and society at 
large: industry. It has made great investments in genetics/genomics, is the first to 
offer applications in the form of genetic testing through the internet and 
increasingly participates in science142. In society’s interest, some rules and 
regulations for market parties are needed. If pills or whole foods (by genetic 
modification) are concentrated with the phytochemicals that are presumed to be 
responsible for the effect of vegetable X, possible adverse effects need to be 
monitored. These can be, for example, overdoses, adverse combinations with other 
foods of medication, or not-foreseen impact on unknown pathways that become 
apparent after large-scale introduction.  
Though ultimately perhaps beneficial to health, it is not so self-evident that 
tailor-made dietary advice is overall beneficial to our well-being. 
 
SOCIETAL PERSPECTIVE: CONCLUSION 
At his point, it is not self-evident that polymorphisms will have a legitimate place 
in nutritional prevention strategies. Their functionality on the societal level has not 
been shown. In addition, the efficiency and efficacy of high-risk groups based on 
genotype is still under debate. Also, identification of high-risk groups or 
individuals, especially based on genetic information, comes with valid ethical 
issues, adding an extra dimension of reflection to the issue of individual nutritional 
preventive strategies. 
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FINAL REFLECTION 
The relation between fruit and vegetable consumption and protection against 
carcinogens in cancer prevention is complex. Many variables play a role: there is a 
large array of polymorphisms, epigenetic processes, biotransformation enzymes, 
bioactive plant components, other dietary variables and environmental influences 
(among which different (pro)carcinogens), possible doses, tissues, microbiotal 
influences  and, expectedly, synergy and antagonism. The long-term effects for the 
whole organism of single substances or entire dietary patterns are not yet 
understood. Even if the interactive effects of the above variables could be mapped 
and understood, there would still remain an element of chance which individual 
would develop cancer. In addition, many other mechanisms besides 
biotransformation are likely to play a role in the prevention of cancer by fruits and 
vegetables, such as by scavenging reactive oxygen species and by influencing DNA 
repair and apoptosis, increasing the number of possible associations even further.  
Also, there are many life processes and thus disease etiologies, e.g. in hypertension 
and diabetes, in which fruits and vegetables are thought to play a role. Given the 
above, there is currently no reason to exchange the population advice of high, 
diverse, daily fruit and vegetable consumption, for genotype-specific and 
phytochemical-specific advice. 
 
FUTURE RESEARCH  
Biotransformation induction by fruits and vegetables and genetic variability. 
The question remains whether there is a real net beneficial effect of fruit and 
vegetable consumption on the detoxification potential of the colorectal area in vivo, 
which plant subtypes or compounds are most beneficial and what the role of 
genetic variation is in this. This will not be solved by single intervention studies 
uncoordinately focussing on single vegetable types and single genetic 
polymorphisms. A series of systematically designed human feeding trials can 
provide a more complete picture. Different types of vegetables, vegetable 
constituents, doses, exposure times, phase II enzymes, phase I enzymes and 
polymorphisms would ideally be included. The obvious difficulties are that they 
are expensive, and the possible combinations of the above are endless. A large-
scale collaboration could be a good framework, each center performing the part on 
its own expertise, thus uniting knowledge and standardizing methods. Outcomes 
should include but surpass the level and activities of the biotransformation 
enzymes (which could be measured by means of an X-omics approach115, 117 to take 
the many possible effects into account97 , with a focus on the protein level, as the 
correlation with RNA is generally low143) and take functional effect-measures of 
144 Chapter 6 
 
possibly increased detoxification potential of the colorectum into account (e.g. 
urinary markers of carcinogen metabolism and markers of DNA damage).  
Crucifers and glutathione S-transferases. The protective effect against 
colorectal cancer of high consumption of cruciferous vegetables among those with 
genetic variants associated with lower GST detoxification potential (as investigated 
in chapter 3), remains debatable. There are clues that the effect may differ between 
crucifer types. Thus, detailed questionnaires separating crucifer types, or crucifer 
subtype-specific biomarkers, are required. Ideally, large (new and existing) cohorts 
could be used to reduce selection and information bias and have the power needed 
for high-dimensional genotype analysis, taking the various GSTisoenzymes into 
account. Finally, other cancer sites need to be taken into account, because higher 
intake of a certain vegetables may affect tissues differently. 
Validity and reproducibility of measuring fruit and vegetable consumption 
in epidemiological studies. The validity and reproducibility of fruit and vegetable 
assessment in epidemiological studies may not be sufficient. Questionnaires 
incorporating questions on growing, storing and preparation of fruits vegetables 
may improve precision. However, information bias due to the ‘subjectivity’ of the 
subjects filling out the questionnaires cannot be avoided (although it can be 
somewhat lessened by avoiding those with disease states affecting their answers, 
such as can be done in cohort studies). Thus, the search for valid and reproducible 
biomarkers for the intake of (different types of) fruits and vegetables in small-scale 
human trials needs continued effort. Biomarkers have the additional advantage 
that they do not only represent intake, but can also be a measure of absorption and 
metabolism (in which not to forget genetic variation). If valid and reproducible 
links can be established between intake and marker, then epidemiological studies 
will have higher power. The most precise and valid results are expected from 
large, prospective populations in large scale collaborations144, 145, in which biobanks 
are extremely valuable146, 147 to enlarge power or provide posterior mechanistic 
back-up of exploratory findings. 
The use of more integrated measures of diet such as dietary patters can give a 
more balanced representation of pro- and anticarcinogens.   
In general. The ability to sequence genomes and the array of technologies that 
developed from this, is giving a whole new dimension to epidemiology (and 
public health). Communication between the different disciplines is highly 
important. The epidemiologist must not discard a certain degree of skepticism 
towards the increasing bulk of data that is being generated, but must also be open-
minded. 
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SELECTED WEBSITES OF INTEREST 
-http://www.ornl.gov/sci/techresources/Human_Genome/home.shtml  
(human genome project) 
- http://www.ornl.gov/sci/techresources/Human_Genome/elsi/elsi.shtml  
(social, legal and ethical implications in hpg) 
-www.ncbi.nlm.nih.gov (public database) 
 -SNP 
 -dbGaP (db of genotype-phenotype studies) 
-www.hapmap.org 
(HapMap project)  
-www.cdc.gov/genomics/HUGEnet.default.htm 
(Human Genome Epidemiology network) 
- http://www.cdc.gov/genomics/gtesting/EGAPP/about.htm 
(Evaluation of Genomic Applications in Practice and Prevention) 
-http://www.hupo.org/   
(human proteome project) 
- http://www.epigenome.org/  
(human epigenome project) 
 
ADDENDA 
1) Study findings, elaborate version 
2) GSTA1, GSTP1 and NQO1 DNA sequences 
3) Associations between NFE2L2 polymorphisms and GST phenotype 
4) Botanical definition of vegetables 
5) Background to project and ethics  
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Below, in the genomic sequences for the genes under study (i.e. GSTA1, GSTP1 and NQO1), 
are indicated:  
-the sequence primers used for sequencing the regulatory areas 
-the SNPs that were studied in this thesis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene: GSTA1 
Genbank accession no. L13269  
[Human glutathione S-transferase PJ-1A pseudogene, exons 6 and 7; glutathione S-transferase A1 
(GSTA1) gene, exon 1, total sequence 1-4786] 
 
ORIGIN       
    2761 tattgaagag caaacagacc caccctctgc tctcaggcca acttgtcatc ccttacagtg 
  2821 catgtgctcc tggctcatcc tcactctcct caaggctctg tggggacccg ggcatgagct 
                       ------------------Æ GSTA1-prom-fw 
  2881 tccctcagtt cgttcagtgc cactcaggcc tggctgcgaa gatacagatg gtatatgcga 
  2941 attacatata agtaactata tgcaaaatta tttttccctg gtgtgtcatt gtgccagcgt 
  3001 gtttggatta gaagtgattt ccaggaatcc ttccctgcgt cttctagctt ctgggggctc 
  3061 ttggctttct ggactttcat ggatcatgac cacatcactc taatttctgc ctctgtgttc 
  3121 cagcacctca ccccctgtgt gttgtgtctt ctcttctctc tgctgtgagg acaattgtca 
  3181 ttggatttgg ggcctatcca gatataccaa gatgatctca tctcaaattc ttttacttca 
  3241 ttacatctgc aaagagcctt tttccaaata agatcaagtt cacaggatct agggatttct 
  3301 atatggacct atctttcttg ggggccaaca taacccccta catggtatag gtgaaataag 
  3361 attatttgca attgatgaat ccaggtgatg aatactttca gatttgttat attatgggca 
  3421 atttgagtga cgcaaagagg atagcatatg caaatagggt ctctggattt gtcagataaa 
  3481 atacaggata cccacctaaa tgtgaatttc agataaacaa taaataatat ttcagtataa 
  3541 tctggtttca taccgtgttt ggaacatagc tataactaaa aaattgttga ttgtttgcct 
  3601 gaaattcaca tttacatgga tgtcctatat tttatttggc aacccagtaa gaaaacggtg 
  3661 gcatcagctt gcccttcaca gacatcctct cccagctatg ctcacagtag agatttttca 
  3721 gttgccctag tctttgcacc caactcatga aaaaaagcat ctttaaaaag ccagtttctg 
  3781 ctgacttgca aaaagagcaa aatctcggtg aaatgtattg tgtaaacttt gattgccaac 
  3841 cttgaaaagg aacacattaa ccagtttctt ctgataagca gatcacttgc ctcatgtctt 
  3901 agaatccagt aggtggcccc ttggcatgaa atgtgtggga gtggcttttc cctaacttga 
  3961 cccttctttc agtgggaggg aactattgag aggaacaaag agcttataaa tacattagga 
        t-69              a-52 
  4021 cctggaattc agttgtcgag ccaggacggt gacagcgttt aacaaagtaa gtactgatct 
                               -------------- GSTA1-prom-rv 
  4081 tataaatttc tctacattgc cttacaccct cctgtctagc ctcctagaaa aatatgctaa 
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Gene: GSTP1 
Genbank accession no. AY324387 
[Homo sapiens glutathione S-transferase pi (GSTP1) gene, complete cds, total sequence 1-5635] 
Transcription initiation site: 1887 
Translation start (ATG): 1916 (A) and 2207+2208 (T+G) 
 
ORIGIN   
   961 agctaaggga tactgggctt aatacctggg tgatgggatg atctgtacag caaaccatca 
  1021 tggcgcacac acctatgtaa caaacctgca catcctgcac atgtacccca gaacttcaaa 
  1081 taaaagttgg acggccaggc gtggtggctc acgcctgtaa tcccagcact ttgggaagcc 
  1141 gaggcgtgca gatcacctaa ggtcaggagt tcgagaccag cccggccaac atggtgaaac 
  1201 cccgtctcta ctaaaaatac aaaaatcagc cagatgtggc acgcacctat aattccacct 
  1261 actcgggagg ctgaagcaga attgcttgaa cccgagaggc ggaggttgca gtgagccgcc 
  1321 gagatcgcgc cactgcactc cagcctgggc cacagcgtga gactacgtca taaaataaaa 
  1381 taaaataaca caaaataaaa taaaataaaa taaaataaaa taaaataaaa taaaataaaa 
  1441 taaaataaaa aaataaaata aaataaaata aaataaagca atttcctttc ctctaagcgg 
                                                    FW primer HT -----Æ 
  1501 cctccacccc tctcccctgc cctgtgaagc gggtgtgcaa gctccgggat cgcagcggtc 
  1561 ttagggaatt tccccccgcg atgtcccggc gcgccagttc gctgcgcaca cttcgctgcg 
  1621 gtcctcttcc tgctgtctgt ttactcccta ggccccgctg gggacctggg aaagagggaa 
  1681 aggcttcccc ggccagctgc gcggcgactc cggggactcc agggcgcccc tctgcggccg 
  1741 acgcccgggg tgcagcggcc gccggggctg gggccggcgg gagtccgcgg gaccctccag 
  1801 aagagcggcc ggcgccgtga ctcagcactg gggcggagcg gggcgggacc acccttataa 
  1861 ggctcggagg ccgcgaggcc ttcgctggag tttcgccgcc gcagtcttcg ccaccagtga 
                                   +1                          +1 
  1921 gtacgcgcgg cccgcgtccc cggggatggg gctcagagct cccagcatgg ggccaacccg 
  1981 cagcatcagg cccgggctcc cggcagggct cctcgcccac ctcgagaccc gggacggggg 
  2041 cctaggggac ccaggacgtc cccagtgccg ttagcggctt tcagggggcc cggagcgcct 
                         FV primer-n=5 -----Æ 
  2101 cggggaggga tgggaccccg ggggcgggga ggggggggca ggctgcgctc accgcgcctt 
                                         a 217      a 227 
  2161 ggcatcctcc cccgggctcc agcaaacttt tctttgttcg ctgcagtgcc gccctacacc 
                                         ------ RV primer-HT 
  2221 gtggtctatt tcccagttcg aggtaggagc atgtgtctgg cagggaaggg aggcaggggc 
  2281 tggggctgca gcccacagcc ccctcgccca cccggagaga tccgaacccc cttatccctc 
  2341 cgtcgtgtgg cttttacccc gggcctcctt cctgttcccc gcctctcccg ccatgcctgc 
        ----- RV primer-n=5 
  2401 tccccgcccc agtgttgtgt gaaatcttcg gaggaacctg tttccctgtt ccctccctgc 
  2461 actcctgacc cctccccggg ttgctgcgag gcggagtcgg cccggtcccc acatctcgta 
  2521 cttctccctc cccgcaggcc gctgcgcggc cctgcgcatg ctgctggcag atcagggcca 
  2581 gagctggaag gaggaggtgg tgaccgtgga gacgtggcag gagggctcac tcaaagcctc 
  2641 ctgcgtaagt gaccatgccc gggcaagggg agggggtgct gggccttagg gggctgtgac 
  2701 taggatcggg ggacgcccaa gctcagtgcc cctccctgag ccatgcctcc cccaacagct 
  2761 atacgggcag ctccccaagt tccaggacgg agacctcacc ctgtaccagt ccaataccat 
  2821 cctgcgtcac ctgggccgca cccttggtga gtcttgaacc tccaagtcca gggcaggcat 
  2881 gggcaagcct ctgcccccgg agcccttttg tttaaatcag ctgccccgca gccctctgga 
  2941 gtggaggaaa ctgagaccca ctgaggttac gtagtttgcc caaggtcaag cctgggtgcc 
  3001 tgcaatcctt gccctgtgcc aggctgcctc ccaggtgtca ggtgagctct gagcacctgc 
  3061 tgtgtggcag tctctcatcc ttccacgcac atcctcttcc cctcctccca ggctggggct 
  3121 cacagacagc cccctggttg gcccatcccc agtgactgtg tgttgatcag gcgcccagtc 
  3181 acgcggcctg ctcccctcca cccaacccca gggctctatg ggaaggacca gcaggaggca 
  3241 gccctggtgg acatggtgaa tgacggcgtg gaggacctcc gctgcaaata catctccctc 
         g 313(exon 5) 
  3301 atctacacca actatgtgag catctgcacc agggttgggc actgggggct gaacaaagaa 
  3361 aggggcttct tgtgccctca ccccccttac ccctcaggtg gcttgggctg accccttctt 
  3421 gggtcagggt gcaggggctg ggtcagctct gggccagggg cccaggggcc tgggacaaga 
  3481 cacaacctgc acccttattg cctgggacat caaccagcca agtaacgggt catgggggcg 
  3541 agtgcaagga cagagacctc cagcaactgg tggtttctga tctcctgggg tggcgagggc 
  3601 ttcctggagt agccagaggt ggaggaggat ttgtcgccag tttctggatg gaggtgctgg 
  3661 cacttttagc tgaggaaaat atgcagacac agagcacatt tggggacctg ggaccagttc 
  3721 agcagaggca gcgtgtgtgc gcgtgcgtgt gcatgtgtgt gcgtgtgtgt gtgtacgctt 
   
  Cauchi et al.1: SNPs at position: -282, -287, -289, -354 relative to transcription initiation site 
1. Cauchi S, Han W, Kumar SV, Spivack SD. Haplotype-environment interactions that regulate  
the human glutathione S-transferase P1 promoter. Cancer Res 2006;66:6439-48. 
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Gene: NQO1  
Genbank accession no. M81596 
[Human NAD(P)H:quinone oxireductase gene, exon 1], total sequence  
Transcription initiation site: 1824 
Translation start (ATG): 1935 
 
ORIGIN 
     1 tgccactgca ctccagcctg ggcgacacag tgaaaccccg cctcaaaaaa taaattttta 
    61 aaaaattaat ttaattacaa ttaaaacttc acttcctcag tccactggcc actttttttt 
   121 ttttaatttc catttttttt cttttattga gtccaccact gcggccttga attcctgggc 
   181 tcaagcgatc tttttgcctc agatcctgag tagctgggac acaggcgcct gccaccacgc 
   241 ctggctgctg gccacatttc caggctcaat agctacttga agcttgtggc taccttactt 
   301 gggcagcaca gatagggaaa gttctattgg acagggctgc ctacctagcc cttttttaaa 
   361 acgtcctttt atactatttt gtcagatggg gtctcacttt gttgctcagg cttttctcaa 
   421 actcttgggc tcaagtgatc ctcctgcctc agcctcccaa agtaatttgt aaatacgtgt 
   481 aaataatata gtcctctctt gttgcatcaa aatgaatgca aaaatgtcac gatggggccg 
   541 ggcgcggtgg ctcatgcctg taatcccagc acttcgggag gccgaggcgg taggatcacc 
   601 tgaggtcggg agttggaaac cagttttctg gtgcctcctt aacttttctg gtgcctcctt 
   661 aacttttgca ctggagggac aacggaaggg ccctgtgtca tcctcacctc ccccatctgt 
                           fw primer --------------Æ 
   721 aattcttctg atggttaatt accacttaaa gctctagttc tttttccttc acctactgag 
   781 agtatatctc cttctttaca gtaactttta ctttatagag ttttttttga gacggagtct 
   841 cacttcgtca cccaggcggg agtgcagtgg cacgatctcg acccactgca acctccgcct 
   901 tccgggttca agcgattctc ctgcctcagc ctcccgagta gctgggactt acaggcgccc 
   961 gccatcacgc ccagctaatt tttcagtaca gacggggctt caccaggttg gccaggctgg 
  1021 tctcgaactc ctgacctcag gtgatccacc cacctcggcc tcccatattg ctgggattac 
  1081 aggcgtgagc accgcgcctg gtcccgtttt ggctattctt taatatgctt ccctataact 
         a-718 
  1141 gctatctcca caccagcctt gccttagctc atgggaaaca aaaccaatta gttccccatt 
  1201 acctgccttg aggagcaggg gtggtgcagt ggcatgcacc cagggaagtg tgttgtatgg 
  1261 gcccccaagt gcagaatctg aatcttgcaa aggaagaaac aaattcgtct ccacggagca 
  1321 tgtctcccca ggactctcag ccttccaaat cgcagtcaca gtgactcagc agaatctgag 
  1381 cctagggcac cacagtaatc gcatcggctc tttttctgct ccatttcgtg ccaaggctaa 
  1441 aagggcatgc ccacttgatc ctggactctc ttgggacgac ttccaccctg catcctcttg 
  1501 cacctcaggg cacagtgcgc agatgggctt gccttagcac ccccagccag atttttgagg 
  1561 cctctgtcac acacacccct acaatcccct cccccagccc cgagagactt ttcttgactt 
  1621 ccaccagttg ctccggcggg tgagagtgga gaggcccctc cttcatcccc caggctccct 
  1681 cccttcctgg agctgcagcc tcagcatcct ccgcccagca ccccaggatt caggcgttgg 
  1741 gtcccgccct tgtaggctgt ccacctcaaa cgggccggac aggatatata agagagaatg 
  1801 caccgtgcac tacacacgcg actcccacaa ggttgcagcc ggagccgccc agctcaccga 
                           ---+1--------- rv primer 
  1861 gagcctagtt ccggccaggg tcgccccggc aaccacgagc ccagccaatc agcgccccgg 
  1921 actgcaccag agccatggtc ggtgagtgct gcaaagggcg gggtgcttgg cggtcgtctc 
                      +1 
  1981 tcgagcactg gtgcctgtgg aggaggttgt aggggcttgg cctgaatttt gttccttgac 
  2041 tcaaaaccca caaagggaag agattaggga cctgggatga gccttgatcg gactccggga 
  2101 gaaggagagc ttctgtttgt atccggtgtc gcggatcctt cctcactcca ccccacgaac 
  2161 tctagtgggc atttaggaga aacttgacct tggaagcaga aattccctcc aaaactgtgg 
  2221 tcagaaactg gccgtcagag gccaaatcag gcttacggtc acagcccata cctcttttgg 
  2281 tctatagtat ctaaaacact ttgaaataag ttgctaacat taaaatgggt gatttcactt 
  2341 aaaaatgtgg attccgagct tctgaagaaa atgagaatat ctggcgattg gtggacagga 
  2401 gtggaggaaa ctgatgcctt tggtttgacg gagaccagaa ccggctccag gctgccaggc 
  2461 acaggttttg ttttgttttg ttttgttttg tttgagacgg agttttgctc ttgtcaccca 
  2521 ggtgtagtgc aatggcgcta tctcagctca gcgaaacttc cgcctcccgg gttcaagcga 
  2581 ttctcccatc tcagcctccc gagtagctgg gattacagga gtgcgccatc atgcgcggct 
  2641 aatttt  
(coding region continues at genbank accession number M81597; contains NQO1 c.609C>T SNP) 
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RESULTS 
The NFE2L2 -684GA genotype was associated with a higher GSTM1 and GSTT1 
level (Table 1). GSTA level appeared to be slightly higher with the NFE2L2 -686AG 
genotype.  
The NFE2L2 polymorphisms did not significantly affect total rectal GST 
activity (Table 2). Total lymphocyte GST activity was significantly higher among 
those with the NFE2L2 -684GA genotype (Table 2).  
Consumption of Solanaceae possibly influenced GSTA level (data not shown). 
This was most pronounced for the NFE2L2 -686AA genotype: consumers had a 273 
ng/mg protein higher  GSTA level (p=0.016) compared with non-consumers, 
whereas for both the AG and GG genotype there was no difference (+101 ng/mg 
protein, p=0.51 and +1.06 ng/mg protein, p=0.99, respectively, data not shown). 
The NFE2L2 -684GA genotype appeared to be associated with a higher raise in 
GSTP1 level with consumption of Alliaceae: +3151 ng/mg protein, p=0.028 (data not 
shown). 
For citrus fruit and juice, both combined and apart, there appeared to be a 
difference among those with the NFE2L2 -684GG genotype and those with the -
684GA genotype; for citrus fruit and juice combined, the difference between 
consumers and non-consumers was +956 ng/mg protein, p=0.042 among the -
684GG genotype, compared to -370 ng/mg protein, p=0.86 among those with the -
684GA genotype. For Cruciferae there was a similar trend, with numbers of +878, 
p=0.063 and -2037, p=0.17, respectively. 
 
Table 2: Rectal and white blood cell total GST activity (nmol/min/mg protein), by NFE2L2 genotype 
  Rectal total GST activity  White blood cell total GST activity 
   Leukocytes  Lymphocytes 
Genotype 
  
n 
92 
reference mean* 
+/- difference 
(95% CI) 
p-
value  
n 
75 
reference mean* +/- 
difference (95% 
CI) 
p-
value  
n 
93a 
reference mean* 
+/- difference 
(95% CI) 
p-
value 
NFE2L2  
g.-650C>A 
 
CC 
CA 
AA  
80 
11 
1 
214±6.10 
+20.0 (-14.7, 54.7) 
+40.1 (-69.2, 149.3) 
 
0.26 
0.47  
65 
9 
1 
134±4.73 
+5.54 (-21.7, 32.8) 
-21.0 (-98.0, 56.0) 
0.69 
0.59  
81 
11 
1 
129±5.76 
+5.85 (-27.3, 38.0) 
-24.3 (-129, 80.1) 
0.73 
0.65 
NFE2L2  
g.-684G>A  
 
GG 
GA 
AA  
69 
22 
1 
219±6.57 
-6.36 (-32.8, 20.0) 
-72.8 (-182, 36.5) 
0.63 
0.19  
54 
20 
1 
135±5.22 
-1.08 (-21.0, 18.9) 
-23.6 (-101, 53.3) 
 
0.92 
0.54  
70 
22 
1 
123±6.07 
+25.5 (1.28, 4936 
-39.9 (-141, 63.0) 
0.039 
0.45 
NFE2L2 
g.-686A>G 
 
AA 
AG 
GG  
35 
47 
10 
218±9.44 
-1.12 (-25.7, 23.4) 
-12.9 (-52.2, 26.3) 
0.93 
0.51  
29 
4 
5 
132±7.10 
+4.42 (-14.1, 23.0) 
+3.31 (-33.7, 40.4) 
0.64 
0.86  
36 
47 
10 
129±8.59 
+5.72 (-16.9, 28.3) 
-24.1 (-60.6, 12.4) 
0.16 
0.19 
*adjusted for age, sex, sample storage time  
a1 outlier deleted 
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Table 1: Botanically defined vegetables, English version
Botanical group* English common* Examples English  
Liliaceae (Alliaceae) Lily Leek, Onion 
Umbelliferae (Apiaceae) Carrot Celery, Carrots, Fennel 
Compositae 
 
Daisy 
 
Andive, Oyster plant, Lettuce, 
Chicory, Artichoke 
Cruciferae (Brassicaceae) 
 
 
 
Mustard 
 
 
 
Cauliflower, Kale, Broccoli, Red 
cabbage, Brussels sprouts, Paksoi, 
hodgepodge (correction factor for 
potato content), Radish, Garden cress 
Cucurbitaceae Gourd Cucumber, Gherkins, Zucchini 
Solanaceae Night shade Egg plant, Bell pepper, Tomato 
*after Smith et al.1  
 
 
 
Table 2: Botanically defined vegetables, Dutch version
Botanische groep Dutch common Examples Dutch 
Liliaceae (Alliaceae) Lookfamilie Prei, Ui 
Umbelliferae (Apiaceae) Schermbloemfamilie Selderij, Wortelen, Venkel 
Compositae 
 
Komposietenfamilie 
 
Andijvie, Schorseneren, Sla, Witlof, 
Artisjok 
Cruciferae (Brassicaceae) 
 
 
 
Kruisbloemfamilie 
 
 
 
Bloemkool, Boerenkool, Broccoli, 
Rode kool, Spruiten, Paksoi, 
stamppotten* (*correctiefactor voor 
aardappel inhoud), Radijs, Tuinkers 
Cucurbitaceae Komkommerachtigen Komkommer, Augurken, Courgette 
Solanaceae Nachtschadefamilie Aubergine, Paprika, Tomaat 
  
 
 
 
1. Smith SA, Campbell DR, Elmer PJ, Martini MC, Slavin JL, Potter JD. The University of 
Minnesota Cancer Prevention Research Unit vegetable and fruit classification scheme (United 
States). Cancer Causes Control 1995;6:292-302. 
 
 
 
Addendum V: Background to Project and Ethics 163 
 
 
STUDY OBJECTIVES IN ETHICAL PERSPECTIVE, A BACKGROUND 
The objective of the project described in this thesis, funded under the 'innovation' 
subprogram of the Health Promotion and Disease Prevention Programme 1998-
2002 of the Health Research and Development Council of the Netherlands 
(ZonMw), was to study the significance of genetic variation in certain regions of 
detoxification genes with respect to colorectal adenoma risk and risk modulation 
by various plant food components. Its ultimate goal was described in the project 
proposal as the provision of "the necessary knowledge on the interaction between 
the genotype of an individual and plant food components in order to enable 
genotype-based dietary counselling aimed at colorectal cancer 
biochemoprevention". ZonMw aims to "allow the innovation cycle to flourish and 
help create a cutting-edge society", by actively promoting exchange of ideas, 
knowledge and experience among all relevant stakeholders (identified as health 
researchers, health professionals, patients/consumers and the general public), 
along "a single 'knowledge continuum': from basic, strategic and applied research 
to daily health care services" (www.zonmw.nl). Thus, implementation of generated 
knowledge plays an important role. In the project proposal, no difficulties were 
expected there: "Once the required genetic and biochemical knowledge will be 
available, the ensuing implementation into practice will be relatively straight-
forward, and will essentially involve the creation of the necessary information 
infrastructure allowing effective dietary guidance, expecially for those at elevated 
risk to develop colorectal cancer. The chances for practical implementation of such 
a cancer prevention strategy are particularly good, since no complex or disturbing 
life style intervention is needed, but only a dietary adaptation, which is likely to be 
well-acceptable to the general public”. The introduction of such a technique, 
however, has ethical implications on an individual and a societal level. Realising 
this, ZonMW granted in subprogram 3 'implementation aspects' of the Prevention 
Programme 1998-2002, a research proposal by the Bioethics Institute Utrecht 
(Brom, Verweij and Meijboom) that deals with the ethical issues raised by the 
concept of personalised diets. Researchers are part of the "innovation cycle". As 
such, they might reasonably be attributed a responsibility to account for the ethical 
and societal implications of the knowledge they generate. During the stage of 
generating knowledge, choices are made by researchers. A second research 
proposal triggered by the process of studying genetic information consisted of an 
ethnographic exploration of normativity in biomedical research (Nelis). To what 
degree do choices in the research process determine the choices for consumers 
once the knowledge can be implemented? 
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Colorectal cancer is a significant cause of morbidity and mortality in the 
Netherlands and worldwide. Consumption of fruits and vegetables is thought to 
protect against the development of colorectal tumors. One possible mechanism is 
the induction of detoxification enzymes such as glutathione S-transferase (GST) 
and NAD(P)H:quinone oxidoreductase (NQO1) by fruit and vegetable 
components. These enzymes reduce the levels of carcinogens in the cells and 
tissues and thus contribute to the reduction of DNA damage and cancer risk. 
The strength of the inverse association is uncertain, however. An explanation 
for this may be the difficulty of valid and reproducible fruit and vegetable 
measurement. Another explanation may be interindividual genetic variation and 
its interaction with diet that has not been considered enough. GSTs and NQO1 are 
known to be polymorphic. These polymorphisms may influence the effect the 
presumed effect of fruits and vegetables. This may especially be true for 
polymorphisms in the regulatory regions of the genes, affecting individuals’ 
responsiveness.  
In previous studies, GST levels and activities have been noted to be higher by 
consumption of cruciferous and allium vegetables and citrus fruits. However, 
results are inconsistent. Rarely is more than one fruit and vegetable subtype or 
more than one GST isoenzyme considered, and often blood is used as a surrogate 
tissue. Genetic polymorphisms are usually not taken into account. For NQO1 there 
are little data in humans. Also, with respect to further integrated measures in 
colorectal carcinogenesis and prevention, such as adenomas, the interaction 
between polymorphisms in GST and NQO1 and consumption of fruits and 
vegetables is not sufficiently known. In addition, from previous research, little is 
known about polymorphisms in GST or NQO1 regulatory regions. 
In this thesis, we evaluated fruit and vegetable consumption and different 
polymorphisms in GSTA1, GSTP1 and NQO1 in relation to the expression and 
enzymatic activity of GSTA1, GSTP1 and NQO1 in human rectum (endpoint 1), as 
target tissue, and white blood cells, as possible surrogate tissue. Also, we evaluated 
genotype-diet interactions in relation to the occurrence of colorectal adenomas 
(endpoint 2). This can enlarge scientific insights in aspects of carcinogenesis and 
cancer prevention and may lead to the identification of specific groups suitable for 
nutritional intervention. 
With regard to the first endpoint, enzyme phenotype (i.e. mRNA level, enzyme 
level, enzymatic activity level), the following research questions were formulated:  
1) Are genetic polymorphisms in regulatory and coding DNA sequences of 
GSTP1, GSTA1 and NQO1 associated with altered GST and NQO1 enzyme 
phenotype?
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2) Is recent fruit and vegetables consumption associated with altered GST and 
NQO1 enzyme phenotype? 
3) Does high fruit and vegetables consumption modulate enzyme phenotype in 
combination with specific genotypes (is there gene-environment interaction)? 
4) Is white blood cell GST and NQO1 enzyme phenotype a good surrogate 
measure for colorectal GST and NQO1 enzyme phenotype?  
To answer these questions, an observational phenotyping study was 
conducted among 94 sigmoidoscopy patients without colorectal inflammation or 
cancer. Polymorphisms in GSTA1, GSTP1, GSTM1, GSTT1, NQO1 and NFE2L2 
were determined, recent fruit and vegetable consumption was assessed by food 
record, and GST en NQO1 enzyme levels and activities were measured in rectal 
biopsies and white blood cells. 
In chapter 2, the results for the GSTs are described. Rectal GST isoenzyme 
levels differed between those with and without recent consumption of Alliaceae, 
Cucurbitaceae, Apiaceae and citrus fruit. Rectal GST activity, however, was not 
clearly influenced by fruit and vegetable consumption. It was most significantly 
determined by the GSTP1 c.313A>G polymorphism; compared to the 313AA 
genotypes, the 313AG and 313GG genotypes showed 36 and 67 nmol/min.mg 
protein (p<0.001) lower GST activity, respectively. The correlation between rectal 
and white blood cell GST activities was low (r=0.40, p<0.001), and the relevance of 
the various genetic and dietary factors appeared to differ between the two tissues.  
Chapter 4 describes the results for NQO1. Consumption of fruits and 
vegetables did not yield higher mRNA level or activity, but rather appeared to 
have a repressive effect. Rectal NQO1 activity was higher among NQO1 609CC-
genotypes as compared to 609CT-genotypes (p<0.0001; 609TT-genotypes were 
absent), whereas mRNA was higher among 609CT-genotypes (p<0.001). mRNA 
and activity correlated among NQO1 609CC-genotypes (r=0.50, p=0.0001) but not 
among 609CT-genotypes (r=0.14, p=0.45). The NFE2L2 -684A-allele was associated 
with higher NQO1 mRNA levels (p=<0.05). The other polymorphisms did not 
affect phenotype significantly. Rectal and white blood cell NQO1 activities did not 
correlate.  
With regard to the second endpoint, colorectal adenomas, the following 
research questions were formulated:  
1) Are genetic polymorphisms in regulatory and coding DNA sequences of 
GSTP1, GSTA1 and NQO1 associated with altered adenoma occurrence? 
2) Is fruit and vegetable consumption associated with altered adenoma 
occurrence? 
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3) Is fruit and vegetable consumption associated with a different adenoma 
occurrence between genotypes (is there gene-environment interaction)? 
In a case-control study among 1477 endoscopy patients (746 adenoma cases 
and 698 controls), GSTA1, GSTP1, GSTM1, GSTT1, NQO1 and NFE2L2 
polymorphisms were determined and habitual fruit and vegetable consumption 
was assessed by food frequency questionnaire.  
In chapter 3, the results for the GSTs are described. High cruciferous vegetable 
consumption was slightly positively associated with colorectal adenomas, odds 
ratio (OR) 1.15, 95% confidence interval (CI) 0.92-1.44. For GSTP1, a positive 
association with higher cruciferous vegetable intake was only apparent in 
individuals with the low activity GSTP1 genotype (GG genotype, OR 1.94; 95% CI 
1.02-3.69), contrary to our hypothesis. This interaction was more pronounced in 
men, with higher age and with higher meat intake. The GSTA1 polymorphism may 
have a modifying role as well: the OR for higher intake compared to lower intake 
was 1.57 (0.93-2.65) for individuals homozygous for the low expression variant (TT 
genotype). This appeared to be stronger with younger age and higher red meat 
intake. Cruciferous vegetable consumption and the combined GSTA1 and GSTP1 
genotypes showed a statistically significant interaction (p for interaction=0.034). 
The GSTM1 and GSTT1 genotypes did not seem to modify the association between 
cruciferous vegetable intake and colorectal adenomas.  
Chapter 5 describes the results for NQO1. The NQO1 609CT genotype was 
associated with a higher adenoma risk (OR 1.27, 95% CI 1.00-1.62) compared to the 
609CC genotype, whereas the 609TT genotype was not (OR 1.03, 95% CI 0.56-1.88). 
The higher risk with the NQO1 609CT-genotype was seen among smokers (OR 
1.96, 95% CI 1.40-2.76), but not among non-smokers (OR 0.91, 95% CI 0.62-1.35; 
interaction p=0.030). Fruit and vegetable consumption did not protect smokers 
from adenomas and did not interact with the NQO1 609C>T polymorphism or the 
NFE2L2 polymorphisms. A higher adenoma risk seen with high fruit and vegetable 
consumption among NQO1 -718GG genotypes was absent among -718GA 
genotypes (p for interaction=0.071). Gene-gene interactions were observed between 
the NQO1 609C>T and NFE2L2 -686A>G polymorphisms (interaction p=0.056) and 
between the NQO1 -718 G>A and NFE2L2 -650C>A polymorphisms (p for 
interaction=0.013).  
In chapter 6, the main findings are summarized and placed in a broader 
context of methodology and concepts, and their implications are discussed. The 
focus of the chapter is on the concept of polymorphism functionality, interpreted 
from and structured into different perspectives: molecular, physiological, 
epidemiological and societal. These represent a continuum of increasing 
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integration levels. Emphasis is on the physiological and epidemiological 
perspective.  
It remains uncertain whether the GSTA1, GSTP1 and NQO1 genes contain 
regulatory polymorphisms with experimentally shown functional induction 
differences in relation to fruit and vegetable components (molecular perspective).  
It was, however, clearly seen that GSTA1, GSTP1 and NQO1 contain 
polymorphisms with consequences for enzyme phenotype. Different botanically 
defined fruit and vegetable subtypes may be capable of upregulating or 
downregulating enzyme phenotype. The effect of polymorphisms and fruit and 
vegetable consumption may be interactive in enzyme phenotype, but this could 
not clearly be shown. White blood cells are probably not a good surrogate tissue 
for rectum with respect to GST and NQO1 enzyme phenotype (physiological 
perspective).  
The lower enzyme activity for GSTP1/GSTA1 and NQO1 that is the result of 
genetic variation may lead to a slightly increased colorectal adenoma risk in 
combination with high consumption of certain fruits and vegetables. 
Methodologically, it cannot be ruled out that specific fruits and vegetables actually 
confer some unfavourable effects in certain subgroups, but it also cannot be ruled 
out that some unknown confounding factor or selection bias plays a role 
(epidemiological perspective).  
It is by no means clear that polymorphisms will ever have a legitimate place in 
(nutritional) prevention strategies. If they should, we must take social, legal and 
ethical issues into account (societal perspective). 
 The relation between fruit and vegetable consumption and biotransformation 
enzymes in cancer prevention is complex. From the example of two important 
biotransformation enzyme systems, it is not clear what the true integrated effect of 
total fruit and vegetable consumption, or their subtypes, is on the capacity to 
detoxify carcinogens in the colorectum. Information contributing to the 
establishment of dietary advice on a high-risk group level (let alone on an 
individual level) to prevent colorectal cancer was not delivered. In a larger picture, 
fruit and vegetable components may affect an array of anti-cancer mechanisms 
besides biotransformation, may affect organs (and thus cancer sites) differently and 
may affect disease etiologies differently. The total picture is not clear yet. On a 
population level, diverse high fruit and vegetable consumption is found to be 
beneficial for human health. Whether there are individual exceptions to this 
paradigm remains to be seen.  
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In het onderzoek dat in dit boekje beschreven wordt, is een grote rol weggelegd 
voor het begrip ‘genetische variatie’. Onderliggende aanleiding voor het 
onderzoek is het voorkómen van darmkanker. Hieronder worden eerst de 
begrippen ‘genetische variatie’ en ‘kanker’ kort toegelicht en vervolgens wordt het 
proefschrift samengevat.  
Beide begrippen, genetische variatie en kanker, hebben betrekking op DNA. 
Het DNA is een code, aanwezig in elke cel, die uitgedrukt wordt in de letters A, G, 
C  en T. Deze aaneenschakeling van letters bevat de informatie voor de aanmaak 
en het functioneren van allerlei stoffen die tezamen ons lichaam draaiende houden. 
Genetische variatie. De DNA code bestaat uit ongeveer 3 miljoen letters. Er zijn per 
cel twee versies van de DNA code, 1 geërfd van de vader en 1 van de moeder. Aan 
de basis van elk kenmerk staan dus eigenlijk twee codes die het tot uiting komen 
ervan bepalen. Die twee stukjes informatie kunnen voor sommige letters 
verschillen: dat is genetische variatie. Als de stukjes verschillen, dan ben je 
‘heterozygoot’ (bijv. ‘AG’).  Als de twee stukjes hetzelfde zijn, dan ben je 
‘homozygoot’ (bijv. ‘AA’). Twee individuen kunnen ook homozygoot zijn voor een 
ander stukje (bijv. individu 1 ‘AA’ en individu 2 ‘GG’). Een heel zichtbaar 
voorbeeld van genetische variatie is het kenmerk ‘oogkleur’. Maar ook bijv. in de 
aanmaak en het functioneren van een (ontgiftings)eiwit kan genetische variatie een 
rol spelen. De plek van de variatie kan ook nog een rol spelen. Er is meer en 
minder functioneel DNA, dus met meer of minder consequenties als er een 
verandering in is. Grofweg zijn er twee typen functioneel DNA: coderend en 
regulerend DNA. Coderend DNA bevat de code voor de bouw van eiwitten, welke 
allerlei belangrijke functies in het lichaam vervullen. Regulerend DNA zorgt er 
voor dat de eiwitten op het juiste moment in- of juist uitgeschakeld worden. 
Kanker. Kanker is een ziekte van het DNA. Elke cel zorgt er normaliter zorgvuldig 
voor, met de hulp van allerlei ingebouwde beschermingsmechanismen, dat het 
DNA in goede staat blijft. Dit is erg belangrijk, want als het DNA aangetast wordt, 
kan het gebeuren dat ook het mechanisme, dat verantwoordelijk is voor de 
celgroei, wordt ontregeld en dat de natuurlijke rem hierop verloren gaat. De cel 
gaat dan in het wilde weg groeien en andere cellen, weefsels en organen 
overwoekeren. Dit is kanker. De cellen van de dikke darm vernieuwen heel vaak  
en hierdoor kan de groei vaker fout gaan. Daarnaast staan ze ook veel in contact 
met stoffen van buitenaf. De dikke darm is daarom erg kwetsbaar voor ongezonde 
voedingspatronen. 
Samenvatting van het proefschrift. Achtergrond. Dikke darm kanker is een 
belangrijke oorzaak van ziekte en sterfte in Nederland en in de wereld. Er wordt 
gedacht dat consumptie van groenten en fruit beschermt tegen het ontstaan van 
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dikke darm tumoren. Een mogelijke reden hiervoor is dat het de aanmaak van 
ontgiftingseiwitten bevordert. Ontgiftingseiwitten, zoals glutation-S-transferases 
(GSTs) en NAD(P)H:quinon oxidoreductase (NQO1). Deze ontgiftingseiwitten 
pakken stoffen aan die schadelijk zijn voor het DNA en zorgen er voor dat de 
hoeveelheid van deze stoffen niet te groot worden. Zo wordt voorkomen dat deze 
stoffen schade aan DNA aanrichten en daarmee de kans op kanker vergroten. 
Eerder onderzoek. In welke mate groenten en fruit beschermend werken is echter 
onduidelijk. Een verklaring hiervoor zou kunnen zijn dat het erg moeilijk is om de 
consumptie van groenten en fruit te meten. Een andere mogelijke verklaring is dat 
er tussen mensen genetische verschillen zijn in de manier waarop de 
ontgiftingseiwitten reageren op groenten en fruit. Eerdere studies hebben laten 
zien dat de hoeveelheid en de activiteit van de GSTs hoger wordt na de 
consumptie van groenten en fruit, met name van koolsoorten en ui-achtigen. In de 
meeste studies is slechts naar 1 type eiwit en 1 type groente of fruit gekeken. 
Meestal is niet in de darm gekeken, maar alleen in bloed. Ook is niet vaak naar 
genetische variatie gekeken. Met betrekking tot NQO1 zijn heel weinig gegevens 
bekend. Tevens is weinig informatie beschikbaar over het samenspel tussen 
groenten en fruit en genetische variatie in het ontstaan van dikke darmkanker of 
darmpoliepen, een mogelijk voorstadium van kanker. Verder is niet bekend of er 
genetische variatie is specifiek in regulerende regio’s van de genen. 
Het huidige onderzoek. In de studies die in dit proefschrift beschreven worden, is 
niet daadwerkelijk naar kanker gekeken. Eén uitkomstmaat was de hoeveelheid en 
activiteit van de GST en NQO1 ontgiftingseiwitten in het laatste stukje van de 
dikke darm (eindpunt 1). Er is onderzocht wat de invloed is van groente- en 
fruitconsumptie en genetische variatie in GSTA1, GSTP1, en NQO1 hierop. Ook is 
dit bekeken in witte bloedcellen. Een andere uitkomstmaat was de aanwezigheid 
van darmpoliepen (eindpunt 2), die op zichzelf niet kwaadaardig zijn, maar 
waarvan wel gedacht wordt dat ze bij veel darmkankers een voorstadium zijn 
geweest. Er is onderzocht hoe groente- en fruitconsumptie en genetische variatie 
mogelijk samenspelen bij het ontstaan hiervan. Dit kan meer inzicht geven in 
bepaalde aspecten rondom het ontstaan van kanker. Ook kan het er toe leiden dat 
bepaalde groepen mensen geïdentificeerd worden die meer baat hebben bij het 
eten van groenten en fruit. 
Wat betreft de eerste uitkomstmaat, de hoeveelheid en activiteit van de 
ontgiftingseiwitten, werden de volgende onderzoeksvragen geformuleerd: 
1) Zijn er genetische variaties in de regulerende en coderende gebieden van 
GSTP1, GSTA1 en NQO1, die samenhangen met verschillen in GST- en NQO1-
hoeveelheden en -activiteiten? 
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2) Houdt recente consumptie van groenten en fruit verband met verschillen 
GST- en NQO1-hoeveelheden en -activiteiten? 
3) Kan een hoge groente- en fruitconsumptie de GST en NQO1 hoeveelheid en 
activiteit veranderen in combinatie met specifieke groepen van genetische variatie? 
4) Is de hoeveelheid en activiteit van de GSTs en NQO1 in witte bloedcellen een 
goede afspiegeling van de hoeveelheid en activiteit van de GST’s en NQO1 in de 
darm? 
Om deze vragen te beantwoorden, is informatie over de voeding verzameld en 
zijn stukjes darmweefsel en bloed onderzocht bij 94 mensen, die de polikliniek 
bezochten voor een kijkonderzoek van de dikke darm. Bij dezen mensen zijn 
genetische variaties in verschillende GST’s, in NQO1 en in NFE2L2 bepaald en de 
recente inname van groenten en fruit is gemeten door middel van een 
voedingsdagboekje. De hoeveelheid en activiteit van de GSTs en NQO1 is gemeten 
in weefsel van het laatste stukje van de dikke darm, d.w.z. het rectum, en in witte 
bloedcellen. Wat betreft NQO1 is in de darm ook mRNA gemeten, een soort 
overgangsvorm tussen DNA en eiwitten.  
In hoofdstuk 2 worden de resultaten beschreven voor de GST’s. GST 
hoeveelheden in het rectum verschilden tussen degenen die recent ui-achtigen, 
komkommer-achtigen, schermbloem-achtigen en citrus-fruit hadden gegeten en 
degenen die dat niet hadden gedaan. De GST activiteit in het rectum werd echter 
niet duidelijk beïnvloed door groente- en fruitconsumptie. De activiteit werd 
voornamelijk bepaald door een genetische variatie in GSTP1 (313A>G): vergeleken 
met de 313AA varianten, hadden de 313AG en 313GG varianten respectievelijk een 
36 en 67 nmol/min.mg eiwit lagere GST activiteit. De correlatie tussen de activiteit 
in de darm en in witte bloedcellen was laag (r=0,4) en de verscheidene genetische 
en voedingsfactoren leken een andere betekenis te hebben voor de twee weefsels. 
Hoofdstuk 4 beschrijft de resultaten voor NQO1. De inname van groenten en 
fruit ging niet gepaard met meer mRNA of een grotere eiwitactiviteit, maar eerder 
met minder mRNA en een lagere activiteit. De NQO1 609CC varianten hadden een 
hogere rectale NQO1 activiteit vergeleken met de 609CT varianten (er waren geen 
609TT varianten). Er was een correlatie tussen mRNA en activiteit voor de 609CC 
varianten (r=0,5), maar niet voor de 609CT varianten (r=0,14). De NFE2L2 -684A-
variant hing samen met een hogere hoeveelheid NQO1 mRNA. De andere 
varianten beïnvloedden mRNA of activiteit niet. De NQO1 activiteit in rectum 
correleerder niet met de activiteit in witte bloedcellen. 
Met betrekking tot de tweede uitkomstmaat, de aanwezigheid van 
darmpoliepen, werden de volgende onderzoeksvragen geformuleerd: 
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1) Zijn er genetische variaties in de regulerende en coderende gebieden van 
GSTP1, GSTA1 en NQO1, die samenhangen met de aan- of afwezigheid van 
darmpoliepen? 
2) Hangt consumptie van groenten en fruit samen met de aan- of afwezigheid 
van darmpoliepen? 
3) Hangt groente- en fruitconsumptie samen met een verschil in de aan- of 
afwezigheid van darmpoliepen tussen verschillende genotypes? Met andere 
woorden, is er een samenspel tussen consumptie en genetische factoren? 
Dit is als volgt onderzocht. Onder 1477 mensen die de polikliniek bezochten 
voor een kijkonderzoek van de dikke darm is een patiënt-controle vergelijking 
gemaakt. Genetische variaties in verschillende GST’s, in NQO1 en in NFE2L2 zijn 
bepaald en de dagelijkse inname van groenten en fruit is gemeten door middel van 
een voedselfrequentie vragenlijst. 
In hoofdstuk 3 worden de resultaten van de GSTs beschreven. Een hoge 
inname van koolsoorten hing licht samen met een grotere kans op darmpoliepen. 
Kijkend naar GSTP1, dan was dit alleen zo voor mensen met het GSTP1 313GG 
genotype, dat gepaard gaat met een lagere GST activiteit. Dit was tegengesteld aan 
onze hypothese. Het samenspel was duidelijker te zien bij mannen, bij hogere 
leeftijd en bij hogere vleesinname. De GSTA1 variatie zou ook een modificerende 
rol kunnen spelen: de kans op darmpoliepen was hoger bij hogere kool-inname 
voor mensen met het -69TT genotype, dat gepaard gaat met een lagere hoeveelheid 
eiwit. Dit leek sterker te zijn bij een lagere leeftijd en hogere vleesinname. Voor 
mensen met varianten van beide genotypes was het samenspel statistisch 
significant. Voor de GSTM1 en GSTT1 varianten kon er geen dergelijk samenspel 
ontdekt worden. 
Hoofdstuk 5 beschrijft de resultaten voor NQO1. Het NQO1 609CT genotype 
hing samen met een groter darmpoliep risico vergeleken met het 609CC genotype, 
maar het 609TT genotype had geen groter risico. Dit grotere risico was zichtbaar bij 
rokers, maar niet bij niet-rokers. Groente- en fruitconsumptie beschermde rokers 
niet. Er was geen samenspel met de NQO1 609C>T en NFE2L2 variaties. Het was 
wel opvallend dat het hogere polieprisico dat werd gezien bij hogere consumptie 
van groenten en fruit voor mensen met het NQO1 -718GG genotype, niet werd 
gezien bij mensen met het -718GA genotype. Er leek een samenspel te zijn tussen 
de NQO1 609C>T en NFE2L2 -686 varianten en tussen de NQO1 -718 en NFE2L2-
650 varianten).  
In hoofdstuk 6 worden de hoofdbevindingen nog eens op een rijtje gezet, in 
bredere context geplaatst en worden de implicaties besproken. Uitgangspunt 
hierbij is het concept ‘functionaliteit’. Dit concept wordt in verschillende 
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perspectieven geplaatst: moleculair, fysiologisch, epidemiologisch en 
maatschappelijk. Deze perspectieven weerspiegelen een continuüm van niveaus 
die steeds meer geïntegreerd zijn. De nadruk is op het fysiologische en 
epidemiologische perspectief.  
Het blijft onduidelijk of de onderzochte genen variaties bevatten in het 
regulerende DNA met experimenteel aangetoonde verschillen in hun reactie op 
groente- en fruitcomponenten (moleculair perspectief). 
De GSTs en NQO1  bevatten wel duidelijk variaties die gevolgen hebben voor 
de hoeveelheid en activiteit van de eiwitten. Verschillende typen groenten en fruit 
zouden de ontgiftingseiwitten kunnen bevorderen of juist tegengaan. Wellicht is er 
een samenspel tussen groenten en fruit en genetische variaties, maar dit kon niet 
duidelijk aangetoond worden. Witte bloedcellen zijn geen goed surrogaatweefsel 
voor de dikke darm wat betreft GSTs en NQO1 (fysiologisch perspectief). 
De lagere eiwitactiviteit voor GSTP1/GSTA1 en NQO1, het resultaat van een 
genetische variatie, zou in combinatie met hogere groente- en fruitinname kunnen 
leiden tot een groter risico op darmpoliepen. Methodologisch kan het niet 
uitgesloten worden dat bepaalde groente- en fruitsoorten ongunstige effecten 
opleveren in bepaalde subgroepen, maar het kan ook niet uitgesloten worden dat 
een onbekende verstorende variabele of selectie ‘bias’ een rol speelt 
(epidemiologisch perspectief). 
Het is nog niet zo vanzelfsprekend dat genetische variaties ooit terecht een 
plaats krijgen in (op voeding gerichte) preventie strategieën. Hoe dan ook moeten 
sociale, wettelijke en ethische zaken ook in beschouwing genomen worden. 
De relatie tussen groente- en fruitconsumptie en ontgiftingseiwitten in kanker 
preventie is complex. Uit het voorbeeld van de twee belangrijke onderzochte 
ontgiftingssystemen komt niet duidelijk naar voren wat het werkelijke, 
geïntegreerde effect is van groente- en fruitconsumptie op het vermogen van de 
darm om schadelijke stoffen te ontgiften. De studies hebben geen informatie 
opgeleverd om voedingsadvies te kunnen geven aan bepaalde genetische hoog-
risico groepen (laat staan op individueel niveau) om dikke darm kanker te 
voorkomen. In het grotere geheel beschouwd, kunnen groente- en 
fruitcomponenten een scala aan kankerbeschermende mechanismen beïnvloeden, 
naast ontgifting, kunnen ze verschillende organen anders beïnvloeden en kunnen 
ze verschillende ziekten anders beïnvloeden. Het totale plaatje is nog onduideljk. 
Op populatie-niveau wordt gevarieerde consumptie van groenten en fruit als 
gunstig gezien voor de gezondheid van de mens. Of hier op individueel niveau 
uitzonderingen op zijn, valt nog te bezien. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dankwoord 
 
   
 
178 Dankwoord 
 
Dit proefschrift kwam tot stand door de bijdrage van velen.  
Iedereen hartelijk dank daarvoor!  
Hieronder noem ik, met een greep uit vele mogelijke woorden: 
 
DANK 
 
Co-promotoren: 
Ellen Kampman: voor alle kennis en kunde 
Jac Aarts: voor grondige inzet en openheid voor vakoverstijgende zaken 
Promotor: 
Frans Kok: voor inzicht en structuur 
 
Projectdeel Toxicologie, Wageningen Universiteit: 
Ivonne Rietjens: voor de welkome kritische opmerkingen 
Anne-Marie Boerboom: voor het werk in het moleculaire deel van het project 
Liesbeth Op den Camp: voor het harde werk in het lab 
 
Humane Voeding, Wageningen Universiteit: 
Marleen Visker: voor de belangrijke bijdragen aan het project, van sequencing tot 
kritisch co-auteurschap 
Elgin Lichtenauer: voor de hulp bij de NQO1 genotypering 
Lucy Okma: voor de ondersteuning bij de benodigde labmaterialen 
Afdeling Diëtetiek: voor de voedingsgegevens, en met name Petra Vissink: voor de 
flexibiliteit en het onderbreken van vrije dagen 
Dione Bouchaut: voor de hulp bij de figuren 
 
GF-studie: 
De GF-studie deelnemers: voor alle inzet onder lastige omstandigheden  
UMC St. Radboud Universiteit te Nijmgen: 
Fokko Nagengast: voor de mogelijkheid om de GF-studie te starten en uit te voeren 
Wilbert Peters, Hennie Roelofs, René te Morsche en Annie van Schaik: 
voor de ondersteuning op het lab MDL; Wilbert: voor de GST-kennis 
Marloes Berkhout: voor de gezelligheid op de Nijmeegse werkplek 
Endoscopie: voor de flexibele houding tijdens het werk; speciale dank voor de 
bloedafnames 
Canisius-Wilhelmina Ziekenhuis te Nijmegen: 
Adriaan Tan: voor de mogelijkheid om de GF-studie uit te voeren en verdere hulp  
Endoscopie: voor de flexibele houding tijdens het werk 
Dankwoord 179 
 
 
POLIEP-studie:  
De POLIEP-studie deelnemers: voor alle inzet 
De ziekenhuis-medewerkers: voor het mogelijk maken van de POLIEP-studie 
Het POLIEP-team van Humane Voeding: Petra Wark, Maureen van den Donk, 
Edine Tiemersma, Brenda Diergaarde, Maria van Vugt: voor de samenwerking  
Jan Harryvan en Annelies Bunschoten: voor alles rondom DNA en genotyperingen 
 
Eva van Soest, Cordny Nederkoorn, Wijnand Laan en Bram-Sieben Rosema: voor 
het meedenken en het praktische werk tijdens de MSc-projecten 
 
Mijn mede-aio’s: voor luisterende oren en gezellige momenten 
Speciale dank voor de PhD-tour groep van 2005: super-reis 
 
Mijn achtereenvolgende kamergenoten Siti Muslimatun, Mark Boekschoten en 
Cora Busstra: voor jullie gezelschap 
Speciale dank aan Cora: voor het aanhoren van frustraties en kolf-gezoem, voor de 
lay-out aanwijzingen welke de realisatie van dit proefschrift erg geholpen hebben  
 
Annemiek Nelis, Franck Meijboom, Frans Brom: voor de uitbreiding van mijn 
inzichten op gebied van ethiek en sociale wetenschappen 
 
Mijn RIVM collega’s: voor de interesse en sfeer 
 
Speciaal nog eens: mijn paranimfen Maureen en Marleen; Maureen: voor het 
verblijden van de tijd in Wageningen, Marleen: voor alle positieve woorden. 
Beide dank dat jullie naast mij willen staan 
 
Vrienden en familie: voor alle steun, op velerlei manieren.  
Speciale dank aan: 
Mijn vriendinnetjes: voor alle zorgen en gezelligheid 
Mimi en Camille: voor jullie belangstelling en steun. Camille: voor de wetenschap 
dat de kaakjes met Jens fantastisch zouden zijn geweest 
Mijn ouders: voor het besef dat jullie altijd bereid zijn te helpen en voor alle hulp 
die jullie al geboden hebben 
Jens: voor je enorme enthousiasme en vrolijkheid, voor je knuffeltjes en kusjes 
Milo: voor zó veel, voor de blijdschap om thuis te zijn 
 
Mariken
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Curriculum Vitae 
 
   
 
 
182 Curriculum Vitae 
 
ABOUT THE AUTHOR 
 
Mariken Joan Tijhuis was born on 14th April 1976 in Enschede, The Netherlands. 
She completed secondary school (St. Willibrord Gymnasium, Deurne) in 1994. In 
1995 she started her studies of Health Sciences at the University of Maastricht, 
specialising in Nutrition and in Epidemiology. Her MSc research and thesis were 
on ‘nutrition, homocysteine and heart failure’. In 2001 she started the PhD-project 
of which this thesis is the final result. It comprised the conduct of observational 
studies, the writing of scientific publications and the attendance of several courses 
and conferences, see below. Mariken is currently employed at the Center for 
Nutrition and Health at the National Institute for Public Health and the 
Environment in Bilthoven. 
 
 
PUBLICATIONS 
 
Full-text 
• Tijhuis MJ, Wark PA, Aarts JMMJG, Visker MHPW, Nagengast FM, Kok FJ,  Kampman E. GSTP1 
and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk. 
Cancer Epidemiol Biomarkers Prev 2005,14,2943-2951.  
• Tijhuis MJ, Visker MHPW, Aarts JMMJG, Peters W, Kok FJ, Kampman E. Genotype-Phenotype 
Relations in Glutathione-S-Transferases and the Role of Fruit and Vegetable Consumption in a 
Dutch Sigmoidoscopy-Based Population. Carcinogenesis 2007;28,4,848-57. 
• Tijhuis MJ, Visker MHPW, Aarts JMMJG, Laan W, de Boer SY, Kok FJ, Kampman E. NQO1 and 
NFE2L2 polymorphisms, fruit and vegetable intake and smoking, and the risk of colorectal 
adenomas in an endoscopy-based population. Int J Cancer, in press. 
• Tijhuis MJ, Boerboom AMJF, Visker MHPW, Op den Camp L, Nagengast FM, Tan ACITL, Rietjens 
IMCM, Kok FJ, Aarts JMMJG, Kampman E. The influence of fruit and vegetable consumption and 
genetic variation on NAD(P)H:quinone xidoreductase (NQO1) phenotype in an endoscopy-based 
population. Nutrition and Cancer, in press. 
• Siezen CL, Tijhuis MJ, Kram NR, van Soest EM, de Jong DJ, Fodde R, van Kranen HJ, Kampman E. 
Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a 
polymorphism in peroxisome proliferator-activated receptor delta. Pharmacogenet 
Genomics.2006,16(1):43-50. 
Abstracts 
• van Soest E, Tijhuis MJ, Tiemersma E, Kampman E. The association between 
prostaglandinsynthetase inhibitors and colorectal adenoma: a Dutch case-control study [in Dutch]. 
In: Heterogeniteit, kwantiteit en toepasbaarheid,  27ste WEON symposium, programma en 
abstracts 2002. ISBN 90-9015597-X.  
• Tijhuis MJ, Wark PA, Aarts JMMJG, Kampman E. Consumption of Brassica vegetables, 
glutathione-S-transferase genotypes and the risk of colorectal adenomas. [In Dutch]. In: Preventie 
& interventie : 30ste WEON symposium, programma en abstracts 2005. ISBN 90-6754-906-1.  
Curriculum Vitae 183 
 
 
• Wark PA, Van der Kuil W, Ploemacher J, Tijhuis MJ, Braam H, Van Muijen GNP, Van ’t Veer P, 
Kampman E. Meat  consumption, NAT2 genotype and colorectal adenomas with and without a K-
ras mutation [In Dutch]. In: Preventie & interventie : 30ste WEON symposium, programma en 
abstracts 2005. ISBN 90-6754-906-1.  
• Tijhuis MJ, Wark PA, Aarts JMMJG, Visker MHPW, Nagengast FM, Kok FJ, Kampman E. 
Cruciferous Vegetable Consumption, Glutathione-S-Transferase Polymorphisms, and Colorectal 
Adenoma Risk in a Dutch Case-Control Study. J. Nutr. 135: 3044S, 2005. 
• Tijhuis MJ, Visker MHPW, Aarts JMMJG, Peters W, Kok FJ, Kampman E. Genotype-Phenotype 
Relations in Glutathione-S-Transferases and the Role of Vegetable Consumption in a Dutch 
Sigmoidoscopy-Based Population. J. Nutr. 135: 3044S, 2005. 
 
 
TRAINING 
 
Discipline-specific activities 
• Masterclass Nutrigenomics, WUR/VLAG/OSPT/HNE, 2001 
• Molecular Epidemiology, IARC, 2001 
• Geriatric Nutrition, VLAG, 2004 
• Searching Genes of Complex Disorders, ESP, 2004 
• Bioinformatics in Medicine, ESP, 2004 
• History of Epidemiological Ideas, ESP, 2005 
• Annual Epidemiology Symposium (WEON) 2001, 2002, 2005 
• Nutrition and Cancer Conferences, Lyon 2001, Washington DC 2005 
• Meetings of Learned Societies on Nutrition, Cancer, SNPs, 2001-2006 
 
General courses 
• VLAG PhD Week, 2001 
• Organising and supervising MSc thesis work, WUR, 2003 
• Regression Analysis, ESP, 2005  
• The Future Genomics society, VLAG, MGS, Biosystems genomics, Society & 
Genomics and WCFS-CMSB, 2005 
• International Seminar: Genetically Tailor-made Diets: future prospects and 
ethical challenges, Bio-ethics Institute Utrecht University, 2005 
 
Optional courses and activities 
• Preparation of Research Proposal 
• Journal Club, 2001-2005 
• PhD Study Tour UK & Republic of Ireland, 2005 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The project described in this thesis was financially supported by the Netherlands 
Organisation for Health Research and Development (ZonMW), grant number: 
21000054, and the Dutch Digestive Diseases Foundation (MLDS), grant number WS 
00-31 
 
The printing of this thesis was financially supported by Wageningen University 
 
Printing: Ponsen en Looijen BV, Wageningen 
 
Cover: Prithivi & Akasha 
 
© Mariken J. Tijhuis 
